Skip to content
FrontierPicks

Filtered library · Conviction

LOW conviction · 568 dossiers

Every dossier the model currently rates LOW conviction — 568 names, with thesis, invalidation trigger, archetype and catalyst.

All dossiers
ARCB ArcBest Corporation fresh LOW The twice-tested $135.76/$135.89 shelf lost on the 2026-08-24 close of $134.45, a 4.2% drop taken with the whole transport complex after Trump's 50% Canada auto/truck/parts/steel tariff post. No issuer catalyst until Q3 results… Special situation · Freight & logistics · Cyclical industrials catalyst · ATEX Anterix Inc. fresh LOW The 2026-08-21 reclaim at $93.25 gave back to $90.38 on 2026-08-24 with RSI(14) at 29.8, the $88.20 shelf still holding on closes. No spectrum sale agreement announced in the 126 days since 2026-04-21 and no company item filed since… Defensive · Industrial power & grid · Squeeze & momentum setups catalyst · CNC Centene Corporation fresh LOW Margin-repair guide raise of 2026-07-28 stays fully priced: the 2026-08-24 close of $65.65 is 2.7% under the 2026-08-14 close of $67.47 and 4.5% below the $68.72 52-week high, with no analyst target moved since Argus on 2026-08-11.… Earnings inflection · Managed care & health services catalyst · DAVE Dave Inc. fresh LOW Beat-and-raise fully modelled by 13 firms and sold on the day; the recovery has now stalled under $358–360 for three weeks, with the 2026-08-24 close at $354.79 and RSI(14) at 31.8. No rating action since 2026-08-17 and nothing operating… Compounder · Fintech & consumer credit · Squeeze & momentum setups catalyst · DELL Dell Technologies Inc. fresh LOW One-session reclaim failed: the 2026-08-24 close of $433.19 is back under the 2026-08-11 shelf of $440.97, RSI(14) 41.3, 12.4% below the 08-13 high of $494.51. Morgan Stanley's 08-24 raise to $434 sets a target at the market while Evercore… Cyclical recovery · AI datacenter infrastructure catalyst · HNGE Hinge Health, Inc. fresh LOW Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating… Compounder · Managed care & health services · AI enterprise software catalyst · HPE Hewlett Packard Enterprise Company fresh LOW The one green close failed: 2026-08-24 closed $52.43, undercutting the 08-20 low close of $52.89 and marking seven of eight sessions lower off the 2026-08-13 high of $59.82, with no dated HPE news since 2026-08-19. The 2026-09-02 Q3 print… Special situation · AI datacenter infrastructure · AI enterprise software catalyst · JBHT J.B. Hunt Transport Services, Inc. fresh LOW The $267 floor broke: the 2026-08-24 close of $259.88 is ~5.7% below the prior session, on the day Washington set Canada auto, truck and parts tariffs to 50% from 2027-01-01. The freight-recovery re-rating now has no company datapoint… Compounder · Freight & logistics · Cyclical industrials catalyst · LSTR Landstar System, Inc. fresh LOW Supply-driven truckload repricing still unconfirmed on the weekly tape, but declines decelerated: FTR Week 33 (ended 2026-08-21) showed dry van -2c vs -7c prior, reefer +1.3c, loads +0.8%, against truck postings +4.4% and the demand index… Defensive · Freight & logistics · Managed care & health services catalyst · MRVL Marvell Technology, Inc. fresh LOW Custom-silicon ASIC royalty story intact, but the AI-semi theme is mid-correction — chips posted their worst month vs software on record (7/17) with money rotating into energy. Buying a falling sector with no confirmed higher low is the… Cyclical recovery · AI datacenter infrastructure · AI chips & memory catalyst · NTAP NetApp, Inc. fresh LOW Three sell-side targets near $210 in eleven days (Goldman 08-13, Citi 08-18, Evercore 08-24) have stopped moving the tape: $186.86 on 2026-08-24, 9.8% below the $207.08 high, RSI 46.4, with the 20-analyst average target $186.31 sitting at… Special situation · AI datacenter infrastructure · AI chips & memory catalyst · OSCR Oscar Health, Inc. fresh LOW Still maturing and range-bound: the 2026-08-24 close of $31.81 is the sixth session without a new high since the 2026-08-14 closing high of $32.76, and it sits 4.6% above the $30.40 consensus mean target. Short interest fell to 17.83M from… Earnings inflection · Managed care & health services catalyst · SEZL Sezzle Inc. fresh LOW Growth leg was retired by management's own 2026-08-06 H2 guide and the −33.89% gap; only a re-rating argument is live at 19.68x forward on the 2026-08-24 close of $117.93. That close lost the $118.02/$118.00 shelf with RSI(14) at 21.5,… Compounder · Fintech & consumer credit catalyst · SIMO Silicon Motion Technology Corporation fresh LOW Controller mix re-rating still rests on the untouched 2026-07-29 Q3 guide of $519–541M against ~$431.8M consensus, but the 2026-08-24 close of $243.18 gave back the whole 08-19/08-21 bounce and sits on the $238.51 shelf after a… Cyclical recovery · AI chips & memory · AI datacenter infrastructure catalyst · SNX TD SYNNEX Corporation fresh LOW Second-order AI re-rating still unconfirmed by company data, and the tape has now taken it back: the 2026-08-24 close of $243.65 leaves a three-month price change of +1.7% with RSI(14) at 27.3. The 11-analyst panel has not revised since… Theme leader · AI datacenter infrastructure · AI enterprise software catalyst · STX Seagate Technology Holdings PLC fresh LOW Maturing AI-storage supercycle with sell-side still chasing: Wells Fargo upgrade to Overweight $1,100 (7/10) and Citi Street-high $1,240 (7/13). But the DRAM ETF is down ~30% and Seagate's Q4 FY26 print ~2026-07-22 is a binary about two… Cyclical recovery · AI chips & memory · AI datacenter infrastructure catalyst · TXG 10x Genomics, Inc. fresh LOW First lower close of the run: 2026-08-24 at $63.80, 2.0% under the 2026-08-21 record close of $65.12, with price still above every published target (high mark Stephens $65, 08-12; 16-analyst average $49.54). No company item since the 08-06… Special situation · Medtech & diagnostics · AI enterprise software catalyst · UMC United Microelectronic Corp. fresh LOW Silicon-photonics pivot re-rated the ADR ~3x, but the July blowoff to $28.96 round-tripped -26% to $21.25 in days while sell-side finally upgraded (Macquarie Outperform 2026-07-14) — late-stage distribution behaviour. The 2026-07-29 Q2… Special situation · Semi foundry & equipment · Networking & optical catalyst · WDC Western Digital Corporation fresh LOW The 29% bounce off the 2026-07-28 low stalled: WDC closed $527.22 on 2026-08-03, −3.23% on a day its sector rose 0.58%, back under a rising 50-day at $562.65. Consensus (~$3.69B / $3.31–$3.35) still sits above the company's own $3.65B… Cyclical recovery · AI chips & memory · AI datacenter infrastructure catalyst · XMTR Xometry, Inc. fresh LOW JP Morgan assumed coverage Overweight with a $120 target on 2026-08-24 — the highest posted on the name — and the close only moved $83.59 to $84.58, a fourth straight session under the $85.00 June follow-on level. Seven positive sell-side… Theme leader · Cyclical industrials · Physical AI & robotics catalyst · XPO XPO, Inc. fresh LOW Record 79.9% adjusted LTL operating ratio and a raised full-year guide (2026-07-30) now sit against two negative July industry prints — ATA tonnage -0.5% YoY and Cass shipments -4.8% YoY. The $197.01 shelf gave way on the 2026-08-24 close… Compounder · Freight & logistics · Cyclical industrials catalyst · AAOI Applied Optoelectronics, Inc. fresh LOW The $110 shelf that defined the August leg is gone: the 2026-08-24 close of $107.63 fully unwinds the 2026-08-04 policy gap (pre-gap close $110.21), three sessions after a second $600,000,000 ATM was filed on 2026-08-21. Q2 revenue +86%… Cyclical recovery · Networking & optical catalyst · AEHR Aehr Test Systems fresh LOW Wafer-level burn-in toll on AI silicon: FY2027 guided $130–150M against $50.0M in FY2026, guide unamended. But the 2026-07-21 shelf at $98.91 gave way on the 2026-08-24 close of $96.43 — a fifth straight lower close from $145.61… Cyclical recovery · Semi foundry & equipment catalyst · AMSC American Superconductor Corporation fresh LOW Grid/advanced-conductor supplier to data-center and utility power; backlog still ~+40% YoY (~$280M), but the tape broke after the 2026-05-28 beat-and-soft-guide and a late-June Russell removal piled on passive selling. Below the lost ~$40… Cyclical recovery · Industrial power & grid catalyst · APLD Applied Digital Corporation fresh LOW BTC→AI landlord whose operating build (>1 GW contracted, ~$31B backlog, 175 MW live) has decoupled from an equity that halved from $49.65 to a $25.79 low, now bouncing off the $25.56 April base into a binary FY26 print on 2026-07-27.… Special situation · GPU cloud & neoclouds catalyst · ASML ASML Holding N.V. fresh LOW The $1,740 July band floor is being tested: the 2026-08-24 close of $1,740.13 sits on it after the $1,805 shelf reclaim failed. Consensus has been flat at $2,195 for a fourth reading, nothing ASML-dated resolves before 2026-10-14, and the… Cyclical recovery · Semi foundry & equipment catalyst · ASTS AST SpaceMobile, Inc. fresh LOW Deployment-cadence leg goes dead: the 2026-08-24 close of $62.35 (-9.2%, per GuruFocus) erased the 08-21 reclaim and broke below the 08-20 intraday low of $62.89, with BlueBirds 14/15/16 still undated 15 days after "ready to ship shortly."… Retail squeeze · Space economy catalyst · AVGO Broadcom Inc. fresh LOW The three-session bounce failed at the 200-day: $368.45 on 2026-08-21 gave way to $358.76 on 2026-08-24 with RSI(14) at 18.4 and no company-specific headline — a fourth straight close under a rising 200-day marked $369.20. The unwithdrawn… Cyclical recovery · AI chips & memory catalyst · AXTI AXT Inc fresh LOW The prior break level failed: 2026-08-24 closed $65.40, roughly a third below the 2026-08-17 intraday $97.79 and back at the $64.25 April secondary price, erasing almost the whole post-Q2 gap while contracted InP demand keeps building. The… Cyclical recovery · Semi foundry & equipment catalyst · CCJ Cameco Corporation fresh LOW Nuclear-uranium theme maturing and CCJ's structure has broken twice into improving news: mkt cap $44.79B (06-29) → ~$39.9B (07-25), ~$88, ~35% off the $135.24 high, absorbing a $17.5B federal AP1000 program and NJ's $24B plan. Barclays cut… Theme leader · Nuclear & uranium catalyst · CEG Constellation Energy Corporation fresh LOW Post-print reclaim still failing: $282.50 (2026-08-14) is the only close above the broken $281 shelf, and 08-24 printed $273.43 thirteen sessions after the beat-and-raise. Seven sell-side cuts since 07-27 against one raise, PJM's 2028/29… Theme leader · Nuclear & uranium catalyst · COIN Coinbase Global, Inc. fresh LOW Fourth session of the CLARITY repricing gave ground: adjusted close $179.48 on 2026-08-24 vs $186.49 on 08-21, RSI(14) 67.3 from 74.9, with the $160.20 gap floor still intact. The 08-24 tokenized-stocks launch on Base (Chainlink oracle,… Compounder · Crypto exchanges & financials catalyst · CRCL Circle Internet Group, Inc. fresh LOW Still a policy trade, but the first company-level support in weeks arrived: Bernstein's 2026-08-24 note reports USDC supply +$1.7B in a week after ~six months flat, reiterating $140 while Susquehanna raised to $92 on a Neutral. Circle has… Earnings inflection · Crypto exchanges & financials catalyst · IONQ IonQ, Inc. fresh LOW Broken gov-capital quantum leg, now publicly capitulated: seven-plus down weeks, an inverse-ETF complex up to +108%, and Cramer warning it off air on 2026-07-23. Washed out but not based, heading into a binary Q2 print (est. 2026-08-05 to… Retail squeeze · Quantum computing catalyst · IREN IREN Limited fresh LOW Neocloud re-rate has fully round-tripped: $33.62 close 7/17, -42% in 30 days, late-May Microsoft breakout base surrendered. Contracts intact ($9.7B MSFT, prepaid tranches) but Q3 AI revenue was only $17.3M vs a $3.4B ARR ambition, and… Special situation · GPU cloud & neoclouds catalyst · LITE Lumentum Holdings Inc. fresh LOW Optical-content-per-rack leg intact, but the cohort just repriced on a peer's dilution rather than on anything Lumentum said: the 2026-08-24 close of $830.17 sits 1.2% over the 2026-08-11 shelf at $820.59 after Applied Optoelectronics'… Cyclical recovery · Networking & optical catalyst · META Meta Platforms, Inc. fresh LOW Capex-into-revenue leg bought ~28% under the high while an Oakland courtroom sets the daily print. The 2026-08-24 close of $559.02 is the first close back above the $556 shelf broken 2026-08-19, RSI(14) 37.4. Executive testimony —… Compounder · Mega-cap AI platforms catalyst · MSTR Strategy Inc fresh LOW Eighth straight week with no bitcoin bought: the 2026-08-24 8-K shows ~$2.01B of common sold at an average near $109.88 into the rally, with 100% routed to STRC buybacks, a $5.1B USD Reserve and a new $1.59B "USD Cash" pool. Credit… Retail squeeze · Crypto exchanges & financials catalyst · MTUM fresh LOW The AI-memory leg MTUM rotated into at the May reconstitution has rolled over: SOX -20%+ from its June peak, memory names in a bear market, and the fund closed $302.09 on 2026-07-17, below the $310 shelf that defined the… Compounder · AI chips & memory · AI datacenter infrastructure catalyst · NNE Nano Nuclear Energy Inc. fresh LOW Nuclear-microreactor narrative has stopped converting news into demand: a Truist Hold/$22 initiation (7/14) and a Virginia consortium announcement (7/17) landed inside four sessions and NNE still printed a fresh 52-week low at $15.78… Compounder · Nuclear & uranium catalyst · OKLO Oklo Inc. fresh LOW Three straight cohort-driven sessions carried OKLO from the 2026-07-29 close of $36.84 to $43.33 on 2026-08-04, with no Oklo release behind any of them. The 2026-08-07 Q2 call is the binary. Earnings inflection · Nuclear & uranium catalyst · PL Planet Labs PBC LOW Every reported close since 8/14 has stepped down — $24.69 to $22.17 on 8/20 — the 50-day/200-day gap widened to $25.53 vs $26.55, and the 8/20 low of $21.57 sat four cents above the 8/3 close. The unrevised 6/4 guide (FY27 $425–441M, Q2… Compounder · Space economy catalyst · PLTR Palantir Technologies Inc. fresh LOW The 2026-08-21 breakout close of $179.94 did not hold: 2026-08-24 closed $175.89 (-2.25%), back inside the $171.04–$179.01 August range, with RSI(14) down to 60.9 from 79.0. No company input until roughly 2026-11-02, so the ~08-25 FINRA… Compounder · AI enterprise software catalyst · QBTS D-Wave Quantum Inc. fresh LOW Coverage supply keeps producing one-day rallies that do not hold: BMO's 2026-08-21 initiation at $35 closed shares $20.39 (+8.46%) on no company release, and 2026-08-24 gave it all back at $18.68 (-8.39%), also on no release. Three named… Retail squeeze · Quantum computing catalyst · QUBT Quantum Computing Inc. fresh LOW The 2026-08-21 group bounce round-tripped in one session — the 2026-08-24 close of $8.24 gave back the move to $8.92, with IonQ, Rigetti and D-Wave all off ~8.5% the same day. Price sits two cents above the $8.22 shelf, under a 50-day at… Retail squeeze · Quantum computing catalyst · RGTI Rigetti Computing, Inc. fresh LOW Quantum pure-play basket is in outright hype-cycle deflation: RGTI ~$14.19 (2026-07-17), -27% MoM, and the $14 shelf that held the May CHIPS-stake gap and the June executive-order pop has broken. Inverse quantum ETFs printing +108% and the… Retail squeeze · Quantum computing catalyst · SMR NuScale Power Corporation fresh LOW Funded wait on one unsigned ENTRA1–TVA power purchase agreement, with the company silent for twenty days since the 2026-08-05 Q2 release. The 2026-08-24 close of $9.05 gave back most of the bounce off the 2026-08-18 floor at $8.64 and… Earnings inflection · Nuclear & uranium catalyst · SPCX SpaceX (Space Exploration Technologies Corp.) fresh LOW Flight 14's ship catch is deferred (Musk, 2026-08-20); the mission is now a first orbital-class flight with ~20 Starlink V3, FCC window opening 2026-08-28. NVIDIA's 2026-08-24 release dated orbital compute — Starmind gen-1 on Vera Rubin… Compounder · Space economy · AI datacenter infrastructure catalyst · TSEM Tower Semiconductor Ltd. fresh LOW Picks-and-shovels silicon-photonics foundry leg has de-rated straight into the range where July's pre-arranged CEO sales printed: the 2026-08-24 close of $211.10 sits inside $210.33–$211.27 and 33.4% under the 2026-06-22 high, with no… Cyclical recovery · Semi foundry & equipment catalyst · TSLA Tesla, Inc. fresh LOW Cybercab has a hard date — 2026-09-03, Austin, invite-only — but the first session to price it went down: $348.95 on 08-24 vs $362.86 on 08-21, RSI(14) back to 61.0 from 72.7. Reporting says the rollout starts with employee rides, and… Compounder · EV & autonomous mobility catalyst · VST Vistra Corp. fresh LOW Weekly break confirmed but not extended: 2026-08-24 closed $135.66, 2.3% above the $132.66 May low that is also the 52-week floor. A Mizuho Outperform initiation at $169 and a reported CEO purchase of 2,000 shares at $135 both landed that… Theme leader · Nuclear & uranium catalyst · ARM Arm Holdings plc fresh LOW Data-center royalty doubled YoY for a second quarter, but Q2 FY27 royalty growth is guided to ~13% against 22% delivered. No Arm-specific disclosure has landed since 2026-07-29, so the bid is set by third parties — BofA's 2026-08-13… Cyclical recovery · AI chips & memory catalyst · BFLY Butterfly Network, Inc. fresh LOW Butterfly Embedded chip-licensing story got marquee validation — Midjourney's up-to-$74M/5yr full-body scanner on 40 Ultrasound-on-Chip modules (2026-06-18) plus 2nd partner Aleph Neuro (2026-06-25). Fundamentals still accelerating, but… Defensive · Medtech & diagnostics · AI chips & memory catalyst · COHR Coherent Corp. fresh LOW Copper-to-optical interconnect narrative intact as a business (bookings into 2028, ~$1.9B NVDA stake) but the positioning trade is in distribution — ~35% off the 2026-06-02 ATH after correlated basket flushes. Week-of-7/21 semi rebound is… Cyclical recovery · Networking & optical catalyst · GLW Corning Incorporated fresh LOW Optical/AI-infrastructure demand is intact (Q1 Optical +36% YoY; Amazon/Meta/Nvidia deals) but the tape broke — a 43% drop off the 2026-06-30 ATH of $271.78 to ~$155. The 2026-07-28 Q2 print is the binary; two trading days out, nothing in… Cyclical recovery · Networking & optical catalyst · GLXY Galaxy Digital Inc. fresh LOW Legacy crypto-financials name re-rating to AI-data-center landlord: Phase I ~200MW at the Helios campus was delivered to CoreWeave on 2026-07-06, turning the ~$4.5B/15-yr lease from promise into live contracted revenue while shares still… Special situation · AI datacenter infrastructure · Crypto exchanges & financials catalyst · HUT Hut 8 Corp. fresh LOW Bitcoin-miner-to-AI-datacenter-landlord re-rate is now financed fact ($4.25B IG notes 6/4, ~$16.8B contracted backlog), but the momentum leg rolled from ~$127 to ~$105 as peers WULF/IREN captured the marquee Anthropic tenant deals (7/6)… Special situation · AI datacenter infrastructure · Bitcoin miners catalyst · INTC Intel Corporation fresh LOW Funded legacy-pivot leg is holding the $101.65 pre-announcement shelf by under a dollar after the 2026-08-14 close of $102.50; CEO Tan's Form 4 (105,263 sh at $95.00) is the only fresh company datapoint in a week of 13F-derived coverage.… Special situation · Semi foundry & equipment catalyst · KYMR Kymera Therapeutics, Inc. fresh LOW Oral STAT6 degrader (KT-621) re-rated on early BROADEN2 enrollment (6/25) and the $10.9B AbbVie–Apogee read-through, but the analyst upgrade cycle topped with RBC's 7/13 downgrade to neutral and the binary topline is 2H-2026 — a maturing,… Defensive · Oncology & immunology · Precision biotech & therapeutics catalyst · LRCX Lam Research Corporation fresh LOW The WFE/AI-memory capex trade that ran Lam +119% YTD into June has rolled into a group-wide correction — the worst month for chip stocks since 2008, memory momentum broken (Micron/SanDisk). The ~2026-07-29 FQ4 print is now the binary: it… Cyclical recovery · Semi foundry & equipment · AI datacenter infrastructure catalyst · MP MP Materials Corp. fresh LOW US critical-minerals-independence trade keeps getting rejected: a bullish 2026-07-20 defense-sourcing executive order failed to lift MP, which fell 7.5% on 07-24 to a fresh 52-week low ~$41 (~58% off the Oct-2025 high). Best-case policy… Compounder · Critical materials & rare earths catalyst · NVDA NVIDIA Corporation fresh LOW July de-rating unresolved and now compounded by capex scrutiny — Alphabet's first cash-flow-negative quarter since 2004 and Intel's punished $20B capex plan raise the question of whether hyperscaler spend slows. Jensen's open-weight-AI… Cyclical recovery · AI chips & memory catalyst · ONTO Onto Innovation Inc. fresh LOW June breakout fully round-tripped: ATH $386.46 (6/30) to $279.85 (7/17), now below the 50-DMA at $294.49. The tell is non-participation — TSMC raised capex to $60-64B and ASML guided up twice on 7/15-16, and ONTO closed the week at its… Cyclical recovery · Semi foundry & equipment · AI chips & memory catalyst · PURR Hyperliquid Strategies Inc fresh LOW The gamma-squeeze/index leg is over: PURR is -42% from its 6/1 high of $11.62 to $6.68 (7/17), through the $7.70 shelf, and now trades at roughly 0.78x the value of its 17.6M HYPE stack — a treasury premium that has flipped to a discount,… Retail squeeze · Crypto exchanges & financials catalyst · QCOM QUALCOMM Incorporated fresh LOW The data-center re-rating already failed: QCOM spiked to a 52-week high of $259.92 on the ~2026-06-24 Investor Day $15B-by-2029 guide, then gave back ~34% in 17 sessions to $171.78 as Hold downgrades and Apple modem-attrition math… Special situation · AI datacenter infrastructure · AI chips & memory catalyst · RIOT Riot Platforms, Inc. fresh LOW BTC-to-AI-landlord re-rating is structurally intact — AMD $311M/50MW Rockdale lease, $33.2M Q1 data-center revenue, Citi reiterated Buy/PT $28 on 2026-07-08 — but the miner complex rolled over on a Q2 crypto rout and "fresh AI-pivot… Special situation · Bitcoin miners · AI datacenter infrastructure catalyst · RKLB Rocket Lab Corporation fresh LOW Defense-backlog re-fire interrupts the mid-July rollover: the 7/20 $17B NSSL Phase 3 Lane 1 qualification and 7/21 $266M suborbital award stabilized the tape after the 7/13 support break and Piper's 7/16 Neutral $83 cap. An unresolved… Compounder · Space economy catalyst · SHLS Shoals Technologies Group, Inc. fresh LOW Solar/BESS EBOS name re-rated as a 2nd-order AI-datacenter-power play on a record $758M Q1 backlog and the multi-GW ON.energy deal; price reclaimed the $10 pivot but consensus PT sits at spot (~$10.63 vs $10.02), so the confirmed… Theme leader · AI datacenter infrastructure · Solar & clean energy catalyst · SYRE Spyre Therapeutics, Inc. fresh LOW Two of three lead binaries (SPY001, SPY002 anti-TL1A) printed potential best-in-class; the stock absorbed a ~$399.7M director-fund block sale and sits back near its ~$102 ATH (~$95). Next legs — SPY003 IL-23 Part A (guided mid-2026,… Defensive · Precision biotech & therapeutics · Binary-catalyst biotech catalyst · TNGX Tango Therapeutics, Inc. fresh LOW Post-data digestion, not acceleration: the 92% ORR combo print is fully paid for and the tape has faded from $32.90 to ~$27.7, below the $30.00 June secondary. Sell-side keeps marking up (JPM Overweight $46 on 7/15, Mizuho $40 on 7/17)… Defensive · Oncology & immunology · Binary-catalyst biotech catalyst · TSM Taiwan Semiconductor Manufacturing Company Ltd. fresh LOW Q2 (7/16) beat every line and lifted FY26 growth guide above 40%, but the capex raise to $60–64B and a 2026-07-26 Samsung–Broadcom $200B foundry pact reopened the monopoly question. Theme cooled to maturing; price recovered to ~$415, still… Cyclical recovery · Semi foundry & equipment catalyst · WEST Westrock Coffee Company fresh LOW Conway extract/RTD/flavors platform inflecting capex-to-cash: Q1 (5/07) beat + record adj EBITDA + FCF-positive-H2 guide; the 6/30 debt-maturity extension cleared the refi wall. Stock re-rated to ~$9.50 near the $9.81 52-wk high. Q2… Special situation · Cyclical industrials · Consumer discretionary rotation catalyst · AA Alcoa Corporation fresh LOW Policy leg (Section 232 onshoring, 2026-07-20) still bid, but the driver has rolled: LME aluminum $3,360/t on 08-11 to $3,248.75/t on 08-21 while the shares rose from $49.98 to $51.85. Nothing company-dated resolves before the Q3 print… Defensive · Critical materials & rare earths analysed · AAON AAON, Inc. LOW Beat-and-raise on 2026-08-10 (Q2 sales $627.0M, +101.2%; FY guide up to $2.235–2.307B) landed with gross margin 24.3% vs 26.6% and the FY margin guide cut to 25–26%. Targets were cut the next day and the entire 2026-05-07 re-rating gap has… Cyclical recovery · AI datacenter infrastructure · Industrial power & grid analysed · AAPL Apple Inc. LOW July's rotation-crown has slipped — Polymarket now gives Apple 20% odds of ending 2026 as the largest company (7/24) and semis are breaking out again (NVDA 7/23). The live narrative is the 'anti-CapEx AI trade' as Alphabet turns… Earnings inflection · Mega-cap AI platforms catalyst · ABCL AbCellera Biologics Inc. LOW Binary resolved positive: ABCL635 Phase 2 hit both primaries on 2026-08-10 (placebo-adjusted −5.3 hot flashes/day, p<0.001), and the stock re-rated to a 52-week-high $11.38 close on 2026-08-14 at RSI 97.4. The company priced $200M of… Earnings inflection · Precision biotech & therapeutics · AI enterprise software analysed · ABEO Abeona Therapeutics Inc. LOW The 2026-08-13 Q2 print missed both lines — revenue $11.38M vs ~$12.24M, EPS -$0.35 vs -$0.23 — and price has given back 18.4% from the $7.46 high. But treated patients rose to five from three and the QTC network hit its seven-center 2026… Earnings inflection · Rare disease & gene therapy · Precision biotech & therapeutics analysed · ABNB Airbnb, Inc. fresh LOW Post-Q2 re-acceleration re-rating now confirmed on price: the 2026-08-21 close of $187.30 is a new 52-week closing high, clearing the $185.13 shelf. But the last company disclosure was 2026-08-11 (Tripadvisor), the target-revision wave… Compounder · Consumer discretionary rotation catalyst · ABVX Abivax SA LOW Post-binary single-asset UC biotech that has now lost the $125.00 placement shelf — 2026-08-14 close $118.96 — despite a positive 2026-07-30 pre-NDA FDA interaction. Sell-side sits ~$161.55 average against the tape, the CEO has framed a… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics analysed · ABX Abacus Global Management, Inc. LOW Q2 beat everything management guides to — revenue $73.020M vs $66.088M consensus, adj EPS $0.28 vs $0.24, FY $1.00–1.05 affirmed (2026-08-06) — and bought no price: $9.27 close on 2026-08-14, 22.8% off the high and through the $10 shelf.… Special situation · Crypto exchanges & financials · Small-cap value rotation catalyst · ACB Aurora Cannabis Inc. LOW Frame flipped 2026-08-11: Curaleaf's unsolicited proposal — 0.3463 CURLF shares + US$0.75 cash, implied US$4.00, capped at US$5.00 — turned a broken Canadian LP into a live take-over situation. No formal bid has been commenced, the board… Earnings inflection · M&A & special situations · Semi foundry & equipment catalyst · ACDC ProFrac Holding Corp. LOW Hormuz beta re-coupled in August: WTI settled $82.40 and Brent $88.52 on 2026-08-14 with the strait still shut, dragging ACDC to $5.37 at RSI 74.4. But the 2026-08-06 Q2 print missed (-$0.44 vs -$0.30), liquidity is ~$72M against $1,083.6M… Earnings inflection · Oil, energy & geopolitical analysed · ACHC Acadia Healthcare Company, Inc. LOW Post-scandal turnaround re-rate resolved its binary and faded. Q2 (2026-07-28) beat its own guide and lifted the FY26 floor, but printed adj. EBITDA $149.2M vs $201.8M YoY on a $28.6M settlement reserve build. Price gave back two-thirds of… Special situation · Managed care & health services analysed · ACHR Archer Aviation Inc. LOW The 2026-08-10 Boeing-subsidiary re-rating has fully retraced: the 2026-08-21 weekly close of $6.30 sits 0.6% above the $6.26 pre-announcement reference, so the market is valuing >$200M of acquired Insitu revenue at roughly nothing. Compounder · Defense & aerospace · Physical AI & robotics analysed · ACMR ACM Research, Inc. LOW Beat-and-raise on 2026-08-07 (revenue $292.9M +36% YoY, EPS $0.61 vs $0.34, FY26 floor lifted to $1.125B, H1 orders +105% YoY) was sold: the stock round-tripped to $80.42 on 2026-08-14, -36.6% from a $126.89 52-week high. Order curve… Cyclical recovery · Semi foundry & equipment · AI datacenter infrastructure analysed · ACN Accenture PLC LOW Post-crash re-rating leg has extended — $176.89 on 2026-08-14 vs the $118.15 June low — helped by a time-boxed $7.5B buyback and an $821M Pentagon War Data Platform award on 07-28. But RSI(14) is 73.1, the close sits within ~1% of the… Special situation · AI enterprise software catalyst · ADI Analog Devices, Inc. LOW The $405 post-Q2 shelf has broken — the 2026-08-14 close of $389.39 sits 12.6% under the $445.48 52-week high while every published target ($405–$550) is now above spot. Analog recovery plus the Empower AI-power option is a fully told… Theme leader · AI chips & memory catalyst · ADSK Autodesk, Inc. LOW Legacy CAD franchise trying to re-rate on an asset-operations pivot: the $3.6B MaintainX deal closed 2026-08-03, yet the 2026-08-14 close of $251.66 is still 23.0% under the $326.79 high. Two desks picked up coverage in three weeks —… Special situation · AI enterprise software · Housing, homebuilders & proptech catalyst · ADTN ADTRAN Holdings, Inc. LOW ADVA margin-recovery turnaround is finished as a narrative: the 2026-08-03 final Q2 confirmed the July pre-announcement (rev $281.1M vs $290.2M consensus, non-GAAP EPS $0.04 vs $0.10, op margin 3.8% vs 6.9% in Q1), the $9 shelf gave way,… Special situation · Networking & optical · Cyclical industrials analysed · AEIS Advanced Energy Industries, Inc. LOW Datacenter-power picks-and-shovels re-rating is now fully mainstream — Morgan Stanley initiated Overweight $421 (07-22) atop Wells $465 and Susquehanna $535 — yet the stock fell 12.65% on 07-02 and is sitting on its 200-day while analyst… Cyclical recovery · Industrial power & grid catalyst · AEM Agnico Eagle Mines Ltd. LOW Gold-equity operating leverage re-accelerating: spot gold ran from clearing $4,200 on 2026-08-05 to $4,577.49 on 2026-08-21, and Agnico's TTM net income is already +98.5% at $5.87B. The catch is timing — RSI(14) 91.9 and the 2026-08-21… Compounder · Critical materials & rare earths catalyst · AESI Atlas Energy Solutions Inc. LOW Frac-sand legacy pivoting to behind-the-meter gas power for AI data centers, but the story is DORMANT and the structure broken: shares fell from $16.73 (6/29) to an $11.96 close (7/24, -8.5%), losing the ~$15 base and $13 shelf on… Special situation · AI datacenter infrastructure · Industrial power & grid analysed · AFRM Affirm Holdings, Inc. LOW The +80%-off-March recovery re-rate has matured and rolled over: Morgan Stanley pulled its Overweight ('valuation call') on 2026-06-25, and price faded ~30% from the $100 high back onto the reclaimed 200-day near $70 while targets stayed… Compounder · Fintech & consumer credit · Consumer discretionary rotation catalyst · AGX Argan, Inc LOW AI-data-center gas-EPC theme still accelerating (4.1+ GW gas backlog, $973.6M cash, zero debt), but AGX has round-tripped from the $805.75 ATH to $563, losing both the ~$675 breakout and ~$600 shelves. Mean reversion toward the pre-run… Cyclical recovery · AI datacenter infrastructure · Industrial power & grid catalyst · AGYS Agilysys, Inc. LOW Hospitality vertical-SaaS recovery has re-accelerated into its print: AGYS ran ~+18% to $108.98 (2026-07-10) off the June ~$92 base, clearing the two lowest analyst targets ($100/$110) ahead of a confirmed 2026-07-27 Q1 FY2027 binary that… Special situation · AI enterprise software catalyst · AIP Arteris, Inc. LOW Q2 (2026-08-06) beat and raised — revenue $24.1M +46%, TTM variable royalties $8.6M +65%, FY26 guide lifted to $95-98M — and the stock still closed $28.32 on 2026-08-14, 41.7% under the 6/30 high. The $33 weekly break fired while the… Cyclical recovery · AI chips & memory catalyst · AIRO AIRO Group Holdings, Inc. LOW Policy leg intact, price leg fading: the 2026-08-13 Section 232 drone tariffs (up to 100%, most effective 2026-09-03) plus a Q2 beat of $43.180M vs $31.212M consensus have stopped attracting a bid — $8.60 on 2026-08-21 against a $9.57… Defensive · Defense & aerospace · Small-cap value rotation catalyst · AKBA Akebia Therapeutics, Inc. LOW VOICE outcomes win (USRC trial stopped early, June 2026) de-risked Vafseo's dialysis-anemia case, but the tape bled to ~$1.22, only ~48% above the $0.82 low and still fading; the late-July/early-August Q2 print is the binary —… Earnings inflection · Precision biotech & therapeutics analysed · ALGM Allegro MicroSystems, Inc. LOW The June AI data-center power-attach re-rate has flipped from being marked up to marked down: TD Cowen cut its target to $66 (2026-07-13) and Barclays downgraded to Equal-Weight at $48 (2026-07-20), the first target below the June range —… Cyclical recovery · Analog semiconductors · AI datacenter infrastructure analysed · ALHC Alignment Healthcare, Inc. LOW Profitable-MA-disruptor narrative broke on 2026-07-08: a whistleblower suit from a former Chief Transformation Officer alleges the +88% adjusted-EBITDA inflection was manufactured by reclassifying opex as capex across FY2024-25. Shares… Earnings inflection · Managed care & health services · Oil, energy & geopolitical analysed · ALK Alaska Air Group, Inc. LOW The $44–47 shelf failed: the 2026-08-21 close of $40.41 grades the prior break condition as met, with RSI(14) at 22.0 and price 36.7% under the $63.86 high. Special situation · Travel & leisure · Cyclical industrials catalyst · ALLE Allegion Public Limited Company LOW Post-Q2 gap intact but the leg is cooling: $162.31 on 2026-08-21 with RSI(14) back to 51.9 from 61.1 a week earlier, and price now under the $164.75 mean target while every post-print broker update stays Neutral/Equal Weight.… Special situation · Housing, homebuilders & proptech · AI datacenter infrastructure analysed · ALMS Alumis Inc. LOW Psoriasis leg is fully told — 2026-08-10 ONWARD3 48-week data (75% PASI 90 / 54% PASI 100) left the stock 16.5% under its $30.30 52-week high. The only re-rating leg left is the undated LUMUS Phase 2b lupus topline, reaffirmed for Q3 2026… Earnings inflection · Oncology & immunology · Precision biotech & therapeutics catalyst · ALNT Allient Inc. LOW Record-orders story intact — Q2 2026 bookings $201.3M (+49% YoY), 1.31x book-to-bill, backlog $298.0M — but the supply picture changed after the note: the CEO's trusts sold 70,000 shares at $112.49–$115.765 on 2026-08-10 and 13D holder… Cyclical recovery · Cyclical industrials · Physical AI & robotics catalyst · ALOT AstroNova, Inc. LOW Terminal merger-arb pin. Arcline's $29.00 all-cash take-private cleared its HSR condition on 2026-07-31 and goes to a shareholder vote on 2026-08-25; the 2026-08-14 close of $28.91 leaves $0.09 of gross spread against a break tail toward… Earnings inflection · M&A & special situations · Semi foundry & equipment catalyst · ALTO Alto Ingredients, Inc. LOW Ethanol-to-specialty/low-carbon pivot re-rated ~6x off $0.92, but both fuel catalysts — the June 45Z cash sale and the Russell index add — are spent, and price has round-tripped from the $6.11 July high to ~$4.64, losing the $5.10-$5.20… Special situation · Biofuels & low-carbon fuels · Cyclical industrials catalyst · AMAT Applied Materials, Inc. LOW Record Q3 FY2026 (revenue $9.12B, +25% YoY; Q4 guide $10.25B ±$0.50B) keeps de-rating anyway: $507.18 on 2026-08-14, $492.32 on 2026-08-21, 31.8% under the $722.23 high, with every published target from $585 to $740 above the market. No… Cyclical recovery · Semi foundry & equipment · AI datacenter infrastructure catalyst · AMBQ Ambiq Micro, Inc. LOW Q2 (2026-08-11) delivered net sales $33.9M, +89.7% YoY, and a Q3 guide above Street — yet the 2026-08-14 close of $64.51 sits 28.7% under the $90.48 high and below the spent $70 shelf. Fundamental acceleration has stopped buying price;… Defensive · AI chips & memory · Small-cap value rotation analysed · AMKR Amkor Technology, Inc. LOW A second anchor — the $1.5B Nvidia advanced-packaging/test partnership (2026-07-23) stacked on the 2026-06-16 TSMC 10-yr Arizona deal — is re-rating Amkor from single-customer Apple OSAT toward US AI back-end anchor. But every catalyst… Cyclical recovery · Semi foundry & equipment · AI chips & memory analysed · AMLX Amylyx Pharmaceuticals, Inc. LOW Single-asset binary, now inside the guided window: Amylyx reaffirmed on 2026-08-06 that Phase 3 LUCIDITY topline for avexitide in post-bariatric hypoglycemia arrives late August or early September 2026. Sell-side marked targets up into it… Earnings inflection · Precision biotech & therapeutics catalyst · AMN AMN Healthcare Services LOW Healthcare-staffing cyclical recovery, real but maturing and now at the highs: ~$32.9 (2026-07-24), just off a fresh 52-wk high $36.27 (~+120% off $14.87). Truist's 2026-07-22 lift to a Street-high $40 Buy is the first target leading… Special situation · Managed care & health services analysed · AMP Ameriprise Financial, Inc. LOW Wealth-platform operating leverage still delivering — Q2 (2026-07-23) adjusted operating EPS $11.07 +22%, ROE 55%, record $1.81T AUM/AUA — but the August leg is pure multiple expansion: no disclosure since 07-23, new 52-week high… Cyclical recovery · AI enterprise software · Cyclical industrials analysed · ANAB AnaptysBio, Inc. LOW The dateless wait acquired a docket: a 2026-07-28 stipulation set post-trial briefing to an Oct 20 Chancery argument, and ANAB has rebuilt from ~$54 (Jul 24) to $58.47 (Aug 14) on no company news. The written opinion deciding Jemperli… Earnings inflection · M&A & special situations · Precision biotech & therapeutics catalyst · ANRO Alto Neuroscience Inc. LOW Precision-psychiatry TRD re-rate broke to new highs on a low-information 2026-08-12 Q2 print (EPS -$0.65 vs -$0.73 est) and two same-week target revisions (BTIG $37 Buy, Wedbush $26 Neutral). The 2026-08-14 close of $32.14 sits 0.5% under… Earnings inflection · Precision biotech & therapeutics analysed · AOSL Alpha and Omega Semiconductor Limited LOW Post-parabola digestion. The Apr–May "second-order AI power-semi" re-rate (~3x to $54.34) is fully priced, above the $30.50 consensus PT with no fresh company catalyst in 11+ weeks; the 2026-07-15 pop was a newsletter-driven volume spike,… Cyclical recovery · AI datacenter infrastructure · AI chips & memory analysed · APGE Apogee Therapeutics, Inc. LOW HSR expiry (2026-08-05) and shareholder approval (2026-08-11) cleared the last stated conditions on AbbVie's $135.11 all-cash takeout, so what trades now is terminal merger-arb carry into a company-guided Q3-2026 close — capped at the bid,… Earnings inflection · M&A & special situations · Oncology & immunology analysed · APPN Appian Corporation fresh LOW Second-order agentic-AI re-rating has extended past the print without new numbers: after the 2026-08-06 beat and FY26 raise to $845–853M, price ran from a $30.41 pre-print close to $38.30 on 2026-08-21 with RSI(14) 81.5. DA Davidson's… Theme leader · AI enterprise software analysed · ARCT Arcturus Therapeutics Holdings Inc. LOW CSL exit hands back global KOSTAIVE plus flu/RSV/EBV rights, $12M cash and ~$16M of released liabilities, against $191.5M cash and runway guided through end-2028 — a platform-repossession re-rating that has run 91.3% in three months into… Earnings inflection · Oncology & immunology catalyst · AREC American Resources Corporation fresh LOW Critical-minerals refining narrative still producing dated milestones — $25M Department of War investment 2026-07-14, first commercial-scale germanium column 2026-08-07, Minor Source air permit for all planned Marion lines 2026-08-19 — but… Cyclical recovery · Critical materials & rare earths catalyst · ARHS Arhaus, Inc. LOW Written-order inflection is the leg: Q2 comparable written sales +12.5% vs delivered +4.0% (2026-08-06), with $226M cash and no long-term debt. Against it: the EPS beat carried a $23.8M one-time tariff refund, Q3 revenue is guided below… Defensive · Consumer discretionary rotation · Freight & logistics analysed · ARX Accelerant Holdings LOW Signed all-cash take-private at $20.25; the 2026-08-21 close of $19.59 leaves a fixed-price insurance-regulatory arb with the ceiling contractually set. Newly visible merger terms — go-shop ending 2026-09-22, outside date 2027-08-13… Earnings inflection · M&A & special situations · Managed care & health services catalyst · ASST Strive, Inc. LOW Treasury-premium narrative still inverted: the 2026-08-10 Q2 print booked a $257.6M loss, 94.1% mark-to-market, against a $94,761 average cost versus the $64,812 Strive itself paid in early August. Buying restarted (147 BTC, 08-03 to… Retail squeeze · Crypto exchanges & financials catalyst · ASX ASE Technology Holding Co., Ltd. LOW Advanced-packaging pricing power is real — quotes raised 20%+ (2026-07-01), 2026 capex hiked to US$8.5B, CoWoS-equivalent capacity tripling to 25k wpm — but the tape topped at $45.51 the same day and sits ~15% lower inside a 13% semi… Cyclical recovery · Semi foundry & equipment · AI datacenter infrastructure catalyst · ATAI AtaiBeckley Inc. LOW Lilly takeout is now a process, not a story: DEFM14A filed, special meeting 2026-09-08, HSR filed 2026-07-29, close guided Q3 2026. The 2026-08-14 close of $7.26 sits $0.51 over the $6.75 cash leg, so all remaining return is an unread CVR… Earnings inflection · Precision biotech & therapeutics · Semi foundry & equipment catalyst · ATEN A10 Networks Inc LOW AI-security re-rate off the 2026-06-15 TrojAI deal has stalled: ATEN churning ~$35 below the $37.36 ATH, momentum cooling as Mizuho lifts its target to $34 but stays Neutral — analyst catch-up, not fresh conviction. The 2026-08-05 Q2 print… Theme leader · AI datacenter infrastructure · Networking & optical analysed · ATHM Autohome Inc. LOW Cash-return re-rating in a shrinking business, now at negative enterprise value: US$2.62bn market cap against US$2.67bn cash, EV -US$36.57m (2026-08-16), a US$400m buyback authorised 2026-07-28 and an RMB1.5bn 2026 dividend floor. The… Special situation · Emerging markets · Semi foundry & equipment catalyst · ATKR Atkore Inc. LOW Cyclical-repair frame is closed: the 2026-08-02 definitive all-cash merger with Prysmian at $95.00/share pins the stock, and the 2026-08-14 close of $93.80 leaves $1.20 of gross spread. The read is now completion timing — HSR plus… Earnings inflection · Industrial power & grid analysed · AUGO Aura Minerals Inc. LOW Gold/copper producer basing $53–$76 under a broken ~$72 shelf after a ~45% fall from the $110 high. Q2 output slipped 8% QoQ — first sequential drop after a record Q1 — as gold cools to the low-$4,000s and sell-side keeps trimming (JPM to… Compounder · Critical materials & rare earths analysed · AVLN Avalyn Pharma Inc. LOW Post-IPO re-rating in an inhaled-antifibrotic single-asset story: the 2026-08-14 close of $39.25 is +118% over the $18.00 April IPO price with RSI(14) at 89.2, yet the MIST Phase 2b FVC readout that sets the value is guided to 2H 2027.… Earnings inflection · Precision biotech & therapeutics catalyst · AVNS Avanos Medical, Inc. LOW Resolved, not pending: AIP completed the $25.00/share all-cash take-private on 2026-07-27 and AVNS ceased NYSE trading the same day (EV ~$1.272B). Holders received cash; there is no listed security, no narrative leg and no catalyst left.… Earnings inflection · M&A & special situations · Medtech & diagnostics analysed · AVR Anteris Technologies Global Corp. LOW Post-catalyst drift: the CMS/first-patient/France de-risking sequence is spent, and Q2 (reported 2026-08-12) missed both lines — EPS $(0.30) vs $(0.21), revenue $1.009M vs $1.500M — yet the 2026-08-14 close held $9.40 with RSI 66.9.… Defensive · Medtech & diagnostics analysed · AVTR Avantor, Inc. LOW The post-print re-rating is digesting rather than extending: $13.66 on 2026-08-14 versus $13.59 on 2026-08-07, RSI(14) cooling 77.0 to 69.5, and the 2026-07-30 target cluster of $14–$16 already reached. Management's Q3 guide — about 250 bp… Special situation · Medtech & diagnostics · Precision biotech & therapeutics analysed · AVTX Avalo Therapeutics, Inc. LOW The July soft catalyst has passed: Q2 landed 2026-08-06 and delivered a schedule — registrational Phase 3 in hidradenitis suppurativa initiating H1 2027 — so the post-LOTUS story now sits in a ~10-month gap with no company-dated clinical… Earnings inflection · Precision biotech & therapeutics analysed · AVXL Anavex Life Sciences Corp. LOW Governance, not approval, is the leg: PVG's six-nominee GOLD slate meets the board's WHITE slate at the 2026-09-24 annual meeting. Since 2026-08-15 the contest kept filing (8-K 08-17, DFAN14A 08-19) while price stalled — $3.24 on… Earnings inflection · Binary-catalyst biotech · Crypto exchanges & financials catalyst · AZTA Azenta, Inc. LOW No new company information since the Aug 4 print, yet price ran from $33.39 (Aug 11) to $37.40 (Aug 21) with RSI(14) at 81.5 and the six-analyst consensus target of $34.80 now below spot. The self-help leg ($529M cash, no debt, $50.0M… Special situation · Medtech & diagnostics · M&A & special situations analysed · AZZ AZZ Inc. fresh LOW Beat-and-raise fired 2026-07-08 — Q1 adj EPS $1.85 vs $1.69, FY27 guide lifted twice on Metal Coatings momentum — but the catalyst is now behind the stock, which sits at all-time highs (~$157), ~23x forward and above consensus, with Wells… Cyclical recovery · Industrial power & grid catalyst · BAK Braskem S.A. LOW Q2 2026 (released 2026-08-14) printed US$1.043B recurring EBITDA on a Middle East supply shock management called tactical — and the ADR closed $1.95, pricing the capital structure rather than the P&L. The 2026-06-26 São Paulo shield… Earnings inflection · Biofuels & low-carbon fuels · Emerging markets catalyst · BAND Bandwidth Inc. LOW Late-stage small-cap CPaaS squeeze: +360% YoY into the mid-$70s, ~5% below the $79.08 high, with Citizens ($86, 2026-07-20). Riley ($85) both lifting targets in July. A confirmed Q2 print on 2026-07-29 is a binary two trading days out —… Retail squeeze · GPU cloud & neoclouds · AI datacenter infrastructure catalyst · BB BlackBerry Limited LOW Q1 FY27 gave the pivot real numbers (QNX $72.3M vs the $60-64M guide, FY27 raised to $594-621M), but the parabola broke: after a $13.59 high the stock fell ~37% to ~$8.54 on a meme unwind plus insider selling. Narrative maturing, price… Retail squeeze · AI enterprise software · Cybersecurity analysed · BBBY Bed Bath & Beyond, Inc. LOW Lemonis "Everything Home" roll-up keeps closing deals — Container Store now wholly owned (2026-07-08), TwoPonds folded in (2026-07-01) — but the tape has bled from $5.83 to ~$4.96 and sits on the $4.26 52-week low as shares balloon past… Special situation · Cyclical industrials · Consumer discretionary rotation analysed · BBWI Bath & Body Works, Inc. LOW Citi upgraded to Buy at $25 on 2026-08-18 and JPMorgan lifted to $24 the same day, but the 6.5% pop to $20.04 fully retraced to $19.45 by 2026-08-21 — attention arrived without a lasting bid. The 2026-08-26 Q2 print is the binary:… Special situation · Consumer discretionary rotation · Small-cap value rotation catalyst · BBY Best Buy Company, Inc. LOW Tape flipped since early July: BBY broke to a fresh 52-week high $87.35 (~$85.41 on 2026-07-17, +27.6% YTD) on RGB-LED TV exclusivity plus an AI-PC/MacBook refresh cycle. But price sits ~8% above the $79.15 consensus target while Loop… Special situation · Consumer discretionary rotation · AI datacenter infrastructure catalyst · BCAX Bicara Therapeutics Inc. LOW Bifunctional EGFR/TGF-β narrative in HPV-negative head & neck cancer stalled after the ASCO 2026 three-year-OS re-rate: $27.76 close is ~10% off the $30.99 high on roughly half prior turnover, consensus PT ~$31.46 sits only 13% above spot,… Earnings inflection · Oncology & immunology · Binary-catalyst biotech analysed · BHC Bausch Health Companies Inc LOW Levered deleveraging/separation stub: $2.41B equity on $20,239M long-term debt principal, with an 87% Bausch + Lomb stake as the main asset. The 2026-07-29 beat-and-raise (adj EPS $1.26 vs $1.04, FY sales guide to $10.790–11.040B) drove… Special situation · Precision biotech & therapeutics · Binary-catalyst biotech analysed · BHVN Biohaven Ltd. LOW Binary-catalyst biotech: the re-rate off the $7.48 Nov-CRL low stalled at ~$16 in early July and drifted to $13.85 on 2026-08-21. The undated 2H-26 RISE3 topline now races a live $350.0M J.P. Morgan ATM (424B5, 2026-05-04) against ~$270.5M… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics analysed · BIDU Baidu, Inc. ADS fresh LOW Q2 print confirmed for 2026-08-18 pre-market is the binary. The ADR bleed flattened — cap $37.10B (08-10) vs $37.21B (07-24) — but the 2026-08-14 close of $103.67 sits under the $110 shelf, -36.2% from the $162.52 high, RSI 45.7.… Special situation · Mega-cap AI platforms analysed · BIOA BioAge Labs, Inc. LOW The ESC venue hypothesis failed: ZEUS is absent from the published ESC 2026 Hot Line programme (Munich, 2026-08-28 to 08-31), so the full dataset that would separate NLRP3 from IL-6 blockade does not land in August and no substitute date… Earnings inflection · Precision biotech & therapeutics · Oncology & immunology catalyst · BIRK Birkenstock Holding plc LOW The August frame's $36 weekly level broke — the week ending 2026-08-21 closed $35.64, retracing the entire 2026-08-13 beat-and-raise reaction ($41.01 premarket, then a −4.02% close at $39.35 on 2026-08-14). Fundamentals still guide to 15%… Defensive · Consumer discretionary rotation · Oil, energy & geopolitical analysed · BJRI BJ's Restaurants, Inc. LOW The 2026-07-30 re-acceleration (comps +6.5%, traffic +8.3%, FY comp guide raised to +3–4%) is priced; no new operating datapoint or target revision since 2026-07-31, and the next print is ~10 weeks out. Special situation · Consumer discretionary rotation · Freight & logistics analysed · BKNG Booking Holdings Inc. LOW Capital-return compounder re-rated on the 2026-08-04 Q2 print (adj EPS $2.54, +15%, on +8% revenue and $3.7B repurchased), but the sell-side reset ended with Argus at $245 on 2026-08-10 and price has stalled — $212.06 on 2026-08-14, RSI… Compounder · Travel & leisure · AI enterprise software catalyst · BKSY BlackSky Technology Inc. LOW Gen-3 subscription ramp landed in Q2 (2026-08-06): revenue $33.316M vs $30.68M est, +50% YoY, adjusted EBITDA $4.7M, FY26 guide affirmed at $130–150M. But EPS missed at $(0.54) vs $(0.36), cash is $36.9M against a $50–60M capex guide, and… Defensive · Space economy analysed · BLDP Ballard Power Systems, Inc. LOW Q2 (release 2026-07-31) delivered the backlog inflection — $156.6M, +38.8% QoQ, 20% gross margin — and the stock still made new lows at $2.70 (2026-08-14), -57.7% from the $6.38 high. The £275M GeoPura deal converts the turnaround into an… Special situation · Solar & clean energy · Industrial power & grid analysed · BLKB Blackbaud, Inc. LOW Buyback-driven re-rating extended rather than stalled: $47.52 on 2026-08-21 versus $45.45 on 2026-08-11, with RSI(14) cooling from 80.1 (2026-08-07) to 62.8 while price rose. Price now sits within ~2% of the $48.50 consensus average… Special situation · AI enterprise software analysed · BLMN Bloomin' Brands, Inc. LOW Margin-repair re-rating off the 2026-08-05 raise (FY26 adj EPS to $0.90–$1.00) is holding but no longer expanding: $10.55 close 2026-08-14, RSI cooled 71.1→66.0, flow down to two hold-rated $12 targets. Brinker's 2026-08-12 print showed… Special situation · Consumer discretionary rotation analysed · BMA Banco Macro S.A. LOW Credit-recovery leg broke on the company's own numbers at the 2026-08-19 Q2 print: NPLs 6.25% (from 5.40%), coverage 95.39% (from 109.8%), FY cost-of-risk guide raised to 6.5–7% and real loan growth cut to 2–5% from ~20%. ADR closed $72.84… Compounder · Emerging markets · Biofuels & low-carbon fuels catalyst · BMNR BitMine Immersion Technologies, Inc. LOW Premium-to-NAV funding engine is closed; the 2026-08-10 release shows capital flipping from coin to float — 7,391 ETH bought for $14.3M (smallest week of 2026) against 3.0M shares retired, with cash down to $104M from $173M. The narrative… Compounder · Crypto exchanges & financials catalyst · BOLD Boundless Bio, Inc. LOW Merger-arb wrapper, not an oncology stock: the object is a planned $44–48M pre-close cash dividend plus a 3.69% stub in the AATD base-editing NewCo. Week of 2026-08-14 added owners (ADAR1 13G at 8.8%) but no deal documents — still no S-4,… Earnings inflection · M&A & special situations · Rare disease & gene therapy analysed · BRBR BellRing Brands, Inc. LOW The $11–12 post-print shelf broke on no news: $11.56 on 2026-08-07 to $10.75 on 2026-08-14, RSI 27.9, -74.8% off the $42.68 high. A third FY26 EBITDA cut ($275–295M from $315–335M) killed the margin narrative; the repair — a double-digit… Defensive · Fintech & consumer credit · Consumer discretionary rotation analysed · BRKR Bruker Corporation LOW Post-ASMS instrument re-rate broke back toward the $64.54 high and added a second leg: semiconductor-metrology strength (orders +20% YoY) pulled Leerink to $70 and top targets to $65–70. But at ~$62 the name sits ~13% over its 50-DMA and… Special situation · Medtech & diagnostics · AI chips & memory analysed · BROS Dutch Bros Inc. LOW Drive-thru coffee comps re-accelerating (Q1 +8.3%, FY guide raised) and the sell-side is now catching up — Stephens initiated Overweight $80, Morgan Stanley to $88 in mid-July. But June's run to ~$72 cooled to the mid-$60s, and the… Defensive · Consumer discretionary rotation analysed · BSIN Big Sky Industrial Inc. LOW Helium/45Q pivot still on schedule after the 2026-08-11 Q2 print; the 2026-08-20 Sidoti deck added a first Phase 1 EBITDA figure (~$15M/yr). Same day a final 13D/A put Sage Road Capital at 4.9%. Price $1.40 against the $1.43 closing high,… Special situation · Oil, energy & geopolitical · Industrial power & grid analysed · BTBT Bit Digital, Inc. LOW Both legs of the wrapper are now rolling over: WhiteFiber (WYFI, ~70.5% owned) de-rated from $38.50 to $27.57 as the June neocloud mania cooled, and BTBT slid to ~$1.50, a step above its $1.25 low. SOTP discount still ~49% (~$745.6M WYFI… Special situation · GPU cloud & neoclouds · AI datacenter infrastructure catalyst · BTDR Bitdeer Technologies Group LOW Spring miner-to-AI re-rate has fully unwound: BTDR lost the $15 shelf to $12.56 (2026-07-09) as AI-cloud ARR plateaued at ~$69M for a 2nd month. A signed-but-not-effective Tydal colocation lease (2026-06-29) and a $36M Nevada plant are the… Special situation · Bitcoin miners · AI datacenter infrastructure catalyst · BTE Baytex Energy Corp. LOW July's Hormuz flare re-armed the oil-geopolitical premium, but it has since drained — WTI slipped to the low $70s and the 2026-07-17 sanctions wind-down passed with no barrel shortage, a contained-conflict bid rather than a supply shock.… Compounder · Oil, energy & geopolitical catalyst · BTGO BitGo Holdings, Inc. LOW Broken IPO that cleared its 2026-07-21 lockup without a supply flood but is grinding on the $4.665 all-time low with no bounce; Goldman cut its target to $7.75, and the undated $100M Galaxy verdict plus the ~2026-08-26 Q2 print are the… Earnings inflection · Crypto exchanges & financials · M&A & special situations catalyst · BWIN The Baldwin Insurance Group, Inc. LOW Take-private premium is bleeding while sell-side chases it higher: price slipped to $27.25 (2026-07-17) from $28.41 (2026-07-02) even as KBW went to $31 and JPM to $30. Nothing is signed, and the 2026-07-30 Q2 print (guide $485–490M,… Earnings inflection · Semi foundry & equipment · AI enterprise software analysed · BWMN Bowman Consulting Group Ltd. LOW Not a growth story — a cash-deal spread. Bernhard Capital's $43.00 all-cash take-private (signed 2026-08-10) caps the name; the 2026-08-21 close of $42.61 is $0.39 under it, down from a $0.70 gap on 2026-08-14. The go-shop expires 5:00… Earnings inflection · M&A & special situations · AI datacenter infrastructure catalyst · BXC BlueLinx Holdings Inc. LOW Housing-distribution margin inflection in a 7.86M-share float has stopped generating headlines: after a 52-week high at $91.41, the 2026-08-21 close of $84.60 sits back inside the $83–$84 target band raised 2026-08-06, and the 2026-08-18… Cyclical recovery · Housing, homebuilders & proptech catalyst · CAI Caris Life Sciences, Inc. LOW Oncology molecular-profiling re-rate: the 2026-08-05 Q2 beat ($263.7M vs $238.1M est) plus an FY26 guide lift to $1.030–1.040B and positive adjusted EBITDA of $55.7M flipped the story to self-funding growth, driving a 68.9% three-month… Theme leader · Medtech & diagnostics analysed · CAKE Cheesecake Factory Incorporated (The) LOW Casual-dining re-rate got a genuine second leg: Citi's 2026-07-10 raise to a street-high $90 (Buy) on a rewards/app traffic-inflection thesis gapped shares 7% to all-time highs (~$86, 52wk high $86.66 on 2026-07-18). For the first time the… Special situation · Consumer discretionary rotation catalyst · CARG CarGurus, Inc. LOW Post-print re-rate has stalled and faded: $38.98 on 2026-08-07 (0.1% under the $39.03 52-week high) to $36.85 on 2026-08-21, with RSI back to 49.7. Seven desks now carry $39–$44 targets and zero upgrades, two insiders sold into the level,… Special situation · Managed care & health services · Consumer discretionary rotation catalyst · CBLL CeriBell, Inc. LOW August re-rating is reimbursement-driven: CMS granted an NTAP of up to $2,171 per eligible Medicare case for the Ceribell Delirium Monitor on 2026-08-03 (effective 2026-10-01) and FY26 guidance went to $114–117M on 2026-08-10. Narrative… Defensive · Medtech & diagnostics · Managed care & health services analysed · CBRL Cracker Barrel Old Country Store, Inc LOW Legacy-diner turnaround where the leadership leg is now spent: Deno took over 2026-08-10 and price went nowhere (2026-08-07 close $57.79 → 2026-08-21 $57.65) while RSI(14) reset from 63.9 to 49.6. The sell-side chased in late July (Piper… Special situation · Consumer discretionary rotation · Managed care & health services catalyst · CBZ CBIZ, Inc. LOW Deal-completion story now, not an operating one: the 2026-08-21 close of $54.66 sits $0.34 under the signed $55.00 all-cash terms, in from $0.54 on 2026-08-14. The go-shop expiring 11:59pm ET 2026-08-27 is the only mechanism that can print… Earnings inflection · M&A & special situations · Semi foundry & equipment catalyst · CCRN Cross Country Healthcare, Inc. LOW Situation settled: the Knox Lane take-private became effective 2026-07-21 at $13.25 cash, Nasdaq suspended trading that morning and filed Form 25 the same day. No listed security, no residual claim, no forward catalyst — any CCRN bar dated… Earnings inflection · M&A & special situations · Managed care & health services analysed · CCXI Churchill Capital Corp XI LOW De-SPAC humanoid pure-play now maturing: Unitree's 2026-08-19 STAR debut (+487% close, ~$53B) lifted CCXI for one session before the move fully round-tripped — $17.07 on 2026-08-14 to $14.57 on 2026-08-21, RSI 73.4 to 43.5. Still no public… Earnings inflection · M&A & special situations · Physical AI & robotics analysed · CDNL Cardinal Infrastructure Group Inc. LOW Post-blowoff digestion is deepening: the ~4x data-center site-work roll-up has bled from a $96 high back to its $63 average analyst target, now below the $73 secondary price and the 50-DMA. Q1 organic +64% and an $854M backlog keep… Cyclical recovery · AI datacenter infrastructure · Cyclical industrials analysed · CDW CDW Corporation LOW Second-order AI-server reseller whose ~37% recovery off the $97 low has stalled: a mid-July push to $144 round-tripped to $133 by 2026-07-17, right in the fairway of the ~$145 consensus target. The re-rate (JPM, MS $170, Citi $145) is… Theme leader · AI datacenter infrastructure · AI enterprise software catalyst · CECO CECO Environmental Corp. LOW 2nd-order AI-power name — Q1 orders +97% YoY and a first-ever >$1B backlog (2026-04-28) feed the datacenter/electrification capex wave, and the closed Thermon merger doubled EBITDA. But price rolled over ~25% off the $101.24 ATH to $75.63,… Theme leader · Industrial power & grid · AI datacenter infrastructure analysed · CERS Cerus Corporation LOW Profitability inflection intact — 9th straight positive adjusted-EBITDA quarter (+$3.0M) and a $30M term-loan paydown at the 2026-07-30 Q2 print — but product growth halved to +10% YoY from +24% in Q1 and gross margin fell to 51.4% from… Special situation · Precision biotech & therapeutics · Small-cap value rotation analysed · CEVA CEVA, Inc. LOW Edge-AI IP momentum leg has broken: June's reclaim to within ~3% of the $51.60 high failed, and the mid-July AI-capex scare (Moonshot model) drove shares back through the ~$44 base to the mid-$30s. Sell-side still carries $48–$55 targets,… Cyclical recovery · AI chips & memory · Physical AI & robotics analysed · CGC Canopy Growth Corporation LOW The rescheduling binary CGC trades on came and went: the DEA hearing closed 2026-07-15 with no verdict, briefs due 2026-08-17 and the ALJ recommendation undated into H2 2026, likely litigated into 2027. Shares closed $0.89 on 2026-07-24,… Earnings inflection · Cannabis reclassification · Crypto exchanges & financials catalyst · CHYM Chime Financial, Inc. LOW Busted-IPO fintech: operations accelerating (Q1 rev +25% to $647M, first GAAP profit, FY guide raised to $2.66–2.69B) but the stock trades ~19% below its $27 IPO and bases near post-IPO lows — a compressed multiple, not an accelerating… Earnings inflection · Fintech & consumer credit analysed · CIEN Ciena Corporation fresh LOW The 1.6T WaveLogic demand cycle is intact at the order book, but the trade has broken: $627.00 (06-02) to ~$370 (07-18) is a ~41% de-rating, and the $455–$467 shelf that framed the prior read is gone. Multiple compression from 54x forward,… Cyclical recovery · Networking & optical catalyst · CLFD Clearfield, Inc. LOW The May earnings-miss squeeze has fully round-tripped to a dead tape in the mid-$30s, below the ~$36 gap base, with the retail-sentiment narrative spent. The sole live driver is the 2026-08-05 fiscal-Q3 print — guided to a sharp sequential… Retail squeeze · Networking & optical · AI datacenter infrastructure analysed · CLMT Calumet, Inc. LOW Deleveraging-plus-SAF-ramp re-rate extended to a new 52-week high at $50.81 after the 2026-08-07 Q2 print; Goldman's second raise in 19 days ($45 on 2026-08-18) still lands below the 2026-08-21 close of $49.01. Nothing dated resolves the… Special situation · Oil, energy & geopolitical · Solar & clean energy analysed · CLPT ClearPoint Neuro, Inc. LOW Picks-and-shovels delivery play on CNS gene therapy: ClearPoint's SmartFlow cannula and MRI navigation are the standard route to the brain for uniQure's AMT-130 Huntington's BLA (soft Q3-2026 window). The June re-rate held near $18.72… Cyclical recovery · Medtech & diagnostics · Rare disease & gene therapy analysed · CLS Celestica, Inc. LOW AI-datacenter EMS picks-and-shovels story still fundamentally climbing after the 2026-04-27 Q1 crush (rev +53% to $4.05B, FY26 guide raised to $19B), but the tape broke ~21% off its $474 June high and heads into a binary 2026-07-27 Q2… Cyclical recovery · AI datacenter infrastructure · Cyclical industrials catalyst · CLYM Climb Bio, Inc. LOW Anti-CD19 autoimmune re-rate: budoprutug's 2026-06-11 EHA ITP data (>90% B-cell depletion, n=15) plus $239.2M cash funding into 2H 2028 lifted CLYM to a 52-week high at $16.33 on 2026-08-14. The 2026-09-03 R&D Spotlight (CLYM116 Phase 1… Earnings inflection · Precision biotech & therapeutics catalyst · CMBT CMB.TECH NV LOW July's non-confirmation resolved upward: CMBT closed 2026-08-14 at $17.24, a 52-week high on the adjusted series, RSI 79.4, into a confirmed 2026-08-27 Q2 print whose rates were pre-disclosed on 2026-05-19 (81% of VLCC days at… Special situation · Oil, energy & geopolitical · Freight & logistics catalyst · CNMD CONMED Corporation LOW Six weeks on, the deal leg is still the only unresolved one: no process headline since 2026-07-10, no sell-side action since 2026-07-30, no company event dated inside 30 days — yet price drifted to $51.07 on 2026-08-21, 10.9% above the… Earnings inflection · Medtech & diagnostics · M&A & special situations analysed · CNTA Centessa Pharmaceuticals plc LOW Closed cash-plus-CVR takeout; nothing trades. Lilly's scheme ($38.00 cash plus a non-transferable CVR of up to $9.00) went effective 2026-06-24, Form 15-12G dated 2026-07-06. New since the last note: ClinicalTrials.gov lists a Phase… Earnings inflection · M&A & special situations · Precision biotech & therapeutics analysed · COCO The Vita Coco Company, Inc. LOW Q2 FY26 (2026-07-23) beat on every line — net sales $216.2M +28.1%, EPS $0.82 vs ~$0.55, FY guide raised to $790–805M — and the stock still closed $62.25 on 2026-08-07, -25.9% from the post-print high. Beat-and-raise absorbed by sellers;… Compounder · Consumer discretionary rotation · Cyclical industrials analysed · COMP Compass, Inc. LOW Now stretched into a binary ~2026-07-29 Q2 print ($4.0–4.2B guide) with an open NY AG antitrust probe. Special situation · Housing, homebuilders & proptech · Cyclical industrials catalyst · CORT Corcept Therapeutics Incorporated LOW Lifyorli oncology launch (approved 2026-03-25, NCCN preferred) re-accelerated the tape to fresh 52-week highs near $92, and the 2026-06-17 Cushing's relacorilant resubmission (~Dec PDUFA) adds second-approval optionality. But a fresh entry… Earnings inflection · Oncology & immunology · Binary-catalyst biotech catalyst · COTY COTY INC LOW De-lever leg stalled rather than broke: FY26 net debt fell to $2,912.1M but leverage still printed 3.4x as EBITDA fell 22% to $846.9M, and management withheld FY27 guidance until the Consumer Beauty review closes by end-CY26. RBC cut to… Special situation · Consumer discretionary rotation catalyst · CPIX Cumberland Pharmaceuticals Inc. LOW Deal-arb thesis is now spent: the $100M Apotex asset sale closed 2026-07-01 after a 99.84% shareholder vote on 2026-06-24, so the dated binary that drove the ~3.2x off $1.85 to a $7.36 high is consumed. What remains is a cash-rich clinical… Special situation · M&A & special situations · Precision biotech & therapeutics analysed · CRCT Cricut, Inc. LOW Hardware-to-platform crossover still holding the 2026-08-05 gap: Platform revenue $85.0M now exceeds Products $71.3M, but the Q2 margin fuel was $26.7M of one-time credits and the CEO sold ~360k shares between 2026-08-03 and 2026-08-19.… Special situation · Consumer discretionary rotation · Bitcoin miners analysed · CRL Charles River Laboratories International, Inc. LOW Post-2026-08-05 demand-recovery leg extended to a new 52wk high at the 2026-08-21 close of $295.19 (RSI 86.6, +84.1% over three months) with no rating action since TD Cowen's $300 on 08-10 — price is now inside the $282-$310 target band.… Special situation · Medtech & diagnostics · Precision biotech & therapeutics catalyst · CRNX Crinetics Pharmaceuticals, Inc. LOW Not a narrative any more: the Vertex $85.00/share cash takeout cleared HSR on 2026-08-12, the stockholder vote is 2026-08-28, and closing is guided to early September. At the 2026-08-14 close of $84.70 the gap to terms is $0.30 against… Earnings inflection · M&A & special situations · Rare disease & gene therapy catalyst · CROX Crocs, Inc. LOW Legacy-brand turnaround with fundamentals intact and the tape unwinding: after the 2026-07-30 beat-and-raise (FY2026 adj EPS $13.70–$14.00), shares fell from $131.72 on 2026-08-14 to $122.11 on 2026-08-21, RSI(14) 32.9, -13.5% from the… Special situation · Consumer discretionary rotation · Cyclical industrials catalyst · CRS Carpenter Technology Corp LOW Aero-defense superalloy pricing cycle intact (three contracts at >30% hikes; Q4 op-income guide $205-210M, +37% YoY), but the July flush to $532 has been bought back to ~$603 straight into the 2026-07-30 Q4 print — now four sessions out… Cyclical recovery · Critical materials & rare earths analysed · CRSR Corsair Gaming, Inc. LOW Post-print margin leg has lost its price structure: after a 2026-08-07 close of $14.35 (52-wk high), CRSR closed 2026-08-21 at $10.93, -23.8%, and Goldman initiated at Sell with an $11 target on 2026-08-19 over AI-driven DRAM cost… Special situation · Consumer discretionary rotation · AI chips & memory catalyst · CRTO Criteo S.A. LOW Takeover-premium leg is dead and the tape kept going: the 2026-07-06 Vista/Quinti gap is fully filled, no party has confirmed anything in 46 days, and the 2026-08-05 guide cut re-based FY26 contribution ex-TAC to $1.034–1.058B from… Earnings inflection · M&A & special situations · AI enterprise software analysed · CRVS Corvus Pharmaceuticals, Inc. LOW Calendar still empty until 2027 after the 2026-08-06 push-out (PTCL futility Q1 2027, no data released; SIERRA1 topline Q3 2027), but the tape has recovered: $14.46 close on 2026-08-21 with RSI 62.4 versus $13.92 and RSI 47.5 on… Earnings inflection · Oncology & immunology · Binary-catalyst biotech analysed · CRWD CrowdStrike Holdings, Inc. LOW The August breakout leg has been given back: price closed 2026-08-21 at $191.95, 14.9% under the $225.53 52-week high, while eleven brokers set targets between $205 and $250 in the same five sessions. The binary was pulled forward — Q2… Compounder · Cybersecurity · AI datacenter infrastructure catalyst · CSCO Cisco Systems, Inc. LOW Legacy-networker AI re-rate intact and now at its binary: the $118–120 shelf held through July, price closed $121.43 on 2026-08-07 with RSI(14) at 78.4, and five sell-side target raises landed 07-22 → 08-06 (Citi $112→$139) ahead of the Q4… Special situation · AI enterprise software · Networking & optical catalyst · CSIQ Canadian Solar Inc. LOW Reshoring leg still bidless: the 2026-08-18 dismissal with prejudice of Maxeon's US TOPCon suit and the 2026-08-12 Carwarp COD followed the 2026-07-24 cell-plant opening, and the 2026-08-21 close of $14.55 broke under the 2026-07-08 low of… Special situation · Solar & clean energy · Cyclical industrials catalyst · CTRN Citi Trends, Inc. LOW Sales were pre-released on 2026-08-10 ($211.6M, comps +10.5%), so the 2026-08-25 print is now a pure margin-and-guidance binary. Price faded from $73.91 (08-14) to $71.71 (08-21) with RSI back to 55.6 and no new high above $76.18 — the… Retail squeeze · Consumer discretionary rotation · Biofuels & low-carbon fuels catalyst · CTSH Cognizant Technology Solutions Corporation LOW Legacy IT-services franchise being re-underwritten as an enterprise-AI deployment partner; the leg still works — $61.87 on 2026-08-21, up 18.0% over three months — but the sell-side revision wave ended 2026-07-30, price now sits ~3% under… Special situation · AI enterprise software · AI datacenter infrastructure analysed · CVLG Covenant Logistics Group, Inc. LOW The margin-inflection leg broke at its own catalyst: Q2 (2026-07-29) adjusted OR 95.9% vs 94.6% PY — second straight quarter of YoY deterioration — revenue $332.9M missed $340.4M, and Stephens cut its 23-day-old target to $54 on 07-31.… Defensive · Freight & logistics · Managed care & health services catalyst · CXT Crane NXT, Co. LOW Beat-and-raise on 2026-08-05 has been fully sold: the ~$56.23 post-print quote gave way to a $50.20 close on 2026-08-21, RSI 39.3, and 2026-08-19 opened $48.06 with no company release behind it. Organic growth was only 2.8% of the 22%… Special situation · M&A & special situations · Cyclical industrials catalyst · DDD 3D Systems Corporation LOW June's $50M raise at $3.05 (16.4M sh) is already underwater: shares last $2.775 (2026-07-02), below the offering floor, with ~$50M shelf undrawn and soft Q2 guidance (rev $93–95M, adj. EBITDA still negative) into the 2026-08-10 print. A… Special situation · Defense & aerospace · Critical materials & rare earths analysed · DDOG Datadog, Inc. LOW June's sell-side upgrade wave has exhausted and the first cut printed — Bernstein to Market Perform (PT $226, 2026-07-06) as the stock rolled over. AI-observability narrative intact but maturing; the $278.71 parabola round-tripped and the… Theme leader · AI enterprise software · GPU cloud & neoclouds catalyst · DFTX Definium Therapeutics, Inc. LOW Voyage GAD read out positive on 2026-08-12 — HAM-A 5.4 points over placebo at Week 12, p<0.0001, Cohen's d 0.81 — and eight target actions followed inside seven sessions. Yet the 2026-08-21 close of $44.91 sits under the pre-readout $46.14… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics catalyst · DIOD Diodes Incorporated LOW The AI-server/auto power-content re-rate that carried DIOD to a ~$126 all-time high (June 18) has round-tripped: a double-top, an analyst downgrade, more insider selling and a sector-wide semi selloff pushed it to ~$96 by July 10, through… Theme leader · Analog semiconductors · AI datacenter infrastructure analysed · DJT Trump Media & Technology Group Corp. LOW Fusion pivot is the leg: the 2025-12-18 all-stock TAE Technologies merger (>$6B, ~50/50 fully diluted) is what's actually being bought, while the crypto-treasury leg was terminated 2026-08-07. The S-4 was still unfiled as of 2026-08-05,… Special situation · Cyclical industrials · AI datacenter infrastructure analysed · DLTR Dollar Tree Inc. LOW Guide-raise leg resolves in four sessions: the 2026-08-27 Q2 print (8:00 a.m. ET call, Dollar General the same morning) is the binary. At the 2026-08-21 close of $131.48 the stock trades above both aggregated mean targets ($127.32 /… Special situation · Consumer discretionary rotation · M&A & special situations catalyst · DNUT Krispy Kreme, Inc. LOW Attention returned before the fundamentals changed: BofA lifted its target to $4.90 on 2026-08-10 and the Pokémon collection hit shops 2026-08-18, carrying the close from $3.33 (08-14) to $3.59 (08-21) with RSI(14) at 69.9. The… Retail squeeze · Consumer discretionary rotation · M&A & special situations catalyst · DOCN DigitalOcean Holdings, Inc. LOW The $117 condition from the 2026-08-08 note broke: the 2026-08-21 weekly close is $115.64, under the $117.54 July placement price, with the 200-day at $113.47 just below. Theme leader · GPU cloud & neoclouds · AI datacenter infrastructure analysed · DOCU DocuSign, Inc. LOW Legacy e-signature base re-wrapped as AI agreement management: IAM went 10.8%→12.6% of ARR in a quarter and is guided to ~18% by 2027-01-31, while total growth is still guided to decelerate to ~8%. The 2026-09-03 Q2 print is now confirmed… Special situation · AI enterprise software catalyst · DRD DRDGOLD Ltd. fresh LOW Unhedged tailings-retreatment gold leverage: FY2026 (reported 2026-08-19) beat guidance at 155,577 oz with R2.3bn free cash flow, zero debt, and Vision 2028 guiding toward six tonnes by 2028. But the catalyst already fired — the ADR closed… Compounder · Critical materials & rare earths catalyst · DSGN Design Therapeutics, Inc. LOW A new 52-week high of $15.94 printed in August with no company release since the 2026-08-03 Q2 update, which pushed the next hard data to Q1 2027. RSI(14) 73.9 at the $14.99 close (2026-08-21) and +21.9% for the month, into a 30-day… Earnings inflection · Precision biotech & therapeutics · Rare disease & gene therapy analysed · DUOT Duos Technologies Group, Inc. LOW The pivot is now structural: the rail subsidiary was sold 2026-08-05 (related party — interim CFO owns 50% of the buyer), leaving an edge-colocation operator carrying a 2026-07-16 five-year 10 MW hyperscaler contract worth >$111M. The tape… Special situation · AI datacenter infrastructure · GPU cloud & neoclouds catalyst · DVA DaVita Inc. LOW The $175 weekly-close level from the prior note broke: DVA closed 2026-08-21 at $173.82, 27.9% under the $240.96 high, RSI(14) 10.9, with no company news or filing since the 2026-08-04 Q2 print. The census-recovery re-rate is dead;… Special situation · Managed care & health services analysed · DXC DXC Technology Company LOW Legacy IT-services decliner re-rated on an AI-centric pivot, now digesting: the partnership headline run stopped 2026-08-06, Paul Taylor's presidency took effect 2026-08-10, and price went flat ($10.84 on 08-07 to $10.80 on 08-21) while… Special situation · Cyclical industrials · AI enterprise software analysed · DXCM DexCom, Inc. LOW CGM leader's recovery has aged from catalyst-pop to an analyst-revision grind — Mizuho $90 (7/15), Truist $87 (7/16) into a ~7% two-day pop to $76.65 — but price is high-$70s still under the 200-EMA and the confirmed July 30 Q2 print is… Defensive · Medtech & diagnostics · Precision biotech & therapeutics analysed · DXYZ Destiny Tech100 Inc. LOW Scarcity premium re-underwritten on Anthropic, not SpaceX: DXYZ ran $22.51 (2026-07-28) to $34.43 (2026-08-21), back above the last reported $24.56 NAV (2026-03-31), on Anthropic's June S-1 and $65B July run rate. RSI 89.6, the $1B ATM is… Retail squeeze · AI datacenter infrastructure · Space economy catalyst · EDRY EuroDry Ltd. LOW Dry-bulk operating leverage ran ahead of its own driver: EDRY closed at a 52-week high $46.85 on 2026-08-21 with RSI(14) 91.2, while the BDI sat at 2,841 versus 3,046 on 2026-08-11 and Panamax spot earnings of $18,790/day (2026-08-20) fell… Compounder · Small-cap value rotation · Freight & logistics analysed · EFOR Everforth, Inc. LOW Legacy IT-services base re-rating on an AI-delivery pivot. Since the 2026-07-30 print-day +16.3%, the move has digested rather than reversed: RSI(14) unwound from 94.5 (2026-08-07) to 66.9 at the 2026-08-21 close of $32.70 with price flat.… Special situation · Defense & aerospace · Managed care & health services catalyst · ELVR Elevra Lithium Limited LOW Lithium-recovery narrative re-accelerating off a low base: GFEX carbonate turned (LC2609 CNY 146,360/t on 2026-08-10, +6.24% in six sessions) and on 2026-08-21 Elevra signed a binding 7-year, 144,000 dmt/yr take-or-pay offtake with… Compounder · Critical materials & rare earths · Freight & logistics catalyst · EMBC Embecta Corp. fresh LOW Post-collapse levered stub has now run past its own sell-side: the 2026-08-21 close of $5.23 sits above the highest of four published 12-month targets ($5.00), short interest rose to 12.20% of float from 10.99% on 2026-08-11, and the… Special situation · Medtech & diagnostics analysed · ENOV Enovis Corporation LOW Post-Colfax orthopedic pure-play turnaround: LimaCorporate integration plus FCF-conversion recovery (43% in 2024 toward a 70–80% target) is the self-help story, but price has rolled over from $34 toward $27 while three brokers cut targets.… Special situation · Medtech & diagnostics · Cyclical industrials analysed · ENPH Enphase Energy, Inc. LOW IQ SST AI-data-center pivot (announced 2026-04-28) that drove a spring squeeze has stalled — stock de-rated ~16% in a month to ~$45 (2026-07-09), sell-side uniformly neutral with PTs on top of price (Susquehanna $45, 2026-07-10), and SST… Special situation · Solar & clean energy · Industrial power & grid analysed · EPAM EPAM SYSTEMS, INC. LOW Compounder narrative broken on 2026-08-06: FY26 organic constant-currency growth cut to 2.0%–3.0%, Q3 guided to ~1.7% YoY. Price has stalled rather than extended lower ($99.90 close 2026-08-11 vs $97.43 on 2026-08-07), but the AI-native… Special situation · Cyclical industrials · Managed care & health services analysed · EPC Edgewell Personal Care Company LOW Two legs: a refused $30 take-private approach (2026-06-22) and a first clean quarter (fiscal Q3 organic +1.1%, adjusted EPS $0.72 vs $0.62). Sixty days on there is no competing bid, no process and no 13D, and the shares have coiled within… Earnings inflection · M&A & special situations · Consumer discretionary rotation catalyst · EQNR Equinor ASA LOW European winter gas-security theme re-accelerating; Equinor, the swing Norwegian pipeline supplier, held ~$40 through a Q2 double-miss on a $1.125B buyback bid. Defensive · Oil, energy & geopolitical · Cybersecurity catalyst · ERAS Erasca, Inc. LOW Funded pan-RAS story with part of its calendar restored: the 2026-08-11 Q2 release dates ERAS-4001 BOREALIS-1 preliminary Phase 1 data to H2 2026, ahead of the H1 2027 ERAS-0015 cut. But the 2026-08-21 close of $17.63 sits on the $17.50… Earnings inflection · Oncology & immunology · Binary-catalyst biotech analysed · ERO Ero Copper Corp. LOW Copper-squeeze beta finally re-rated: the 2026-08-21 close of $39.42 is a new 52-week high (RSI 78.1, +46.1% over three months) clearing the prior $38.03 high — but it printed in the week the LME squeeze unwound (backwardation above… Cyclical recovery · Industrial power & grid · Critical materials & rare earths analysed · ESPR Esperion Therapeutics, Inc. LOW Resolved and off the tape. ARCHIMED's take-private closed 2026-07-13 at $3.16 cash plus a non-tradeable CVR of up to $100M; Nasdaq was asked to file Form 25 the same day and reporting duties are being suspended by Form 15. The early-August… Earnings inflection · M&A & special situations · Precision biotech & therapeutics analysed · ESTC Elastic N.V. fresh LOW AI-retrieval-layer narrative accelerating: Q4 FY26 total RPO $1.98B grew 28% YoY against revenue +16%, and the 2026-07-30 OpenAI partnership re-rated the name 56.8% in three months. The 2026-08-27 Q1 FY27 print is the binary — company… Theme leader · AI enterprise software catalyst · EVC Entravision Communication LOW Smadex AI-DSP re-rate broke to a new 52-week high of $13.48 with no dated company news since 2026-07-12 — an anticipatory leg into the 2026-08-10 Q2 print, the binary on whether Q1's +204% ATS growth and ~22% EBIT margin held.… Special situation · AI enterprise software · Cyclical industrials analysed · EVH Evolent Health, Inc LOW The late-June retail bounce has fully unwound — EVH traded ~$5.76 on 2026-07-07, back under the $6.59–6.86 consensus target band and well under Truist's flat $7. Nothing carries the name now except the confirmed 2026-08-06 Q2 print, which… Earnings inflection · Managed care & health services · Oncology & immunology analysed · EXFY Expensify, Inc. LOW Legacy expense-SaaS pivot re-rated on the 2026-08-06 Q2 print: revenue $33.9M beat $33.688M, paid-member decline halved to -2% YoY, FY26 FCF guide doubled to $12M-$14M, ~7% of shares retired, and New Expensify ARR from net-new customers… Special situation · AI enterprise software analysed · EXTR Extreme Networks, Inc. LOW Legacy campus-networking name re-rating ~+140% off Feb lows on the Platform ONE / Agent ONE AI-NetOps story plus SaaS ARR +29% YoY; theme still accelerating but spot ($33.71, 07-10) has run through consensus PT $29.06 into the June bull… Special situation · Networking & optical · AI enterprise software catalyst · FAC Factorial Energy Inc. LOW Freshly de-SPAC'd solid-state battery name has fully unwound its debut mania — down ~78% from the $25.33 ATH to ~$5.67, breaking clean through the former $9.26 floor into a fresh 52-week low at $4.24. Cantor's $18 target now sits ~217%… Defensive · Solar & clean energy · Freight & logistics analysed · FBIN Fortune Brands Innovations, Inc. LOW Activist-plus-new-CEO turnaround has stopped accelerating and started digesting: after the +30% run off Garden's $40.6 buy, price has chopped $50–54 for three weeks while sell-side targets climbed past spot (Goldman $61 on 7/10, Barclays… Special situation · Housing, homebuilders & proptech · Cyclical industrials catalyst · FBRX Forte Biosciences, Inc. LOW Deal-spread endgame: HSR expired 2026-08-18 (SC 14D9/A filed 2026-08-19), leaving only the >50% minimum tender before argenx's $77.00 all-cash offer expires 2026-08-26. The 2026-08-21 close of $76.92 leaves $0.08 of gross gap. Upside is… Earnings inflection · Precision biotech & therapeutics catalyst · FCEL FuelCell Energy, Inc. LOW Street targets re-rated up to the price rather than the reverse: average PT $22.83 across 8 analysts vs the 2026-08-07 close of $20.43, after B. Riley $13→$32 (6/29) and UBS $22→$27 (7/14). The AI-power bid still works (7/30 Microsoft… Retail squeeze · AI datacenter infrastructure · Industrial power & grid catalyst · FDMT 4D Molecular Therapeutics, Inc. LOW Wet-AMD one-and-done durability narrative accelerating on the 2026-07-18 PRISM 2-year data (78% injection-burden reduction, 2.7 vs 12.0 projected, n=30) plus a 2026-07-31 Buy initiation at PT $37 and a 2026-08-13 Q2 beat. Price is 5.5% off… Earnings inflection · Precision biotech & therapeutics analysed · FIG Figma, Inc. LOW Design incumbent re-rated as an AI winner (BofA Buy, $30 PT, 7/7) rather than an AI casualty, yet the stock churns below its 100/200-day moving averages with heavy short interest into its first public earnings print on 8/5 — that print,… Earnings inflection · AI enterprise software catalyst · FIVN Five9, Inc. LOW Legacy-CCaaS AI pivot staged a sharp V-recovery: +29% off the $19.70 June swing low to $25.42, reclaiming the broken $22 shelf on a 2026-06-23 next-gen Voice AI Agents launch and an AI-first leadership overhaul. Now pressing the $26.26… Special situation · AI enterprise software catalyst · FLEX Flex Ltd. LOW AI-manufacturing re-acceleration: the 2026-07-09 Cerebras CS-3 production expansion is the first company-specific bid since the S&P-inclusion +6% pop round-tripped to ~$147, refreshing the data-center power/EMS narrative into the ~07-29 Q1… Special situation · AI datacenter infrastructure · Industrial power & grid catalyst · FLY Firefly Aerospace Inc. fresh LOW Narrative and price have fully decoupled: FLY stacked a $144M CLPS award, a Moon BASE seat and a $13M Mars subcontract into a -47% drawdown, falling 9.6% on 7/16 on the awards headline itself. At $19.27 vs a $45 IPO price and 31% below the… Defensive · Space economy catalyst · FN Fabrinet LOW Optical cluster re-accelerated in July (AAOI +390% YTD, LITE +138%, COHR +107%) while Fabrinet sits ~$478, +0.7% YTD and ~36% under its $748.89 high. Revenue compounds at +30% but the tape has decoupled from its own theme — a… Cyclical recovery · Networking & optical · AI datacenter infrastructure analysed · FOUR Shift4 Payments, Inc. LOW Payments roll-up at ~$50, a hair above its $46.26 52-week low set on a 2026 guide-down. The Global Blue tax-free-shopping integration ("Shift4 One," launched 2026-07-14) is the transformation leg, but the 2026-07-30 Q2 print is the binary… Earnings inflection · Fintech & consumer credit · Travel & leisure catalyst · FPS Forgent Power Solutions, Inc. LOW Second secondary in five weeks — ~43.6M shares at $49 on July 2, now including company primary dilution — confirms the recurring-supply pattern and dragged the stock from its $65.56 June-4 ATH back to the offering line. The… Theme leader · Industrial power & grid · AI datacenter infrastructure catalyst · FRD Friedman Industries Inc. LOW Tariff-driven HRC steel prices at multi-year highs powered record FY2026 (EPS $2.76, sales +46%); FRD hit an all-time-high close $37.42 on 2026-06-18 and was flagged overbought the same day. The narrative is maturing and priced near the… Defensive · Cyclical industrials · Critical materials & rare earths catalyst · FTRE Fortrea Holdings Inc. LOW Post-spin margin-repair narrative is now fully written into sell-side models and no longer into the tape: five target raises through 2026-08-04 (TD Cowen $23) met a slide from $19.17 (7/31) to $17.41 (8/14), surrendering the July… Special situation · Oncology & immunology · Precision biotech & therapeutics catalyst · FWRD Forward Air Corporation LOW Busted-merger workout losing its bid: the +48% June bounce to $14.87 (on a speculative Amazon-bolt-on thesis) has faded ~13% to ~$13, whole-company sale is now reported "unlikely," and the 2026-07-10 chairman exit forfeited… Earnings inflection · Cyclical industrials · Freight & logistics analysed · G Genpact Limited LOW Agentic-operations pivot keeps compounding in the segment data — ATS +24.1% to $363M, FY guide lifted to at least 25% on 2026-08-06 — while the 73% legacy book grew 1.9% and caps consolidated growth near 7%. The 10-Q filed 2026-08-07… Special situation · AI enterprise software · Managed care & health services catalyst · GBTG Global Business Travel Group, Inc. LOW Take-private in its final leg: stockholders adopted the $9.50 Long Lake merger on 2026-08-03, and the 2026-08-14 close of $9.46 leaves $0.04 gross against a roughly 37% break tail to the unaffected $5.93. Only undated offshore regulatory… Earnings inflection · M&A & special situations · Consumer discretionary rotation analysed · GCMG GCM Grosvenor Inc. LOW Alternatives-manager re-rate stalled — GCMG printed a new $14.38 high on the 2026-07-13 Piper upgrade, then reversed ~15% to a $12.20 close into the 2026-08-06 Q2 binary. The AI-datacenter infra/private-credit fundraising thesis is intact… Theme leader · AI datacenter infrastructure · Biofuels & low-carbon fuels catalyst · GCO Genesco Inc. LOW The operating turnaround is real but priced, and its one asymmetric leg — the activist proxy fight — lost its teeth: ISS (2026-07-07) backed all nine board directors and urged holders to withhold from the two Radoff/Jumana nominees, so the… Earnings inflection · Consumer discretionary rotation · Cyclical industrials catalyst · GENI Genius Sports Limited LOW Sports-data toll-booth under the prediction-market boom, but the boom arrived and the toll didn't: Kalshi/Polymarket cleared $50B+ of World Cup volume (Coindesk, 2026-07-14) while GENI slid $6.43 → $6.30 and printed $5.98 intraday July 17.… Cyclical recovery · Prediction markets & betting · AI datacenter infrastructure catalyst · GFS GlobalFoundries Inc. LOW Photonics/CHIPS delivery kept accelerating — comms/data-center revenue +62% YoY in Q2 (2026-08-05), $300M Commerce LoI 2026-07-29 — while the multiple collapsed 39.2% from the $89.83 52wk high to $54.58 on 2026-08-14. What's on offer is a… Cyclical recovery · Semi foundry & equipment analysed · GGAL Grupo Financiero Galicia S.A. LOW Argentina disinflation is still working — June CPI printed 1.9% MoM on Jul 14, an improvement on May's 2.1% — but the ADR faded the good print, dropping ~7% on the week to ~$50 and losing both the $51.07 50-day and the $52.86 200-day.… Compounder · Emerging markets catalyst · GLUE Monte Rosa Therapeutics, Inc. LOW ZEUS (ziltivekimab, MACE HR 0.99) failed on 2026-07-31 and took GLUE −27.16% to $16.52, its worst session on record, because the hsCRP-to-outcomes link under MRT-8102's ASCVD story is exactly what ZEUS could not demonstrate. Platform,… Earnings inflection · Precision biotech & therapeutics · Oncology & immunology analysed · GOLF Acushnet Holdings Corp. LOW Premium-golf consumable franchise (Titleist Pro V1) that ran to a $119.65 all-time high on a defensive-quality rotation, then bled ~11% of the mania premium back to the ~$104–105 June breakout shelf ($104.66 on 2026-07-24). The 2026-08-06… Compounder · Consumer discretionary rotation · Cybersecurity catalyst · GOOG Alphabet Inc. LOW Q2 (2026-07-22) beat — revenue $119.8B +24%, Cloud +82%, backlog $514B — and the stock still fell on capex raised to $195–205B; the ~$370 shelf broke and has not been reclaimed. The leg on offer is Cloud backlog conversion against a tape… Compounder · Mega-cap AI platforms analysed · GRPN Groupon, Inc. LOW The prior $20 break condition registered on the 2026-08-21 weekly close of $19.59, the second shelf lost in eight sessions after $22 went on 2026-08-14. RSI(14) at 4.6 with the reported short base UP to 13.73M shares — it built into the… Retail squeeze · Squeeze & momentum setups · Consumer discretionary rotation catalyst · GSHD Goosehead Insurance, Inc. LOW Post-print re-rating extended on no new information: the 2026-08-21 close of $72.52 is above UBS's $72, above KBW's $72 and above the ~$71 aggregator consensus, while founder-side Class B conversions sell into it. No dated company catalyst… Earnings inflection · Managed care & health services · Small-cap value rotation analysed · GSM Ferroglobe PLC LOW US trade-remedy leg: the 2026-08-03 USITC affirmative vote forces AD/CVD orders on Australian and Norwegian silicon metal, on top of Angola/Laos orders live since 2026-03-17. Q2 (2026-08-04) delivered the sequential recovery — $13.1M adj… Cyclical recovery · Critical materials & rare earths analysed · GTM ZoomInfo Technologies Inc LOW Legacy B2B data business trying to re-price as the data layer under AI go-to-market agents. The 2026-08-05 post-print gap is intact but unextended — $3.97 on 2026-08-21, RSI(14) cooled 76.9→58.9 — and the 2026-08-11 Microsoft Copilot MCP… Special situation · AI enterprise software · AI datacenter infrastructure catalyst · GTN Gray Media, Inc. LOW August's double catalyst — FCC 2-1 repeal of the 39% ownership cap (2026-08-06) and a Q2 beat-and-raise (2026-08-07) — has stopped extending: the 2026-08-21 close of $4.94 lost the $5.00 handle and sits 18.7% under the $6.07 52-week high.… Special situation · Fintech & consumer credit · Precision biotech & therapeutics analysed · GTX Garrett Motion Inc. LOW Turbo cash-cow re-rated (~8–9x → ~18x) on a datacenter/industrial oil-free cooling narrative; the parabolic Feb→June leg (~$20→$36) is spent, shares faded ~11% to the 50-day near $32.30, and the ~late-July Q2 print is the first chance to… Special situation · AI datacenter infrastructure · Cyclical industrials catalyst · GWRE Guidewire Software, Inc. LOW The August breakout extended to $189.19 on 2026-08-21 (RSI 76.2, +34.9% over three months), with Oppenheimer lifting its target to $200 on 2026-08-17 — but price now sits ~6% under the ~$201 consensus and above two of the five most recent… Theme leader · AI enterprise software catalyst · HAE Haemonetics Corporation LOW Legacy medtech pivot moved from promised to reported: the 2026-08-06 Q1 FY2027 beat ($339.4M vs $327.9M, adj EPS $1.14 vs $1.08) turned Interventional Technologies positive (+2.8% organic vs −10.3% in Q4) and lifted FY2027 organic guidance… Special situation · Medtech & diagnostics analysed · HELE Helen of Troy Limited LOW Deleveraging-stub leg broke out: 2026-08-14 close $30.22 is a 52-week closing high with no dated news behind it, above the $26.50 consensus target and both published targets. Forward P/E re-rated 7.55→8.25 on an unchanged $3.25–$3.75 FY27… Special situation · Consumer discretionary rotation · M&A & special situations catalyst · HELP Cybin Inc. fresh LOW Post-dilution CNS microcap re-firing with the psychedelic cohort (ATAI, CMPS all moving 2026-07-16) after a June social-velocity blowoff and a 10.3M-share secondary at $4.85. Both covering shops cut targets in July while holding Buy. No… Retail squeeze · Precision biotech & therapeutics analysed · HIMS Hims & Hers Health, Inc. LOW GLP-1 reaccel gets marked to market on 2026-08-10: guide $680-700M (+25-28%) vs Q1's +4%, street at $698.9M. Since the last note the FTC/CA/UT sued (2026-07-29, N.D. Cal.), BofA cut $37 to $30, and Amazon ($50/mo Medicare GLP-1,… Retail squeeze · Managed care & health services · Precision biotech & therapeutics analysed · HIVE HIVE Digital Technologies Ltd. LOW BTC-miner→AI-compute re-rating has its first blue-chip proof — BUZZ HPC's $220M Bell/Cohere sovereign-AI GPU deal (~$70M ARR) on top of $35M contracted ARR — but the stock stalled ~$3.79 below its early-June highs as BTC bled ~45-50% off… Special situation · Bitcoin miners · GPU cloud & neoclouds catalyst · HNST The Honest Company, Inc. LOW Margin re-rate is consolidating rather than fading: $5.05 on 2026-08-21 is 7.5% under the 2026-08-07 high of $5.46 with RSI down from 83.3 to 72.2, and Morgan Stanley's 2026-08-13 raise to $5.7 restored a target above the market. Nothing… Special situation · Consumer discretionary rotation catalyst · HOV Hovnanian Enterprises, Inc. Class A LOW The housing-bill leg is spent — the Act auto-enacted 2026-07-11 and nothing dated has replaced it — yet HOV has re-rated to $137.78 (2026-08-07), 11.8% off the $156.16 high, on no company news. The confirmed 2026-08-20 Q3 print (quarter… Earnings inflection · Housing, homebuilders & proptech · Cyclical industrials catalyst · HROW Harrow, Inc. LOW Post-Q2 this is a leverage-and-execution show-me: the reaffirmed $350–365M FY guide needs H2 to roughly double the $114.9M booked in H1, against $292.4M loans payable net and $14.8M equity. The 2026-08-20 IHEEZO comfort data supports the… Earnings inflection · Precision biotech & therapeutics · Managed care & health services analysed · HTFL Heartflow, Inc. LOW AI coronary diagnostics re-rated on the 2026-08-13 Q2 print: revenue +48% YoY to $64.1M, FY26 guide lifted to $246–250M from $228–232M, Plaque revenue $7.8M running ~$4M ahead of plan, six targets raised on 2026-08-14. Narrative is… Compounder · Medtech & diagnostics analysed · HTLD Heartland Express, Inc. LOW Margin-recovery leg is already printed — Q2 OR 91.0% vs 105.9% — but flattered by $25.0M of equipment-disposal gains, and the beat drew no sustained bid (Barclays cut to $12 on 2026-08-13, after it). Price has since stabilised near $12–$13… Special situation · Freight & logistics · Cyclical industrials catalyst · HUBS Hubspot, Inc. LOW Agentic-monetization leg still broken since the 2026-08-05 print (7,000 net adds vs 9,000–10,000 guided; Q3 guided +14%), but price has retraced from the 2026-08-07 close of $210.45 to $240.01 on 2026-08-21 with zero new company data —… Special situation · AI enterprise software catalyst · HZO MarineMax, Inc. fresh LOW Deal pin rather than a growth story: the $53.00 all-cash Safe Harbor/Blackstone Infrastructure take-private, signed 2026-08-09, leaves $0.80 to terms at the 2026-08-21 close of $52.20. What trades now is HSR/FDI clearance and a shareholder… Earnings inflection · Consumer discretionary rotation catalyst · IART Integra LifeSciences Holdings Corporation LOW Med-device turnaround re-rating is now fully banked into Hold-grade targets: BMO initiated Market Perform $19 (Jul 9) and Citi raised to Neutral $19 (Jul 8), both landing on the tape (~$18.76). The distressed-to-fair leg is done; only… Special situation · Medtech & diagnostics analysed · ICHR Ichor Holdings LOW Memory-capex WFE subsystem re-rating broke on the 2026-08-03 Q2 print: revenue $294.8M missed $300.2M consensus, the $78 June shelf failed, and the 2026-08-07 close was $68.32 against a $112.28 high. Q3 guidance still beats ($315–345M vs… Cyclical recovery · Semi foundry & equipment · AI chips & memory analysed · IHRT iHeartMedia, Inc. LOW M&A leg is dead — no SiriusXM headline since the 2026-05-29 NYT "stalled" report and the April spike fully round-tripped ($6.33 high → $3.86 on 2026-08-07, -39%). What is left is a binary: Q2 print 2026-08-10 after the close is the first… Earnings inflection · Cyclical industrials · M&A & special situations analysed · IMMX Immix Biopharma, Inc. fresh LOW Single-asset CAR-T regulatory story: NXC-201 posted a 95% CR rate (19/20) in NEXICART-2 on 2026-05-21 and holds FDA Breakthrough Therapy Designation from 2026-01-28, with a BLA guided for 2026. Price closed 2026-08-21 at its 52-week high… Earnings inflection · Oncology & immunology catalyst · IMRX Immuneering Corporation LOW Busted-catalyst pancreatic biotech: atebimetinib's 17.3-mo single-arm 1L OS is real, but the Phase 3 binary is mid-2028 and the tape keeps fading post-ASCO ($5.11→$4.32 in two weeks) even as targets climb to $18–$30. Cheap… Earnings inflection · Oncology & immunology · M&A & special situations analysed · INBX Inhibrx Biosciences, Inc. LOW Non-dilutive bridge into the 2027-04-14 PDUFA, with one item pulled forward: the 2026-08-13 Q2 release moved the INBRX-106 HNSCC PFS readout into Q3 2026 and dated the CRC registrational FDA meeting to Q4 2026. But the two-week advance… Earnings inflection · Precision biotech & therapeutics · Binary-catalyst biotech analysed · INDI indie Semiconductor, Inc. LOW Automotive ADAS-silicon design-win story keeps improving on paper ($7.4B backlog, $25M radar order, ams OSRAM sensor buy) while the tape stays broken below the ~$4.00 50-day MA; TD Cowen's 2026-07-13 lift to a $4.50 Hold is a thaw, not a… Cyclical recovery · Analog semiconductors · AI chips & memory analysed · INFQ Infleqtion, Inc. LOW Neutral-atom quantum with accelerating government-funded revenue: Q2 revenue $12.633M beat at +116% YoY and FY26 guidance went to ~$43M on 2026-08-12, but the 2026-08-14 close of $12.86 is 50.4% under the $25.95 high after ~$443.7M of… Compounder · Quantum computing analysed · INHD Inno Holdings Inc. LOW The frozen tape resolved against the story: T12 lifted 2026-07-31 at noon ET and the reopen has been one-way — $8.46 on 2026-08-14 (-21.96% that session, RSI 13.8) versus the $39.49 halt print. The June AI-agent narrative is broken, a $60M… Retail squeeze · Squeeze & momentum setups · AI datacenter infrastructure catalyst · INOD Innodata Inc. LOW AI training-data pure-play with a still-accelerating fundamental story (Q1 rev +54%, 40%+ FY26 guide reaffirmed 06-17) but a fully broken chart: ~-51% from the June $125.14 ATH to ~$61, with the CEO filing a fresh 200k-share sale on 07-16… Cyclical recovery · AI datacenter infrastructure · AI enterprise software catalyst · INTA Intapp, Inc. LOW Agentic-AI attach on a compliance-locked professional-firm base, now with a number: Q4 FY26 (2026-08-04) put AI bookings above 20% of net new, and the 2026-08-13 10-K disclosed $833.0M RPO. But the 2026-08-21 close of $41.35 is 25% above… Theme leader · AI enterprise software analysed · IPAR Interparfums, Inc. LOW Quality-defensive re-rating has rolled over: the 2026-08-04 binary passed with a $0.95 EPS miss and an FY guide reaffirmed BELOW consensus ($1.480B/$4.85 vs $1.503B/$4.87), then TD Cowen and Goldman both cut to Hold/Neutral on 2026-08-10… Compounder · Consumer discretionary rotation catalyst · IPX IperionX Limited LOW US critical-minerals sovereignty name whose funding overhang cleared the ugly way: a 2026-07-08 US$50M ADS raise priced at $21.98, ~22% below the ~$28 pre-deal level, resetting the stock to $22.94 near its $21.66 52-week low. Pre-revenue,… Compounder · Critical materials & rare earths · Defense & aerospace catalyst · IQ iQIYI, Inc. LOW Long-form streaming growth is broken in the reported numbers (Q1 2026 revenue -13% YoY, operating income to a RMB228.4m loss), so what is left is the micro-drama/overseas pivot — newly branded as Undercurrent Theater in early August 2026 —… Special situation · AI enterprise software · Squeeze & momentum setups analysed · IRWD Ironwood Pharmaceuticals, Inc. LOW Post-print drift: the 2026-08-06 binary resolved with FY26 guidance raised (revenue $460–485M, adjusted EBITDA above $310M) but both reported lines missing consensus, and two weeks on the stock is unchanged at $4.29, 20.4% under the $5.39… Earnings inflection · Precision biotech & therapeutics · M&A & special situations analysed · IT Gartner, Inc. LOW Post-derate re-rating still working on price but the information flow has stopped: since the 2026-08-04 gap (+23.7%) the only new data is BMO cutting its target to $206 on 2026-08-18 and three insider sales at $184–$191. The 2026-08-21… Special situation · AI enterprise software · AI datacenter infrastructure analysed · ITGR Integer Holdings Corporation LOW Signed-deal instrument since 2026-08-03: KKR's $127.00 all-cash agreement leaves $1.80 above the 2026-08-21 close of $125.20 (~1.4%), unchanged from two weeks earlier. The paperwork stage has begun with no paperwork — no merger proxy on… Earnings inflection · M&A & special situations · Medtech & diagnostics analysed · IVA Inventiva S.A. LOW Single-asset MASH binary, still dormant: zero company news in the 30 days to 2026-08-23, with the undated Q4 2026 NATiV3 topline carrying the whole equity. RSI(14) firmed to 66.7 at the $4.68 close on no flow, while the $4.40 June offering… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics catalyst · JACK Jack In The Box Inc. LOW June's move was a float mechanic — Russell Microcap inclusion (effective 2026-06-30) into a 40%-short float drove $8.92 to $18.13, and it is unwinding ($14.98 on 2026-07-17, -7.76%). SSS is genuinely inflecting (-6.7% → -3.8%), but price… Retail squeeze · Squeeze & momentum setups · Consumer discretionary rotation catalyst · JBIO Jade Biosciences, Inc. LOW The post-Q2 revision leg round-tripped: $24.71 on 2026-08-14 back to $21.34 on 2026-08-21, with the 2026-08-11 target raises (Wedbush $47, Jefferies $48 from $40) marking the high rather than starting a leg. The July shelf near $21 is now… Earnings inflection · Precision biotech & therapeutics · Oncology & immunology analysed · JBLU JetBlue Airways Corporation LOW Fuel-reversion bull leg broke: Brent re-spiked to ~$86 (Jul 17) on renewed Mideast conflict, reversing the sub-$73 tailwind the whole trade needed. Raymond James (Jul 6) cut to Underperform flagging a Chapter 11 that wipes equity; $9.3B… Earnings inflection · Travel & leisure · Consumer discretionary rotation catalyst · JOBY Joby Aviation, Inc. LOW eVTOL cert story still advancing (FAA TIA testing, 2026 Dubai target) but the trade rolled over: ~$8 testing support, down ~33% since June 1, recovery base gone, CFO sold ~half his stake June 8, consolidation coverage marks sentiment… Earnings inflection · EV & autonomous mobility · Defense & aerospace analysed · JWEL Jowell Global Ltd. LOW Low-float China e-commerce microcap that repriced +106% intraday on 2026-08-10 with no filing behind it; the leg being bought is float scarcity (2.38M shares out, $7.3M market cap) plus a 0.04x sales optic. Nothing on the calendar resolves… Retail squeeze · Consumer discretionary rotation · Semi foundry & equipment analysed · KALU Kaiser Aluminum Corporation LOW Section 232 aluminum supply-shock (50% duty through 2027) plus a Q1 earnings inflection already repriced KALU ~+175% YoY to a $195 high; the move is maturing toward saturated with price at/above every published target. The estimated… Special situation · Cyclical industrials · Critical materials & rare earths analysed · KALV KalVista Pharmaceuticals, Inc. LOW Resolved cash takeout, not a live security: Chiesi's $27.00/share acquisition closed 2026-06-11, KALV delisted the same morning, Form 15-12G filed 2026-06-22, and Rule 12g-4 registration termination lands ~2026-09-20. The 2026-06-10 close… Earnings inflection · M&A & special situations · Rare disease & gene therapy catalyst · KARO Karooooo Ltd. LOW Record-subscriber-adds narrative intact but fully priced: KARO closed $63.96 on 2026-08-21, 3.0% under the $65.91 high and at the ~$63 six-analyst average, while founder-CEO Calisto kept selling — six disclosed dates 2026-08-10 to… Compounder · Emerging markets · AI enterprise software catalyst · KC Kingsoft Cloud Holdings Limited LOW China AI-compute capacity story is intact on fundamentals — AI gross billing +90% YoY and past half of public-cloud revenue in Q1 (reported 2026-05-27) — but the price leg broke: -32.3% from the $18.21 high with RSI(14) back at 70.0. The… Cyclical recovery · AI datacenter infrastructure · Emerging markets catalyst · KEEL Keel Infrastructure Corp. LOW Former Bitfarms miner→AI/HPC-datacenter pivot has rolled over: June's push to ~$6.14 into Citizens' $10 initiation retraced to a ~$4.975 ref by 07-06, losing the $5.00 convert shelf and drifting toward the $4.00–4.20 base. Still zero… Special situation · AI datacenter infrastructure · Bitcoin miners analysed · KELYA Kelly Services, Inc. LOW Post-Q2 re-rate extended to a new 52-week high at the 2026-08-21 close of $17.09, but the last dated sponsorship input was Noble's 2026-08-12 estimate raise — price is now running ahead of the research behind it. July temp-help payrolls… Special situation · Small-cap value rotation · Managed care & health services catalyst · KFRC Kforce Inc. LOW Cyclical staffing recovery is fully printed — Q1 returned to YoY growth, Q2 guided +~4% — but price ran ~24% in three weeks to a fresh all-time high near $58.6, ~38% above the $42.33 consensus PT, into the confirmed 2026-07-27 Q2 print. A… Special situation · Managed care & health services · AI enterprise software catalyst · KGS Kodiak Gas Services, Inc. LOW Post-print bounce failed: the ~21% rally off the 2026-08-07 low of $53.90 stalled at the 2026-08-14 close of $65.35, and the 2026-08-21 close of $61.46 sits just above the $59 break level. Record Q2 EBITDA and a raised FY26 guide are in… Special situation · Industrial power & grid · AI datacenter infrastructure analysed · KLAC KLA Corporation LOW The $190 weekly level named in prior coverage broke — 2026-08-21 close $183.99, 38.9% under the $301.37 52-week high — and the three-month change of -2.5% makes the June advance a completed round trip. saturated: the $4.0B ±$200M September… Cyclical recovery · Semi foundry & equipment · AI chips & memory catalyst · KLC KinderCare Learning Companies, Inc. LOW Distressed post-IPO childcare name has retraced ~180% off its $1.75 spring low to $4.93 as growth shifts to B2B/employer care and before-after-school (Champions +17% YoY), while the core ECE business still shrinks (−3% enrollment). The ~13… Special situation · Consumer discretionary rotation · Cybersecurity analysed · KNX Knight-Swift Transportation Holdings Inc. LOW Beat-and-raise verified on 2026-07-22 ($0.63 adj vs $0.35 y/y; Q3 guided $0.71–$0.77), yet no new high followed and the driver is decelerating: all-mode tender rejections 17.22% mid-July → 14.88% early Aug → ~13.46% late Aug. Compounder · Freight & logistics · Cyclical industrials analysed · KOD Kodiak Sciences Inc LOW Binary-catalyst redemption arc now inside its final month: DAYBREAK wet-AMD one-year topline guided September 2026. Price keeps stepping down through good news — $42.64 (07-17) to $41.35 (08-14) to $38.33 (08-21), -17.5% from the $46.44… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics catalyst · KOS Kosmos Energy Ltd. LOW Jubilee ramping toward ~90,000 bopd gross (J76 online, J77/J50 imminent) with GTA LNG volumes climbing. Highest-beta E&P expression bounced ~15% off the $2.00 June low; re-accelerating but still a ~$2.30, 'CCC'-rated, most-levered… Compounder · Oil, energy & geopolitical catalyst · KRT Karat Packaging Inc. LOW Tariff-refund re-rating has now run past almost every published target: the 2026-08-21 close of $48.05 sits under only Lake Street's $50 (raised 2026-08-07) and 41% above B. of A.'s $34. A 10% owner sold at $47.33 on 2026-08-20, and… Defensive · Cyclical industrials · Semi foundry & equipment catalyst · KSS Kohls Corporation LOW Squeeze leg has stalled: Morgan Stanley's 2026-07-06 Underweight/$15 reinit broke the one-way upgrade cluster and knocked the stock -5.9% on 07-08. Price ~$17.18 still holds above the 50- and 200-day, but with the sell-side now two-sided… Retail squeeze · Consumer discretionary rotation · Squeeze & momentum setups catalyst · KURA Kura Oncology, Inc. LOW The binary already fired: KOMZIFTI's 2025-11-13 approval and ~40% R/R NPM1 share are priced, and the $24–28 targets need a frontline Phase 3 that doesn't read until 2028. The tape is drifting — $10.39, lower third of the H1 range. A… Earnings inflection · Oncology & immunology · Precision biotech & therapeutics analysed · KVYO Klaviyo, Inc. LOW Aug 5 binary resolved: Q2 revenue $370.576M (+26%) beat $362.110M and FY26 guide rose to $1.526–1.534B, yet shares fell 13.3% to $16.73 on 2026-08-06 before recovering to $18.49. The growth-compounder narrative is broken — deceleration to… Theme leader · AI enterprise software catalyst · LAC Lithium Americas Corp. LOW Post-Q2 bounce failed: the 2026-08-21 close of $3.14 came while the GFEX carbonate benchmark rose to 152,250 CNY/t — commodity up, equity down. The 2026-08-17 S-3ASR registers 72,553,609 Yorkville resale shares, 19.99% of shares… Compounder · Critical materials & rare earths · Freight & logistics catalyst · LAR Lithium Argentina AG LOW Commodity-beta bounce stopped transmitting: GFEX 2609 extended to CNY 156,140/t on 2026-08-22 while the shares went $6.82 (08-14) to $6.83 (08-21) and RSI cooled 66.8 to 58.6. Lithium-recovery narrative reads saturated; two price targets… Compounder · Critical materials & rare earths · M&A & special situations analysed · LEGN Legend Biotech Corporation LOW In-vivo CAR-T re-rate has matured into digestion: EHA (6/13) confirmed LB2501's 100% ORR and clean durability, but the 6/17 $226M raise at $29.35 capped the leg and JPM's 7/13 Neutral $35 reinstatement caps the Street. No fresh catalyst… Compounder · Rare disease & gene therapy · Precision biotech & therapeutics catalyst · LGIH LGI Homes, Inc. LOW Legislative-spike homebuilder fading into rising rates: LGIH gave back over half its 2026-06-24 ROAD-to-Housing gap, closing $58.52 on 2026-07-17 as ~6.65% mortgage rates dragged the whole builder cohort lower. Q2 closings grew +8.8% YoY,… Compounder · Housing, homebuilders & proptech · Cyclical industrials catalyst · LGN Legence Corp. LOW AI-datacenter MEP/HVAC pick-and-shovel story still improving on fundamentals (record $5.38B backlog, FY guide raised to $4.1–4.3B), but the tape has decoupled: ~33% off the $102 May close high, LGN sliced the $76 breakout shelf and rolled… Cyclical recovery · AI datacenter infrastructure · Industrial power & grid analysed · LIFE Ethos Technologies Inc. LOW Q2 re-rating intact but the leg has gone quiet: the 2026-08-21 close of $34.16 versus $34.02 a week earlier with RSI(14) cooling 91.6→82.3, while four Form 4 filers — President Wang, Sequoia's Nalrena/Spelunker, the CEO and the CAO — sold… Defensive · Small-cap value rotation analysed · LILA Liberty Latin America Ltd. LOW Break-up leg intact but the news flow has flipped from company action to downgrades: Morgan Stanley cut to Underweight $7.00 on 2026-08-20, leaving the 2026-08-21 close of $8.47 above all three dated targets ($6.50/$7.00/$8.00). RSI 51.9… Defensive · M&A & special situations · Emerging markets catalyst · LILAK Liberty Latin America Ltd. LOW Post-catalyst drift: the $500M preferred special dividend and the June Malone/Nair insider cluster already drove a ~70% run off $4.76 to ~$8.30, and the tape has stalled at $7.33. Citi cut to Neutral 2026-07-10 with a $8 target already… Defensive · M&A & special situations · Emerging markets catalyst · LMND Lemonade, Inc. LOW Second straight beat-and-raise was sold: Q2 (2026-07-29) delivered revenue $294.4M (+79%) and a 60% gross loss ratio, but soft full-year in-force-premium guidance and an unchanged $47–51M FY adjusted-EBITDA loss guide took the stock -26%… Theme leader · Fintech & consumer credit analysed · LNC Lincoln National Corp. LOW Legacy-risk-transfer re-rating: the 2026-07-30 Talcott deal cedes ~$5.8B of GUL statutory reserves for ~$200M all-in statutory capital, alongside a Q2 adjusted EPS beat at $2.24 vs $1.96. But the information is out, price sits 2.1% under… Special situation · M&A & special situations · Managed care & health services catalyst · LOVE The Lovesac Company LOW The ~$17 reclaim failed: a $17.29 close on 2026-08-14 gave way to $16.07 on 2026-08-21, back under the 50-day at $16.79, while short interest decayed to 3.03M shares (28.35% of float) from ~4.05M on Jan–Mar data. The ~2026-09-10 Q2 FY27… Earnings inflection · Consumer discretionary rotation · Small-cap value rotation catalyst · LPRO Open Lending Corporation LOW Terminal, not fading: ANV's $3.15 all-cash tender expired 2026-07-27 with ~85.65% tendered, shares accepted 2026-07-28, §251(h) merger consummated 2026-07-30. Last public close $3.14 on 2026-07-29. As of 2026-08-23 nothing has reopened it… Earnings inflection · Fintech & consumer credit · M&A & special situations analysed · LQDA Liquidia Corporation LOW The prior break level triggered: LQDA closed the week at $68.62 on 2026-08-21, through the $70 July shelf and the 08-13 low close of $72.10, despite six post-print targets at $90–$111. Q2 sales grew +31% QoQ, but the re-rating leg is… Earnings inflection · Precision biotech & therapeutics · Binary-catalyst biotech analysed · LUNR Intuitive Machines, Inc. fresh LOW The June 30 NASA Moon BASE award ($148.3M Nova-C) bought exactly one green session before the stock broke: seven straight down days into 2026-07-13 for -24.5%, -36.5% on the month, $13.80 on 2026-07-18 versus a $38.55 May high. A live… Retail squeeze · Space economy catalyst · LZ LegalZoom.com, Inc. LOW AI-reset narrative — a busted online legal-forms IPO repositioning as an AI-enabled SMB subscription platform (Anthropic partner, AI "digital mailroom") — drove a +29% 30-day rip into July. But it's stretched into the 2026-08-05 Q2 print,… Special situation · AI datacenter infrastructure · Cyclical industrials analysed · M Macy's Inc. LOW Morgan Stanley broke the all-Hold wall on 2026-07-06, resuming at Overweight with a $30 target and a $3 EPS-power call vs ~$2 consensus — the first real upgrade catalyst since the Q1 beat. But price faded the note ($23.99 → $22.64 by… Special situation · Consumer discretionary rotation catalyst · MAMA Mama's Creations, Inc. LOW The $16.50 shelf from prior coverage is gone: 2026-08-21 weekly close $16.44, RSI(14) 26.3, still under the $18.00 June placement price. Earnings moved forward — Q2 FY2027 lands 2026-09-03 after the close and is the binary on both the… Defensive · Fintech & consumer credit · Small-cap value rotation catalyst · MAN ManpowerGroup LOW Post-squeeze leg extended rather than filled: the $46 gap-fill break flagged in July never printed and MAN closed 2026-08-14 at $58.30, 1.3% off a 52-week high, +129.7% in 3 months. Cyclical staffing inflection confirmed by the 2026-08-07… Retail squeeze · Cyclical industrials · Managed care & health services catalyst · MANH Manhattan Associates, Inc. LOW Cloud-conversion re-rating has closed its discount to the 52-week high on no fresh news: the 2026-08-21 close of $214.56 is 2.2% under the $219.33 high with RSI(14) at 80.2, while the last dated company item is 2026-08-04 and the last… Special situation · AI enterprise software · Freight & logistics analysed · MARA MARA Holdings, Inc. LOW AI/HPC power-buildout re-rate is the leg being bought — the 2026-07-09 HIF deal adds up to 2 GW in Texas, lifting potential capacity toward ~4.8 GW — but the golden-cross base fully round-tripped to ~$11.4 as analysts cut across the board… Special situation · Bitcoin miners · AI datacenter infrastructure catalyst · MATV Mativ Holdings, Inc. LOW Deleveraging leg is holding but no longer advancing: the 2026-08-06 10-Q showed H1 operating cash flow of $68.9M against capex of just $15.9M (vs $22.6M in H1 2025), so part of the debt paydown came from underspend. Shares closed $12.47 on… Special situation · Small-cap value rotation · Managed care & health services catalyst · MAZE Maze Therapeutics, Inc. LOW APOL1 kidney precision-medicine story intact, but the 2026-08-11 Q2 print emptied 2026 of catalysts: MZE782 PKU topline pushed to 2027 and CKD Phase 2 start to H1 2027, leaving only HORIZON's three 10–15 patient cohorts in… Earnings inflection · Precision biotech & therapeutics · Rare disease & gene therapy analysed · MCHP Microchip Technology Incorporated LOW AI-data-center re-rating leg is unwinding — round-tripped from the $105.91 May ATH to the ~$84 50-day EMA under an unrebutted J Capital short thesis and a 2026-07-13 TD Cowen PT cut to $90; only the cyclical MCU/industrial recovery (~93%… Special situation · AI datacenter infrastructure · Analog semiconductors catalyst · MDB MongoDB, Inc. LOW Atlas re-acceleration (+29.4% YoY, record $117M seq add; Q1 FY27, 2026-05-28) is intact, but the +18.5% post-print breakout fully round-tripped from $444.72 to a $294.10 close as the AI-software theme sold on margin-timing fear. Sell-side… Cyclical recovery · AI enterprise software · AI datacenter infrastructure catalyst · MEDP Medpace Holdings, Inc. LOW Bookings-inflection leg (Q2 awards $795.7M, +28.2% YoY, book-to-bill 1.13x, FY26 guides raised 2026-07-22) is intact on fundamentals but stalled on the tape: the $620.59 high faded to a $578.5 close on 2026-08-14, RSI 45, while the CEO… Cyclical recovery · Precision biotech & therapeutics · Oncology & immunology analysed · MESO Mesoblast Limited LOW Platform-inflection story re-accelerated on operational news rather than data: the 2026-08-17 last-patient-treated release for the 350-patient CLBP Phase 3 carried the ADR from $15.60 (08-14) to $17.00 (08-21), reclaiming the July shelf… Earnings inflection · Binary-catalyst biotech · Rare disease & gene therapy catalyst · MGM MGM RESORTS INTERNATIONAL LOW Take-private process went live: WSJ reported substantive Diller talks 2026-07-10, MGM seated a special committee mid-July, and the board reportedly views $48.30 as too low — so the trade is now a bump handicap, not a growth story. At… Earnings inflection · M&A & special situations · Prediction markets & betting catalyst · MKSI MKS Inc. LOW Operating leg accelerating into a de-rating tape: Q2 (2026-08-05) beat at $1.248B revenue / $3.30 adj EPS, Q3 guide $1.310–1.390B tops the $1.243B Street, leverage down to 3.0x — and the stock still fell 4.49% on the print and sits 31.4%… Cyclical recovery · Semi foundry & equipment · AI datacenter infrastructure catalyst · MKTX MarketAxess Holdings, Inc. LOW ICE's $167.00 all-cash agreement (signed 2026-07-30) has fully converted MKTX into a spread instrument, and the spread has drifted wider: $167.00 less the 2026-08-21 close of $162.11 leaves $4.89 gross against an H1 2027 guided close.… Earnings inflection · M&A & special situations · Prediction markets & betting catalyst · MMYT MakeMyTrip Limited LOW MakeMyTrip's mid-year recovery bounce has stalled: after reclaiming the 200-day near $55, MMYT rolled back to ~$49, below both the 50- and 200-day, straight into an August 3 Q1 FY2027 print where consensus models EPS down ~76% YoY on ~137x… Earnings inflection · Travel & leisure · Consumer discretionary rotation analysed · MNPR Monopar Therapeutics Inc. LOW New 52-week high at $123.84 printed and sold — the 2026-08-21 close was $107.72, 13.0% under it, RSI 46.0, on no company news. The rolling NDA clock started 2026-07-22 is live but still undated, and the sell-side finished repricing in… Retail squeeze · Rare disease & gene therapy · Squeeze & momentum setups analysed · MNTN MNTN, Inc. LOW Post-IPO CTV adtech re-rating on a profitability crossover: Q2 (2026-08-04) delivered $82.5M revenue +21% YoY, 80% gross margin, $6.7M GAAP net income vs a $26.2M loss, and a $100M buyback. Shares +53.9% in three months into a 91.4 RSI… Defensive · AI enterprise software · Precision biotech & therapeutics catalyst · MOD Modine Manufacturing Co LOW Operating story still compounding — Data Centers sales $348.6M (+90% YoY) at the 2026-07-29 Q1 FY27 print, FY27 guide affirmed — but the tape broke: the 2026-08-14 close of $209.50 lost the $210 line, -31.7% from the $306.89 high. The… Cyclical recovery · AI datacenter infrastructure catalyst · MOH Molina Healthcare, Inc. LOW Medicaid-trough thesis passed its 2026-07-22 test (FY26 adjusted EPS guided to ≥$5.25), but the price leg expressing it broke: the week ending 2026-08-21 closed $200.29, under the $205 floor of the late-June breakout gap. What is left is… Special situation · Managed care & health services analysed · MOV Movado Group, Inc. LOW Tariff-relief leg is dead (Section 301 put Switzerland in a 12.5% band with no expiry on 2026-07-24); what's left is the Q1 margin re-rate (GM 57.3%, +320bp) and one date. Company confirmed 2026-08-19 that Q2 FY2027 prints before the open… Special situation · Consumer discretionary rotation · Cyclical industrials catalyst · MPC Marathon Petroleum Corporation LOW Record refining cracks are already in the tape: Q2 R&M margin $36.33/bbl vs $17.58 YoY and a 29% EPS beat on 2026-08-04, yet the stock closed 2026-08-07 at $298.20 — RSI 37.3, 6.7% under the $319.76 high — while six desks raised targets… Compounder · Oil, energy & geopolitical · AI chips & memory catalyst · MPWR Monolithic Power Systems, Inc. LOW Fundamentals still accelerating (Q2 rev $980.6M vs $890–910M guide; Q3 guided $1,140–1,160M vs ~$982M consensus) but the tape has fully retraced the print: a 2026-08-18 shareholder-investigation headline took the stock down 6.86% to… Cyclical recovery · AI datacenter infrastructure · AI chips & memory catalyst · MRAM Everspin Technologies, Inc. LOW Sympathy bid off the Micron-led memory supercycle and Russell 2000 inclusion floored the post-parabola markdown in the low-$20s, but the ~2026-07-28 Q2 print is now the binary: Everspin must show a non-casino datacenter/AI design win or… Retail squeeze · AI chips & memory · Squeeze & momentum setups analysed · MRVI Maravai LifeSciences Holdings, Inc. LOW Leg has flipped from operating leverage to mRNA-supplier read-through: Moderna's 2026-08-19 Phase 3 cancer-vaccine data took MRVI +25.8% in one session and to an $8.64 52-week-high close by 2026-08-21 with RSI 79.8 — while FY26 revenue… Cyclical recovery · Freight & logistics · Precision biotech & therapeutics analysed · MSFT Microsoft Corporation LOW AI-capex derating still in control and now colliding with a hostile print tape: Alphabet lost ~$294B on 2026-07-24 punished purely for AI spend, Tesla/Intel/Google all sold post-earnings, and MSFT reports Q4 FY26 on 2026-07-29 AMC below… Compounder · Mega-cap AI platforms analysed · MTH Meritage Homes Corporation LOW Housing-rebound-on-rate-cuts trade that carried MTH to a $85.38 52-week high has reversed: it lost the $75 June breakout shelf to $74.17 (-4.2% on 7/17) as mortgages held at 6.49% and Zelman capitulated to Neutral (7/7). Fundamentals still… Compounder · Housing, homebuilders & proptech · Cyclical industrials catalyst · MTRN Materion Corporation LOW Beryllium critical-materials scarcity narrative still building, but the parabola cracked: a new ATH of $298.76 in early July gave way to a 5.6% reversal on 2026-07-07 to $247.20, now ~$258 and still ~9% above KeyBanc's $237 top target. The… Compounder · Critical materials & rare earths · Defense & aerospace analysed · MTSI MACOM Technology Solutions Holdings, Inc. LOW AI optical-interconnect arms-dealer with fundamentals still accelerating (FY26 DC growth guide >60%, Q3 guide $331-339M) but a July-broken chart: ~36% off the $418.90 high to ~$267 on the semi selloff, Russell Value index removal, and… Cyclical recovery · Networking & optical · AI datacenter infrastructure catalyst · MTW The Manitowoc Company, Inc. LOW Order-cycle plus trade-protection plus deleveraging leg from the 2026-08-06 guidance raise is still working but is now maturing: price extended to a $20.87 52-week high while the two post-print analyst actions (Barclays $16, Wells Fargo… Defensive · Cyclical industrials · Semi foundry & equipment catalyst · MXL MaxLinear, Inc. LOW The $77 shelf from the 2026-07-23 beat-and-raise has broken: the 2026-08-21 close of $66.61 is 48.0% below the $128.03 high, after Seendripu family trusts sold or filed to sell ~$50M of stock between 2026-08-14 and 2026-08-17. The revenue… Cyclical recovery · Networking & optical · AI datacenter infrastructure catalyst · MYE Myers Industries, Inc. LOW Legacy plastics maker re-rated ~2.4x on a "Focused Transformation" — MTS distribution arm in discontinued ops, capital concentrated behind Signature/MegaDeck composite matting (Infrastructure orders +130% YoY, Q1 adj EPS $0.44 vs $0.28).… Special situation · Small-cap value rotation · Cyclical industrials catalyst · MYGN Myriad Genetics, Inc. LOW Legacy hereditary-cancer testing house executing a diagnostics pivot; shares +40% off the June $3.99 base as Prolaris+AI launched (May 26) and Precise MRD colorectal/renal was pulled forward to Q3. Structure has repaired but now… Special situation · Precision biotech & therapeutics · Medtech & diagnostics analysed · NABL N-able, Inc. LOW The cyber-pivot re-rating leg was withdrawn by the company's own 2026-08-10 guidance and nothing since has put it back: ARR fell sequentially to $544.5M, FY26 revenue cut to $539–542M, FY26 ARR to $562–565M. The bounce to $3.63… Special situation · Cybersecurity · AI enterprise software analysed · NBR Nabors Industries Ltd. LOW Leveraged ~2x oil-beta proxy on the Hormuz war premium, +90% YTD near $100 but now rolling over: Susquehanna cut its target to $85 (2026-07-08) as the sell-side stops chasing, and the ~2026-07-23 Q2 print — the first to lap the premium —… Compounder · Oil, energy & geopolitical · Managed care & health services catalyst · NCLH Norwegian Cruise Line Holdings Ltd. LOW The June oil re-rating is over: the 2026-07-30 print cut FY26 net yield to ~-5% cc and EPS to ~$1.50 (second cut after 06-03), shares -8.9%, Morgan Stanley to $13. What is left is an Elliott governance/self-help story — 5 new directors… Defensive · Travel & leisure · Consumer discretionary rotation analysed · NEO NeoGenomics, Inc. LOW Oncology-dx turnaround accelerating — NGS +26%, PTEN IHC CDx (first FDA IHC companion dx in prostate, paired to AZ's TRUQAP) launched Jul 9, and TD Cowen $14→$19 / BofA $11→$16 on Jul 13 lifted consensus to ~$15.67, back above spot. But Q2… Special situation · Precision biotech & therapeutics · Medtech & diagnostics analysed · NEXA Nexa Resources S.A. LOW Cyclical zinc-recovery confirmed and fully priced: Q1 EBITDA +126% YoY and Aripuanã's record 13kt ramp drove a run to the $16.89 high, but the equity now chops $12–13 while LME zinc printed a fresh 2026 high near US$3,622 — a bearish… Special situation · Critical materials & rare earths · Emerging markets analysed · NKE Nike, Inc. LOW The post-Q4 base failed: the 2026-08-14 weekly close of $40.73 took out the $41.35 low that framed the July read, and JPMorgan's 2026-08-04 cut to Underweight (PT $47→$40, EPS ~20% below consensus) turned two quarters of target-trimming… Special situation · Consumer discretionary rotation catalyst · NOK Nokia Corporation LOW AI-networking legacy re-rate extending on a harder catalyst leg — first commercial AI-RAN platform with Nvidia (07-15) plus Taiwan Mobile, Orange Belgium and NestAI defense wins. Theme accelerating, but the 2026-07-23 pre-open Q2 print is… Special situation · Networking & optical · AI datacenter infrastructure catalyst · NP Neptune Insurance Holdings Inc. LOW The 2026-07-21 beat-and-raise has round-tripped: the 2026-08-14 weekly close of $31.71 is under the $32 post-print shelf, BMO cut to Market Perform on 2026-07-30, and the CFO sold 100,000 shares into $30.74–$32.12 on Aug 12–13. Operations… Defensive · Managed care & health services catalyst · NSIT Insight Enterprises, Inc. LOW Genuine VAR margin-mix turnaround (Q1 GM +240bps, cloud GP +35%) but a derivative AI tag: hardware GP guided flat, sales +1%. Range-bound $102–123 since the early-June rejection; ~$110 already sits above the ~$103 street target with a… Special situation · AI datacenter infrastructure · AI enterprise software analysed · NUTX Nutex Health Inc. LOW Re-rating leg has stalled: NUTX closed $162.98 on 2026-07-17 after five straight down days, ~20% off the $204.00 high, giving back the June breakout that B. Riley's 2026-06-26 Buy/$290 initiation topped out. A $55.0M true-up of 18,950… Retail squeeze · Managed care & health services · Squeeze & momentum setups catalyst · NUVL Nuvalent, Inc. LOW Closed, not pending: GSK completed the $124 all-cash acquisition on 2026-07-15 after 91.3% of shares were tendered by the 2026-07-14 expiry; trading was suspended 2026-07-15 and Form 25 delisting requested. No US-listed NUVL equity remains… Earnings inflection · Precision biotech & therapeutics · Oncology & immunology analysed · NVEC NVE Corporation LOW One quarter re-rated the name — revenue +81% to $11.03M, gross margin 81.3% (2026-07-22) — and nothing has confirmed it since. No company datapoint arrives before the ~2026-10-21 Q2 print. Theme leader · Analog semiconductors · Physical AI & robotics catalyst · NWL Newell Brands Inc. LOW Turnaround inflection confirmed: 7/31 Q2 beat ($0.42 vs $0.20 est) plus first core-sales growth in 4+ years (+2.3%), squeezed 21.65% short float and re-rated the sell-side. But the entire FY guide raise ($0.73–0.77 from $0.56–0.60) is 2025… Special situation · Consumer discretionary rotation · Cyclical industrials catalyst · NWPX NWPX Infrastructure, Inc. LOW Legacy steel-pipe maker re-rated into a water-infrastructure + precast roll-up on a record $373M WTS backlog, an ~83% Q1 beat, and the Permalok RBJ field win. Narrative intact but the setup is extended — last near $148, ~35% above the… Special situation · AI datacenter infrastructure · Cyclical industrials analysed · NXPI NXP Semiconductors N.V. LOW The 2026-07-28 beat-and-raise still is not being paid for: the 2026-08-21 weekly close of $225.56 held the $225 break line by 56 cents, and the week's damage came from the 30-year Treasury at 5.33% (19-year high), not from analog demand.… Theme leader · Analog semiconductors · AI chips & memory analysed · OABI OmniAb, Inc. LOW Milestone-and-royalty flywheel turned visible: Q2 revenue $13.415M vs $4.693M consensus (2026-08-06) plus a Lilly ion-channel deal worth up to $370M in milestones (2026-08-17) took closes from $1.96 to $4.33 in thirteen sessions. RSI(14)… Cyclical recovery · Precision biotech & therapeutics analysed · ODD ODDITY Tech Ltd. LOW Compounder narrative is dead (Q1 revenue -26%, first orders -50%) and the drift continued on no news at all: $14.12 on 2026-08-07 to $13.22 on 2026-08-21, now sitting on the $13 shelf. The 2026-09-09 pre-market Q2 print is the only dated… Earnings inflection · Consumer discretionary rotation · Precision biotech & therapeutics catalyst · ODFL Old Dominion Freight Line, Inc. LOW Freight-cycle recovery in the top-margin LTL name is drawing a broadening upgrade cluster now printing above spot (Stifel $256 Jul 21, Truist $250 Jul 15, RJ $241 Jul 13), but growth is still rate and mix with tons/day negative. The… Defensive · Freight & logistics · Cyclical industrials catalyst · OEC Orion S.A. LOW Deep-cyclical carbon black where the 2024–25 tire-restock leg already failed (-32.5% from the $10.72 52-week high). What is left is a trough-and-deleverage read: Q2 2026 adj. EBITDA $58.2M (+26% sequential, -15% YoY), FY26 guide reaffirmed… Defensive · Cyclical industrials · Managed care & health services catalyst · OFIX Orthofix Medical Inc. LOW The CMS-reversal re-rate has fully round-tripped: after the 2026-07-02 rate restoration and a 2026-08-05 beat-and-raise, OFIX closed $10.01 on 2026-08-21 — below where it traded on the 2026-05-21 guidance-cut 8-K — with RSI(14) at 22.8 and… Special situation · Medtech & diagnostics · Small-cap value rotation analysed · OGN Organon & Co. LOW Deal-pinned arb, now purely regulatory: the $14.00 all-cash Sun Pharma offer was approved by holders 2026-07-23 and the 2026-08-21 close of $13.75 leaves $0.25, ~1.8% gross, into a stated early-2027 close. Upside is capped by contract; a… Earnings inflection · M&A & special situations · Precision biotech & therapeutics analysed · OLPX Olaplex Holdings, Inc. LOW Closed by event and now confirmed from the buyer's side: Henkel's all-cash takeout completed 2026-07-07 at $2.06 per share, Nasdaq delisting and a Form 15-12G followed, and Henkel's 2026-08-06 half-year report carries no brand-level… Earnings inflection · M&A & special situations · Managed care & health services catalyst · OMER Omeros Corporation LOW Post-print launch-ramp narrative still accelerating on fundamentals — Q2 net sales $28.5M vs $12.7M consensus (2026-08-12), NTAP effective 2026-10-01 — but the shares added 12.1% from the 2026-08-14 close of $17.19 to $19.27 on 2026-08-21… Compounder · Precision biotech & therapeutics analysed · ON ON Semiconductor Corporation LOW The AI-power re-rate is unwinding, not consolidating: ON closed $87.37 on 7/17, below the 6/26 Synaptics deal-gap floor, with targets cut twice in three weeks (TD Cowen to $95 on 7/13, Mizuho to $125 on 7/1). Merger-arb supply plus a fixed… Theme leader · Industrial power & grid · AI chips & memory catalyst · ONDS Ondas Inc. LOW Q2 (2026-08-13) beat on revenue — $83.772M vs $67.973M — and missed on EPS at $(0.19) vs $(0.05); stock fell 7%. Section 232 drone tariffs signed the same day (effective 2026-09-03) rallied the whole basket, and ONDS still closed… Retail squeeze · Defense & aerospace catalyst · OOMA Ooma, Inc. LOW Legacy residential VoIP re-rating into an SMB cloud-comms roll-up, now pinned 0.5% under the $22.14 52-week high going into the 2026-08-26 Q2 FY2027 print — the first quarter testing whether the December 2025 acquired base retains at the… Special situation · GPU cloud & neoclouds · AI enterprise software catalyst · OPEN Opendoor Technologies Inc fresh LOW Early-July retail squeeze is broken: OPEN lost the $4.88 insider shelf and $4.50 base, fell ~12% to $3.88 on 2026-07-24 on a technical breakdown plus fresh housing weakness, into an Aug 4 Q2 print. A rolled-over meme trading into an… Retail squeeze · Housing, homebuilders & proptech analysed · OPI Office Properties Income Trust Common shares of beneficial interest LOW First post-reorg print landed 2026-08-05: 77.9% leased, $1.707B debt, the book equity, no dividend. The binary passed without breaking the tape — The narrative has matured from deleveraging re-rate into asset-sale arithmetic with insider… Retail squeeze · M&A & special situations · Housing, homebuilders & proptech analysed · ORIC Oric Pharmaceuticals, Inc. LOW mCRPC PRC2 story de-risked as rinzimetostat enters registrational Phase 3 (Himalayas-1, 2026-07-14) with Bayer supplying NUBEQA and a J&J-backed enozertinib lung program behind it. But pivotal data is 2028+, so the only near-term mover is… Earnings inflection · Oncology & immunology · Binary-catalyst biotech catalyst · OTEX Open Text Corporation LOW FY27 is guided as a reinvestment year under a CEO seated 2026-04-20: revenue $5.135–5.185B versus FY26's $5.246B, adjusted EBITDA margin 32–33% versus 36.3%. The 10%-of-float buyback opened 2026-08-12; the shares closed $24.66 on… Special situation · AI enterprise software · Cyclical industrials catalyst · OTLY Oatly Group AB LOW The 2026-07-22 guidance doubling (FY constant-currency growth 8–10% from 3–5%) is now a month old with no follow-on news; RSI(14) reset from 71.0 on 2026-08-07 to 43.7 on 2026-08-21 while price held, leaving a $13.03–$13.15 shelf. Nothing… Special situation · Consumer discretionary rotation · Managed care & health services analysed · OUST Ouster, Inc. LOW Squeeze leg broke: +43% in four sessions to a $63.79 high, then management priced 3.62M shares at $55.22 (~8% discount) and closed ~$191.9M net on 2026-07-06. Price round-tripped to $37.04, under the 20- and 50-day and under the $49… Retail squeeze · Physical AI & robotics · Defense & aerospace analysed · P Everpure, Inc. LOW Hyperscaler design-win re-rating has stalled: 52-week high $118.16 on 2026-08-14, then a 2026-08-21 close of $108.55 with RSI(14) still 79.5 while TD Cowen ($170) and Wedbush ($127) raised targets into the fall. The 2026-08-26 Q2 FY2027… Cyclical recovery · AI datacenter infrastructure · AI chips & memory catalyst · PANL Pangaea Logistics Solutions Ltd. LOW Dry-bulk recovery is in the P&L but not the tape: Q1 2026 (2026-05-11) adjusted EBITDA +70% YoY to $25.2M on $15,252/day TCE, yet the stock closed $7.42 on 2026-08-07, 20.1% under the $9.29 52-week high. The 2026-08-10 Q2 print is the… Earnings inflection · Freight & logistics · Small-cap value rotation catalyst · PARR Par Pacific Holdings, Inc. LOW Record diesel cracks (above $100/bbl mid-August 2026) met a lower tape: the 2026-08-21 close of $79.03 sits 8.1% under the $86.03 high while the company's own July refining index printed $31.34/bbl versus a ~$33 Q2 average. Late-cycle —… Compounder · Oil, energy & geopolitical analysed · PATH UiPath, Inc. LOW RPA vendor left for dead, re-cast as the orchestration layer for enterprise AI agents: first GAAP operating profit ($28M, Q1 FY27 reported 2026-05-28) plus the 2026-08-19 Maestro Flow launch drove +50% in three months to a $16.39 close,… Special situation · AI enterprise software catalyst · PAY Paymentus Holdings, Inc. LOW Beaten-down bill-pay compounder: Q1 2026 revenue +30.2% YoY yet shares carved a $20.11 June 52-week low on margin-mix fear. Now ~40% off that low into a binary ~Aug-4 Q2 print — the read is a recovering base, not a chase. Cyclical recovery · Fintech & consumer credit · AI datacenter infrastructure catalyst · PAYC Paycom Software, Inc. LOW Operating-leverage re-rating on a de-rated HCM name is still working, but the fuel is two weeks stale: since the 2026-08-06/07 target raises the shares added 6.6% to $229.07 (2026-08-21) on no new company datapoint, RSI(14) 83.7, 1.1%… Special situation · AI enterprise software catalyst · PAYO Payoneer Global Inc. LOW Pure merger-arb, now fully scheduled: HSR early termination granted 2026-07-28 and the 2026-08-11 definitive proxy set the shareholder vote for 2026-09-14, yet the 2026-08-14 close of $7.13 still sits $0.27 under Nuvei's $7.40 all-cash… Earnings inflection · M&A & special situations · Fintech & consumer credit catalyst · PAYS Paysign, Inc. fresh LOW Guidance-raise leg intact but the flow has thinned: no company datapoint since the 2026-08-05 print (rev $28.252M +48.1%, FY26 lifted to $114–117M), yet price added another 7% to $14.09 on 2026-08-21, RSI 96.7 at a 52-week high and above… Defensive · Fintech & consumer credit catalyst · PBI Pitney Bowes Inc. LOW PBI broke the $17.62 shelf to a fresh 52-week high $18.62 (Jul 16) — the buyback/cost-cut re-rate is now extending, not consolidating. But revenue still shrinks ~3% YoY, consensus PT $16.43 sits below spot, and Q2 prints after close Jul… Special situation · M&A & special situations · Cyclical industrials catalyst · PCT PureCycle Technologies, Inc. LOW Post-dilution repair story: the June 10–15 raise (~$145M equity + $287.5M 4.75% converts, ~$11.08 conv) roughly halved the stock to ~$8 while the commercial ramp (Q1 record 8.4M-lb output, +161% revenue) held. The 2026-07-15 Mitsui/RM… Retail squeeze · Squeeze & momentum setups · Critical materials & rare earths catalyst · PDFS PDF Solutions, Inc. LOW Yield-analytics software re-rated on a real margin step — operating margin ~18%→25%, Platform revenue +36% YoY (Q1 reported 2026-05-07) — but the ~+280% run peaked at $69.05 on 2026-07-02 and flushed 11.5% intraday; the name is now… Cyclical recovery · Semi foundry & equipment · AI enterprise software analysed · PEB Pebblebrook Hotel Trust LOW The 2026-07-29 binary resolved bullish — Q2 RevPAR +6.5%, AFFO $0.68, FY guide raised to $345–353M EBITDAre — and the stock still has not made a new high, closing 2026-08-14 at $18.25, 7.6% under the $19.75 high with RSI 35.3. Q3 guidance… Earnings inflection · Travel & leisure · Housing, homebuilders & proptech analysed · PESI Perma-Fix Environmental Services, Inc. LOW Binary resolved 2026-08-12 in two directions: the H2C master IDIQ is signed but issues no dollars before 2027-01-01, while Q2 printed a $2.5M gross loss and unalleviated going-concern doubt. No company release since 2026-08-12 and no dated… Earnings inflection · Nuclear & uranium · Binary-catalyst biotech analysed · PGNY Progyny, Inc. LOW Post-print de-rate still extending: $25.65 close on 2026-08-21, RSI(14) 18.1, the $28.75 July shelf lost, even as Wells Fargo initiated Overweight $37 (08-20) and JPM raised to $30 (08-21). The 2026-08-06 revenue guide cut is unresolved… Special situation · Managed care & health services analysed · PI Impinj, Inc. LOW Post-correction RAIN RFID recovery has extended to $138.37 (2026-07-17), holding the reclaimed $128 April gap-fill and pressing the $144.57 post-earnings high — but the entire near-term read is the 2026-07-29 Q2 print (guide $103–106M, EPS… Earnings inflection · Freight & logistics · Consumer discretionary rotation analysed · PII Polaris Inc. LOW The $66 shelf the recovery leg stood on is gone: the 2026-06-05 low of $66.06 broke and PII closed 2026-08-21 at $64.39, three weeks after a beat-and-raise (Q2 sales $2,023M, operational adjusted EPS $1.01 vs a $0.70–0.80 guide). The… Special situation · Cyclical industrials · Consumer discretionary rotation analysed · PKOH Park-Ohio Holdings Corp. LOW The 2026-08-05 beat-and-raise leg is intact on the numbers but has stopped working on price: $52.51 on 2026-08-07 to $45.70 on 2026-08-21 (-13.0%), RSI(14) from 89.3 to 61.4, no company news since Stonegate's 2026-08-10 update and no dated… Theme leader · Industrial power & grid · Cyclical industrials analysed · PLAY Dave & Buster's Entertainment, Inc. LOW Turnaround narrative dead since the 2026-06-15 comp miss (-5.4%, EPS $0.16 vs ~$0.598); CEO seat changed hands 2026-08-03 with CFO Darin Harper replacing Tarun Lal. Price stabilized off the $9.40 July low to $10.19 on 2026-08-14, RSI 47.5,… Earnings inflection · Consumer discretionary rotation catalyst · PLSE Pulse Biosciences, Inc fresh LOW Timeline-compression leg extended by broker coverage rather than new data: Needham initiated Buy with a $58 target on 2026-08-17 and price closed 2026-08-21 at $50.42, a fresh 52-week high with RSI 82.5, above three of four published… Earnings inflection · Medtech & diagnostics analysed · PLTK Playtika Holding Corp. LOW The control-premium bid is gone and the markdown extended: the 2026-08-21 weekly close of $2.37 took out the $2.51 shelf, RSI(14) 12.9, 44.4% under the $4.26 52-week high. The one new disclosure is financing rather than a sale — 2026-08-18… Earnings inflection · M&A & special situations · Consumer discretionary rotation analysed · PLUG Plug Power, Inc. LOW The +475% hydrogen-comeback squeeze has broken: the $3.12 Q1 gap and the 50-day both failed, price is ~$2.17 (-20% in 30d), and Susquehanna cut its target $3.75 → $2.50 on 2026-07-10. The June 30 NY Gateway close resolved as a restructure… Retail squeeze · Solar & clean energy · Industrial power & grid analysed · POWI Power Integrations, Inc. LOW The 800VDC AI-power re-rate has cracked. POWI lost the $74–78 May breakout shelf in a -20% week to $70.45 (2026-07-17) and now sits below the $76.20 average target for the first time since spring. The GaN cohort broke with it — NVTS is… Theme leader · AI datacenter infrastructure · Industrial power & grid catalyst · POWL Powell Industries, Inc. LOW Record orders $934M and a 3.0x book-to-bill lifted backlog to $2.4B (+69% YoY) at the 2026-08-03 print, yet shares fell 13.4% the next pre-market on a second straight EPS/revenue miss and closed 2026-08-14 at $213.48, -33.7% off the high.… Cyclical recovery · Industrial power & grid analysed · PTEN Patterson-UTI Energy, Inc. LOW Rig-reactivation cyclical is basing, not broken: June averaged 95 US rigs (vs ~90 Q2 guide), the July EIA STEO lifted 2026 Henry Hub to $3.67, gas rigs turned up 122→126, and Piper upgraded to Overweight 07-14. Price bottomed $8.57 (07-01)… Special situation · Oil, energy & geopolitical · AI datacenter infrastructure catalyst · PTRN Pattern Group Inc. Series A LOW Squeeze leg is dead: the 2026-08-05 beat-and-raise (revenue $876.8M, +47% YoY, record 129% NRR, FY26 guide up to $3.42–3.46B) and target raises to $29–30 left the stock at $21.44 on 2026-08-14, below its post-print after-hours level.… Cyclical recovery · Managed care & health services · AI enterprise software catalyst · PVH PVH Corp. LOW The August bounce failed: $82.47 on 2026-08-14 to $78.50 on 2026-08-21, RSI(14) 25.0, after a 6.2% sector-wide apparel drop on 2026-08-17. Q2 FY26 lands after the close on 2026-09-02 and is the binary — headline EPS carries the ~$100M… Special situation · Consumer discretionary rotation · Freight & logistics catalyst · PYPL PayPal Holdings, Inc. LOW Bid became negotiation: WSJ (2026-08-14) reports Stripe/Advent in active talks and weighing a raise over the rejected $60.50 offer, while the 2026-07-28 Q2 beat (EPS $1.38 vs $1.28) and a raised FY26 guide lifted standalone value. At… Earnings inflection · Fintech & consumer credit analysed · QDEL QuidelOrtho Corporation LOW Deal-rumor leg fully retraced and still unresolved: the 2026-08-06 cut (FY26 adj EPS to $0.65–0.90 from $1.80–2.00, FCF guide withdrawn) took price back to the $13.79 pre-rumor shelf, and the $14.74 close of 2026-08-21 is drift on no… Earnings inflection · Medtech & diagnostics · Semi foundry & equipment analysed · QLYS Qualys, Inc. LOW The AI-vulnerability-surface reframe got its numbers: Q2 (2026-08-04) revenue $182.2M +11% YoY beat the guide, FY2026 raised to $732–738M, stock +14% after hours, eight targets lifted 2026-08-05. Confirmation is now in the price — the… Special situation · AI enterprise software analysed · QRVO Qorvo, Inc. LOW US antitrust cleared 2026-08-01 and Skyworks' post-print recovery to $69.62 lifted implied consideration to $99.33 (0.960 SWKS + $32.50 cash) against QRVO's $98.11 close — about 1.2% gross for underwriting China's SAMR and Korea's KFTC,… Earnings inflection · AI chips & memory analysed · QUIK QuickLogic Corporation LOW The eFPGA/defense royalty squeeze has fully unwound: QUIK is ~$13, roughly 47% below the $24.33 June high, and the $18 shelf broke exactly as the Russell inclusion passed. July's post-quantum IP announcement drew no bid — good news into no… Retail squeeze · AI chips & memory · Quantum computing catalyst · QURE uniQure N.V. LOW FDA's 2026-06-17 reversal put AMT-130 on an accelerated-approval path with a Q3 2026 BLA — the narrative is genuinely repaired, but the move is spent: $40.25 (7/17) sits below the $45.50 June offering price with the CEO selling into it on… Earnings inflection · Precision biotech & therapeutics · Rare disease & gene therapy catalyst · RAMP LiveRamp Holdings, Inc. LOW Shareholder gate cleared 2026-08-17: 51,578,202 shares voted to adopt versus 60,073 against, leaving CFIUS, HSR and non-US clearances as the only unconfirmed conditions on Publicis' $38.50 cash offer. The 2026-08-21 close of $37.58 sits… Earnings inflection · M&A & special situations · AI enterprise software analysed · RARE Ultragenyx Pharmaceutical Inc. LOW The +50% June reset rally round-tripped from ~$33.46 to $28.62 (2026-07-21), parking price back on the breakout shelf ahead of two binary FDA decisions: DTX401 (GSD Ia) PDUFA Aug 23 and UX111 (Sanfilippo A) PDUFA Sep 19. The July 30 Q2… Earnings inflection · Rare disease & gene therapy · Binary-catalyst biotech catalyst · RBLX Roblox Corporation LOW Broken growth compounder: the age-verification rollout throttled DAUs and forced FY26 bookings guidance down to +8-12%; stock is -66% from its $150 high and below the 200-day. The 2026-07-30 Q2 print is the binary — it needs a DAU… Earnings inflection · Consumer discretionary rotation · AI enterprise software catalyst · RDW Redwire Corporation LOW Post-SpaceX-IPO deflation broke RDW to a 2026-07-18 low near $8.51 (~67% off the 5/28 record). A relief bounce on Huntsville/Indiana facility news and $41.5M of H1 Stalker drone orders keeps running into a ~$850M dilution ceiling: the… Retail squeeze · Space economy catalyst · REAX The Real Brokerage, Inc. fresh LOW Hypergrowth brokerage story has decelerated (Q1 rev +32% vs 70%+ historically, a forecast miss) and the stock sits near 52-week lows after the $880M RE/MAX deal spooked investors on dilution. The read is now a binary consolidation bet, not… Earnings inflection · M&A & special situations catalyst · RFAI RF Acquisition Corp II fresh LOW Near-total redemption — 3,956,323 of 3,998,108 public shares, 98.95% — left almost no tradable float into the 2026-08-19 Nanyang Biologics approval, and RFAI ran +524.3% on the week to close $58.00. The leg being bought is a mechanical… Retail squeeze · M&A & special situations analysed · RH LOW Squeeze leg now ratified by the sell side — TD Cowen $220 (2026-08-08) and Wells Fargo $225 (2026-08-11) against B of A's reinstated Underperform $156 (2026-08-03) — and it resolves into the 2026-09-10 Q2 print with ~56.7% of float still… Retail squeeze · Consumer discretionary rotation · Squeeze & momentum setups catalyst · RHI Robert Half Inc. LOW White-collar staffing in secular decline: Q2 EPS collapsed to $0.26 (2026-07-23) as AI automation and a frozen hiring market gut permanent-placement demand. The >5% dividend yield reads as a value-trap signal rather than a floor. No… Special situation · Cyclical industrials · Prediction markets & betting catalyst · RIVN Rivian Automotive, Inc. LOW The 2026-07-30 binary resolved bullish — revenue $1.658B (+27% YoY), FY delivery guide raised to 65,000–70,000 — and the market gave the entire 2026-07-31 pop back, closing 2026-08-14 at $15.36, under the $15.50 July offering price.… Earnings inflection · EV & autonomous mobility analysed · RLMD Relmada Therapeutics, Inc. LOW The level this coverage was framed around broke: the 2026-08-21 weekly close of $4.63 is under the $4.75 March PIPE strike, and it broke on no disclosure. With the 2026 clinical calendar emptied on the 2026-08-06 call, what remains is a… Earnings inflection · Oncology & immunology · Binary-catalyst biotech analysed · RLYB Rallybio Corporation LOW No new filing since the 2026-08-06 10-Q: as of 2026-08-23 the 2026-07-15 S-4 is still not effective, with no record date or meeting date set. The 2026-08-21 close of $16.83 sits ~7% above the ~$15.68/share implied by the S-4's $83.2M Net… Earnings inflection · M&A & special situations · Precision biotech & therapeutics analysed · RMBS Rambus Inc. LOW Memory theme is ripping — Micron +68% YTD with HBM sold out through 2027 — but Rambus has decoupled, down ~42% from its 2026-06-03 high of $174.10 to $101.44 while the cycle proxy sits near records. Interface content is a DIMM-unit story,… Cyclical recovery · AI chips & memory · AI datacenter infrastructure analysed · RNG Ringcentral, Inc. LOW The late-July fade framing has been overrun: RNG ran from the post-print low-$40s to a $67.78 52-week high on 2026-08-13, closing $64.49 (08-14), +57.7% in three months. The leg is a legacy UCaaS name re-labelled on AI mix (~13% of ARR,… Special situation · AI enterprise software catalyst · RPAY Repay Holdings Corporation LOW The bid discount narrowed on an operating headline: the close ran $3.66 (2026-08-14) to $4.01 (2026-08-21) after REPAY joined Visa Platform Connect on 2026-08-19, leaving Forager's rejected $5.25 cash proposal ~31% above the tape with no… Earnings inflection · M&A & special situations · Fintech & consumer credit analysed · RUM Rumble Inc. fresh LOW The sell-the-news break is now confirmed: RUM lost the $6.46–$6.66 100/200-day shelf and closed $5.76 on 2026-07-17, -19% from the post-rebrand tape and within 25% of the $4.62 52-week low. Every moving average is overhead. The 2026-08-10… Special situation · AI datacenter infrastructure analysed · RZLT Rezolute, Inc. LOW A 10.7% week to $5.09 on 2026-08-21 with zero company news since the 2026-07-21 conference notice — the bid arrived via Friday-gainer screens, not a disclosure. The 2026-06-02 upLIFT interim (6 of 8 responders) is still the entire story,… Earnings inflection · Binary-catalyst biotech · Rare disease & gene therapy catalyst · S SentinelOne, Inc. LOW Agentic-security re-rate has cooled into its print: price $23.11 (2026-08-14) → $21.19 (2026-08-21), RSI 83.3 → 56.3, while seven target raises landed 08-17 to 08-21 and consensus caught spot at $21.52. The 2026-08-27 Q2 FY2027 print is… Theme leader · Cybersecurity · AI enterprise software catalyst · SABR Sabre Corporation LOW June's +20% deleveraging bounce has fully round-tripped: $1.99 (6/26) back to $1.73 (7/17), now under the 50-day near $1.79 after failing exactly at the $1.99 consensus PT. Balance sheet is fixed, narrative is not accelerating, and a… Special situation · Travel & leisure · AI enterprise software analysed · SAFT Safety Insurance Group, Inc. LOW Mapfre's $105.00 all-cash deal (signed 2026-07-23) has pinned the tape: the 2026-08-14 close of $103.35 leaves ~1.6% gross to the contract price, down from ~4.6% on 2026-07-24, with no publicly reported approval milestone in between. The… Earnings inflection · Fintech & consumer credit analysed · SAH Sonic Automotive, Inc. LOW GPU-normalization narrative broke at the 2026-07-30 print: revenue and adjusted EPS beat consensus, but adjusted EPS fell 17% YoY, franchised segment income −23%, and EchoPark FY26 GPU guidance was cut ~$300 at the midpoint. Shares… Special situation · Consumer discretionary rotation · EV & autonomous mobility catalyst · SAIL SailPoint, Inc. LOW Agentic-identity story intact and the post-earnings flush is basing: SAIL clawed from a $13.33 low (6/22) back to $15.68 (7/17), a higher low off the $10.30 bottom. Growth decelerated (ARR +26% vs +30%) and guidance was only affirmed, so… Theme leader · Cybersecurity · AI enterprise software catalyst · SANA Sana Biotechnology, Inc. LOW Type-1-diabetes functional-cure narrative: UP421's no-immunosuppression islet transplant is still producing insulin at 14 months (n=1), de-risking SC451's IND guided "as early as 2026." Rare-disease cell therapy is accelerating, but the… Earnings inflection · Rare disease & gene therapy · Binary-catalyst biotech catalyst · SANM Sanmina Corporation LOW The prior break level gave way: the 2026-08-21 weekly close at $188.89 retraced the entire June re-rate. FQ3 on 2026-07-27 beat and raised — $3.46B revenue, +69.7% YoY, FY26 EPS guide lifted to $11.90–12.20 — and the tape answered with a… Special situation · AI datacenter infrastructure · Cyclical industrials catalyst · SAP SAP SE LOW Post-Q2 repair leg: SAP rallied ~6% on 2026-07-24 and ~7% on 2026-07-27 despite a reported headline EPS miss, because current cloud backlog hit €22.9bn (+27%) and management guided FY26 constant-currency growth near 2025's 10.6% with… Theme leader · AI enterprise software · GPU cloud & neoclouds analysed · SATL Satellogic Inc. LOW The mania leg broke in July — the $6.33 shelf and the $4.97 range low both went — and the 2026-08-05 Q2 print handed the name a different story: revenue $15.9M (+259% YoY) vs $9.6M consensus, plus the first positive operating income and… Retail squeeze · Space economy catalyst · SBET SharpLink, Inc. LOW ETH broke $1,850–$1,950 to ~$2,280 on 2026-08-20 on a $1.9B short-liquidation cascade, carrying SBET to $7.91 with RSI 78.3 — despite a 2026-08-10 Q2 miss and a $394.3M net loss. What trades now is levered ETH beta into the 2026-09-15… Special situation · Crypto exchanges & financials catalyst · SEER Seer, Inc. LOW The take-private ladder has stalled into a stand-off: the $2.55 Radoff-JEC bid lapsed unanswered on 2026-08-10, and the group's 2026-08-13 release demanding the board disclose an evaluation timeline has drawn no company reply through the… Earnings inflection · M&A & special situations · Medtech & diagnostics analysed · SENS Senseonics Holdings, Inc. LOW Only year-long implantable CGM, clinically de-risked at ADA 2026 with revenue +71.9% YoY TTM — and the tape has spent six weeks grinding back toward the $4.79 post-catalyst low ($5.11 on Jul 17). Accelerating fundamentals against a broken… Defensive · Medtech & diagnostics analysed · SFIX Stitch Fix, Inc. LOW Turnaround intact on the income statement, inert on the tape: closes of $3.58 (2026-07-24) and $3.59 (2026-08-14) bracket three flat weeks on the $3.50 shelf, and the 2026-08-10 Form 144 shows a retiring officer selling ~70,000 sh weekly… Special situation · Consumer discretionary rotation · AI enterprise software analysed · SG Sweetgreen, Inc. LOW The turnaround narrative was retracted by management on 2026-08-06 and repriced by eight desks into a $5.00–$8.50 target band. What has run since — $6.28 on 2026-08-14 to $6.99 on 2026-08-21 — is a ~24.5%-shorted float drifting up in a… Retail squeeze · Consumer discretionary rotation · Squeeze & momentum setups catalyst · SGMT Sagimet Biosciences Inc. Series A LOW April denifanstat/acne breakout round-tripped to the $6.00 Series A offering floor; SGMT bases near $7 (last close $7.06, 2026-06-26) with no trend. Dermatology pivot (China NMPA acne NDA accepted Dec 2025, US IND due mid-2026) is real but… Defensive · Precision biotech & therapeutics analysed · SHOO Steven Madden, Ltd. LOW Tariff-recovery leg has stalled into a $39.71–$47.11 range with insiders selling every rally and zero buys; the whole story now hinges on the confirmed 2026-07-30 Q2 print. Consensus targets sit at or below spot ($43.75, 07-16), adjusted… Special situation · Consumer discretionary rotation · Freight & logistics catalyst · SIDU Sidus Space, Inc. LOW Q2 (2026-08-14) cleared the calendar: revenue $583,096, -54% YoY, against $166.5M cash and no term debt. The SpaceX-proxy leg died when SPCX listed 2026-06-12 and the 2026-06-26 Russell add faded; what remains is a cash-heavy micro-cap… Retail squeeze · Space economy catalyst · SITM SiTime Corporation LOW MEMS-timing picks-and-shovels story is fundamentally intact — Q1 datacenter revenue +158% YoY to 67% of sales, Renesas timing deal closed July 1 — but the momentum leg has broken: ~$550 on July 18 is ~39% off the May 11 all-time-high close… Cyclical recovery · AI datacenter infrastructure · Networking & optical analysed · SKM SK Telecom Co., Ltd. LOW Post-Q2 re-rating extended to a $40.29 close on 2026-08-21 with RSI(14) at 74.0, but the 2026-08-07 6-K stretched the funding-disclosure commitment from one month to three — the ~₩1T primary-increase question is now unresolved and undated… Special situation · AI datacenter infrastructure · Emerging markets catalyst · SLDB Solid Biosciences Inc. LOW Post-Sarepta DMD vacuum trade now in a waiting phase: the guided mid-2026 accelerated-approval update never landed — the 2026-08-06 Q2 release moved the FDA meeting to late Q4 2026 while INSPIRE dosing grew to 53 (as of 2026-08-04). Price… Earnings inflection · Rare disease & gene therapy · Binary-catalyst biotech analysed · SLS SELLAS Life Sciences Group, Inc. LOW Cancer-vaccine sector re-rate after Merck/Moderna's 2026-08-19 Phase 3 win carried SLS to a 52-week closing high of $15.46 on 2026-08-21 (+15.4% on the session, RSI 78.7) with no SELLAS data of its own; REGAL's last published count is… Retail squeeze · Oncology & immunology · Binary-catalyst biotech catalyst · SMCI Super Micro Computer, Inc. LOW Dilution leg has broken the story: the $7B raise cleared at $27.50 on June 11 and spot is $24.18, with a live $2B ATM as forward supply. DDR contract prices +32% QoQ crush a business guiding 8.2–8.4% gross margin. Falling knife under all… Retail squeeze · AI datacenter infrastructure · AI chips & memory catalyst · SMMT Summit Therapeutics Inc. LOW Two positive headlines on 2026-08-12 — Akeso's third China approval and a Leerink upgrade — left the stock lower: the 2026-08-21 close of $13.16 sits under the 2026-08-14 close and just above the $12.55 52-week low. The dated binary is the… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics catalyst · SMTC Semtech Corporation LOW The mix-purification leg has lost its price leg: the August bounce round-tripped from a $140.35 close on 2026-08-14 to $124.09 on 2026-08-21, under the 2026-07-17 flush close. The binary moved forward — Q2 FY27 prints 2026-08-25 after the… Cyclical recovery · Analog semiconductors · AI datacenter infrastructure catalyst · SMTI Sanara MedTech Inc. LOW Merger-arb instrument since MIMEDX's 2026-07-29 agreement ($33.00 cash + 0.4735 MDXG per share). The 2026-08-11 Form 425 disclosed a 2027-07-29 outside date, a $22.5M reverse termination fee and 38.9% voting lock-up; at the $34.45 close… Earnings inflection · Medtech & diagnostics · M&A & special situations analysed · SMWB Similarweb Ltd. fresh LOW Post-print repricing has stalled: the 2026-08-12 guidance raise and ~$60M of AI-licensing contract value are in the price, and Form 4 filings dated 2026-08-17 show the CEO selling 709,597 shares (~$6.25M) into it on 08-13/14. The $10.40… Special situation · AI enterprise software analysed · SNEX StoneX Group Inc. LOW The split-momentum leg is dead. SNEX round-tripped from a $139.01 all-time-high close (2026-06-18) to $102.99 on 2026-07-17 — down 12.5% in a week, 22.4% in a month — while insiders dumped $94.2M over three months with zero buys.… Special situation · Crypto exchanges & financials · Prediction markets & betting analysed · SOPH SOPHiA GENETICS SA fresh LOW Cloud-genomics platform narrative inflected on the 2026-08-04 Q2 print: net dollar retention 117% vs 107% YoY, FY26 guide raised to $94–96M, and a two-program AstraZeneca companion-diagnostics deal. Price has already run 77.3% in three… Theme leader · Medtech & diagnostics analysed · SPIR Spire Global, Inc. LOW The 2026-08-12 print removed the binary without restoring the base: revenue $18.048M just under $18.139M consensus, adj EPS $(0.31) a beat, FY26 revenue held at $75–85M with >85% of the midpoint contracted — but both EPS guides were cut… Defensive · Space economy catalyst · SPRY ARS Pharmaceuticals, Inc. LOW Single-product epinephrine name whose one catalyst — a July no-prior-auth formulary add for neffy — came and went unpaid; the stock has since broken its old $6.66 52-week low to fresh lows near $6. The neffy ramp is real but the access… Earnings inflection · Precision biotech & therapeutics · Space economy analysed · SPT Sprout Social, Inc LOW Margin-inflection re-rate on an 11%-growth social SaaS: the 2026-08-06 Q2 print lifted FY2026 non-GAAP EPS guidance to $1.11–1.15 from $0.88–0.97 while the revenue range barely moved, and three targets were raised inside a week. Shares are… Special situation · AI enterprise software analysed · SRAD Sportradar Group AG LOW Binary resolved against the bull leg: the 2026-08-03 Q2 print missed both lines, cut FY sales guidance to $1.765–1.782B, and put only "tens of millions" of euros of 2026 prediction-market revenue on the board — then Genius Sports signed… Cyclical recovery · Prediction markets & betting · AI datacenter infrastructure analysed · STAA STAAR Surgical Company LOW Structure broken, no dated catalyst before the ~2026-10-07 pre-release window. Earnings inflection · Medtech & diagnostics · Semi foundry & equipment analysed · STM STMicroelectronics N.V. LOW The June AI-data-center re-rating has failed its retest: $62.06 on 2026-07-17 is -22% from the 2026-06-22 high of $79.82 and back under the early-June breakout base, with a $1.5B convertible overhang and a 7% selloff that ignored a BofA… Earnings inflection · Analog semiconductors · AI datacenter infrastructure catalyst · STRL Sterling Infrastructure, Inc. LOW The prior $550 break condition landed: last close $516.81 on 2026-08-21, 48% under the 2026-06-04 high, RSI 32.3 — while Q2 (2026-08-03) delivered revenue $1,168.2M (+90% YoY) and a raised $19.70–20.30 adjusted EPS guide. Targets are… Cyclical recovery · AI datacenter infrastructure · Industrial power & grid analysed · STRO Sutro Biopharma, Inc. LOW Single-asset binary now inside its own catalyst window: the STRO-004 (DAR8 Tissue Factor exatecan ADC) Phase 1 readout was guided "mid-2026" and that window is expiring undated. Price has gone flat at ~$29.7 for four weeks after the June… Earnings inflection · Binary-catalyst biotech · Oncology & immunology analysed · STUB StubHub Holdings, Inc. LOW June's busted-IPO recovery leg has fully reversed. D.C.'s RESALE Act (10% resale-markup cap, effective 2027-01-01) plus a Texas AG probe into undelivered World Cup tickets broke the experience-economy narrative; at ~$8.60 STUB trades below… Special situation · Consumer discretionary rotation · Travel & leisure catalyst · SUPV Grupo Supervielle S.A. LOW Q2 beat, tape ignored it: adjusted EPS $0.29 vs $0.13 consensus on 2026-08-10, NIM +253bps to 20.3% — yet SUPV closed $8.05 on 2026-08-14 at RSI 24, with bank ADRs leading the Merval lower and country risk back to 479bps. The company… Compounder · Emerging markets catalyst · SVV Savers Value Village, Inc. LOW Busted-IPO thrift retailer's June recovery has stalled and rolled back toward its ~$9 base as the June 27 Russell-deletion passive-bid loss bites; the July 30 Q2 print is now an imminent, FX-exposed binary rather than a five-weeks-away… Defensive · Consumer discretionary rotation catalyst · SXC Suncoke Energy Inc LOW Coal-policy sympathy trade is fully dead: SXC has gone nowhere for three weeks, $8.39 on 2026-06-27 to $8.37 on 2026-07-17, pinned to the $8 shelf with no narrative velocity. The only live variable is the Q2 print, pulled forward to… Special situation · Cyclical industrials · Critical materials & rare earths catalyst · SYNA Synaptics Incorporated LOW Standalone story ended at the 2026-06-25 all-stock takeout; The week to 2026-08-21 proved it — ON -10.2%, SYNA -10.1%, discount still ~2.5% (1.350 x $74.21 = $100.18 vs $97.66). The S-4 filed 2026-08-21 puts the vote on the clock and… Earnings inflection · M&A & special situations · Analog semiconductors catalyst · TAL TAL Education Group LOW Legacy-pivot re-rating still intact on fundamentals — Q1 FY2027 revenue +31.9% to $758.4M with selling and marketing down 5% — but the post-print impulse has largely round-tripped: $12.16 on 2026-08-11 to $11.32 on 2026-08-21, RSI 37.2,… Special situation · Semi foundry & equipment · Cyclical industrials catalyst · TASK TaskUs, Inc. LOW Mix-shift re-rating: AI Services hit $66.1M (+25.8%) in Q2 CY2026 on 2026-08-05 — seventh straight quarter above 25% — and is guided above 30% YoY in Q4 on AV/robotics work, against a 25%-of-revenue Trust & Safety book the market assumes… Special situation · AI datacenter infrastructure · Physical AI & robotics analysed · TBI Trueblue, Inc. LOW Deep-cyclical industrial staffer re-rated +140% off the $3.18 low on a staffing-demand recovery and a data-center/energy labor boom lifting PeopleReady +19% YoY. Still loss-making (Q1 net -$19.8M), margins compressed, and the… Special situation · AI datacenter infrastructure · Industrial power & grid catalyst · TBRG TruBridge, Inc. LOW Closed and now formally deregistered: the IKS Health merger became effective 2026-07-09 at $26.25/share cash, Form 25 filed the same day, Form 15-12G on 2026-07-24. The adjusted series ends 2026-07-08 at $26.24. A screen still surfacing… Earnings inflection · M&A & special situations · Managed care & health services analysed · TDOC Teladoc Health, Inc. LOW The Walmart/insurance-pivot re-rating broke at the 2026-07-29 Q2 print: revenue -4% YoY, BetterHelp -12%, FY26 revenue guide cut ~5% at the midpoint. What remains is $774M cash and a maintained $130-170M FCF guide against a shrinking top… Special situation · Managed care & health services · Precision biotech & therapeutics analysed · TDUP ThredUp Inc. LOW Tariff/de-minimis "secondhand wins" narrative broke on the 2026-08-05 Q2 print: revenue beat at $90.8M but FY2026 guidance was cut to $344.4–348.4M and Q3/Q4 guided below consensus. Price round-tripped to $3.07 on 2026-08-14, -74.6% from… Retail squeeze · Consumer discretionary rotation · Cyclical industrials analysed · TECH Bio-Techne Corp LOW Closed merger-arb pinned $0.60 under Merck KGaA's $73.00 all-cash bid — 2026-08-14 close $72.40, also the 52-week high. Q4 printed 08-12 with no call and no FY27 guidance; Wells Fargo folded to a $73 target on 08-13. Coverage is fully… Earnings inflection · Medtech & diagnostics · Precision biotech & therapeutics analysed · TEM Tempus AI, Inc. fresh LOW Second-order re-rating: Merck/Moderna's 2026-08-19 Phase 3 INTerpath-001 win — the first positive readout for an individualised neoantigen therapy — repriced TEM as the listed owner of the MRD sequencing layer via its pending $1.5B… Cyclical recovery · Medtech & diagnostics analysed · TENB Tenable Holdings, Inc. LOW Q2 (2026-07-29) confirmed the AI-platform leg — revenue $268.5M +8.6%, Tenable One 50% of new business vs 41% in Q1, FY26 raised to $1.075–1.081B — but the sell-side cut into the beat (five PT cuts, Piper downgrade to $30) and a disclosed… Special situation · Cybersecurity · AI enterprise software analysed · TENX Tenax Therapeutics, Inc. LOW Phase 3 binary resolved negative: LEVEL missed its primary (6MWD +3.5m, p=0.63) and key secondary on 2026-08-10; four desks cut within 24h and the target band went from $27–$50 to $4–$5. Narrative is dead. What is left is a balance-sheet… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics catalyst · TER Teradyne, Inc. LOW Parabolic AI-test leg broke hard: $483.84 closing ATH (2026-06-30) to $322.36 (2026-07-17), −33% in twelve sessions on a memory-glut scare, with the whole $446–$550 analyst band now stranded above spot. Company guided Q2 revenue DOWN… Cyclical recovery · Semi foundry & equipment · AI chips & memory catalyst · TGTX TG Therapeutics, Inc. LOW The catalyst leg is spent; what is left is whether the $46–48 shelf holds through a two-month news vacuum into year-end subcutaneous Phase 3 topline. Compounder · Oncology & immunology · Precision biotech & therapeutics analysed · TH Target Hospitality Corp. LOW The AI-datacenter-landlord re-rate has stalled: TH peaked at $20.85 and has given back ~21% to $16.36 (2026-07-17) as TDR Capital affiliates distribute shares in-kind to partners, losing the $17 secondary clearing shelf while Oppenheimer… Special situation · AI datacenter infrastructure · Cyclical industrials analysed · THC Tenet Healthcare Corporation New LOW Hospital margin-expansion re-rating extended to a new 52-week high of $280.77 (2026-08-21), now above the $273.00 average sell-side target, while revision flow thinned to one new number since 2026-08-03 and six insiders sold into the move… Special situation · Managed care & health services catalyst · TIC TIC Solutions, Inc LOW Post-merger re-rate: engineering/geospatial backlog hit a record $1.18B (+20% YoY) on 2026-08-06 while legacy inspection fell ~5.5% combined, and UBS's 2026-08-11 upgrade (Buy, PT $12.50 from $11.00) prices an inflection that Q2's +2.5%… Special situation · M&A & special situations analysed · TLN Talen Energy Corporation LOW Contracted-floor re-rating has stopped paying: the 2026-08-05 Q2 raised FY26 Adj EBITDA guidance to $2,025–2,225M and PJM's 2028/29 auction cleared >10 GW at the $325/MW-day cap, yet the stock closed $347.71 on 2026-08-07, 22% below the… Theme leader · Industrial power & grid · AI datacenter infrastructure analysed · TLRY Tilray Brands, Inc. LOW Reform binary spent without resolving: the DEA hearing closed 2026-07-15 with only a 2026-08-17 briefing deadline and no ALJ timeline, so Schedule III is now an open-ended administrative process. TLRY printed a fresh 52-week low of $4.20… Earnings inflection · Cannabis reclassification · Bitcoin miners catalyst · TMC TMC the metals company Inc. LOW The deep-sea-mining reshoring leg is broken: TMC has cut through the $3.93 prior 52-week low to a fresh $3.57 low near $3.74, roughly -67% from the $11.35 high, with no bid and no near-term catalyst. The decisive NOAA license decision is… Earnings inflection · Critical materials & rare earths · Bitcoin miners catalyst · TNDM Tandem Diabetes Care, Inc. LOW Beaten-down insulin-pump turnaround; the whole re-rate hinges on the tubeless Mobi ("Toby") 510(k) — planned for a Q2 filing but still unconfirmed after the quarter closed 2026-06-30 — plus margins scaling toward a ~60% Q4 exit. Shares… Special situation · Medtech & diagnostics analysed · TORO Toro Corp. LOW Panagiotidis shipping shell (NOT lawnmower TTC) ran 1.93→8.50 on a sub-NAV/special-dividend story that is now fully paid out and closed. Six weeks of dead tape since the 2026-06-05 payout ($3.8M cash + 5,707,246 NEW shares); on a true… Retail squeeze · Freight & logistics · M&A & special situations catalyst · TRIP TripAdvisor, Inc. LOW Activist sum-of-the-parts leg broke: Q2 revenue $441.9M missed consensus $503.9M on 2026-08-06 (~-20% day), four targets cut to $9–$12.50 by 08-11, and the $11–13 base gave way to a $10.74 close on 2026-08-14 with RSI 25. What's left is an… Special situation · M&A & special situations · Travel & leisure analysed · TSAT Telesat Corporation Class A Common Shares and Class B Variable Voting Shares LOW Legacy GEO operator re-rating on a funded LEO pivot: 2026-08-04 C$2.3B, 15-year Canadian Arctic Mil-Ka contract expands Lightspeed 156→225 satellites and lifts the 2032 revenue target to US$4.9B from US$3.2B. Price closed at the 52-week… Special situation · Space economy · Defense & aerospace analysed · TSHA Taysha Gene Therapies, Inc. LOW Clinical binary printed clean (2026-06-22: 100% milestone response N=12, zero treatment-related SAEs) but the next catalyst slipped to H1 2027 — pivotal six-month interim AND FDA BLA-pathway feedback both guided to the first half of next… Earnings inflection · Rare disease & gene therapy · Precision biotech & therapeutics analysed · TXN Texas Instruments Incorporated LOW Beat-and-raise on 2026-07-22 ($5.46B, +23% YoY, EPS $2.14 vs $1.91) was sold, and three weeks later price is still flat — $279.58 on 2026-08-14, 15.4% under the $330.59 high, RSI 51.1. Fundamentals confirmed, price discovery stalled,… Theme leader · AI datacenter infrastructure · Analog semiconductors catalyst · UCTT Ultra Clean Holdings, Inc. LOW WFE upcycle intact fundamentally but the tape broke: -35% from the $142.59 all-time close (2026-06-30) back under the ~$95 breakout shelf on sector-wide selling with no company news. Failed breakout, no support to $80.55, binary Q2 print… Cyclical recovery · Semi foundry & equipment · Freight & logistics catalyst · UI Ubiquiti Inc. LOW Broken parabola gone flat: six weeks of $530–$570 chop after the May 8 print (GM 47.0%, rev +18.7%, but EPS $3.88 vs ~$4.42 whisper) with zero scheduled catalyst until the Q4 FY26 report on 2026-08-21. Fundamentals intact, tape dead,… Earnings inflection · Networking & optical · Squeeze & momentum setups catalyst · UNIT Uniti Group Inc. LOW Hyperscaler dark-fiber demand turned the post-Windstream deleveraging grind into a growth story (~$1.5B disclosed funnel, $68.7M of Q1 IRU revenue from one hyperscaler), but the June re-rate to ~$11 has stalled in a three-week range above… Special situation · AI datacenter infrastructure · Biofuels & low-carbon fuels analysed · USO United States Oil Fund, LP LOW Hormuz has been shut since late February and USO still closed 2026-08-14 at $126.60, 17.2% under its $152.96 high — the market has stopped paying for escalation. The 2026-08-12 EIA +17.423M bbl build and OPEC's demand-growth cut to 580K… Earnings inflection · Oil, energy & geopolitical · Freight & logistics catalyst · UTZ Utz Brands, Inc. LOW Event fired and fully priced: the 2026-08-14 close of $14.17 sits $0.08 under Intersnack's $14.25 all-cash offer, and the 2026-08-05 Q2 miss moved nothing. What remains is a sub-1% gross spread to a company-guided Q4 2026 close against a… Earnings inflection · Consumer discretionary rotation analysed · VECO Veeco Instruments Inc. LOW Merger-arb tracking stock for Axcelis: fixed 0.3575 ACLS/VECO, both votes cleared 2026-02-06, only China SAMR remains before the 2026-09-30 outside date. ACLS's slide to ~$134 de-pegged VECO to a premium over the exchange ratio (~$48) —… Earnings inflection · M&A & special situations · Semi foundry & equipment analysed · VERI Veritone, Inc. LOW Enterprise-AI growth story broken: FY2026 revenue guide cut ~23% at the midpoint to $100–115M on 2026-08-13 vs $135.032M consensus, ARR flat at $62.0M. What is left is a refinancing binary — $45.6M of 1.75% converts mature 2026-11-15… Earnings inflection · AI enterprise software · AI datacenter infrastructure analysed · VERU Veru Inc. LOW The Novo squeeze is fully round-tripped and the funding answer arrived on 2026-07-02: a $21.8M at-the-market program via Oppenheimer/Canaccord. At $2.42 (07-15) that is ~9M shares against ~16M outstanding — the company will now sell stock… Retail squeeze · Precision biotech & therapeutics · Small-cap value rotation analysed · VIA Via Transportation, Inc. fresh LOW Busted-IPO transit-software re-rating: the 2026-08-06 beat-and-raise (FY26 guide up to $550–553M, adj. EBITDA loss narrowed to $3.4M, Q4 positive-EBITDA goal reiterated) turned a chart 70% below its $46 IPO price into an +80.3% three-month… Defensive · EV & autonomous mobility analysed · VIAV Viavi Solutions Inc. fresh LOW Networking-optical test theme still accelerating and the laggard test-and-measurement sleeve is finally re-rating: Susquehanna lifted its target to $66 (2026-07-01) and the small-cap-over-hyperscaler rotation flagged 2026-06-29 favors… Cyclical recovery · Networking & optical catalyst · VICR Vicor Corporation LOW Operating numbers still inflecting (Q2 guide ~$142M, book-to-bill >2.0, backlog $300.6M) but the chart has broken: $237.62 on 2026-07-17 is ~38% off the $382.65 July high, with $271 and $300 both lost and relentless CEO 10b5-1 supply. The… Cyclical recovery · Industrial power & grid analysed · VIR Vir Biotechnology, Inc. LOW Q2 (2026-08-05) printed $238.9M revenue and $0.47 diluted EPS on Astellas upfront recognition — an accounting swing, and the tape read it as one: $9.24 on 2026-08-14, still under the $10.36 Astellas equity strike, with Morgan Stanley and… Earnings inflection · Binary-catalyst biotech · Oncology & immunology analysed · VKTX Viking Therapeutics, Inc. LOW The ~$34 line from July gave way — $33.19 close on 2026-08-14, -21.2% from the $42.13 high. Only company-guided 2026 event left is the VK2735 maintenance-dose readout (3Q26); pivotal VANQUISH topline is 2027. JPMorgan cut its target to $65… Earnings inflection · Precision biotech & therapeutics analysed · VMI Valmont Industries, Inc. LOW Beat-and-raise was sold: the 2026-07-21 Q2 beat ($6.14 vs $5.75) plus a raised FY26 guide gave way to a ~13% 30-day drawdown, and the $520 weekly shelf broke. Grid fundamentals intact, the re-rating leg unwinding, no base and no dated… Theme leader · Industrial power & grid analysed · VOR Vor Biopharma Inc. LOW Legacy-pivot re-rating held its breakout through the 2026-08-11 Q2 miss — $23.36 close on 2026-08-21 against $23.67 on 08-07 — but the same release disclosed $48.4M of ATM stock sold into July strength. With UPSTREAM MG topline guided… Special situation · Oncology & immunology · Semi foundry & equipment analysed · VPG Vishay Precision Group, Inc. LOW The AI-precision re-rate broke at the print: Q2 (2026-08-05) missed on revenue ($83.936M vs $84.646M) and adjusted EPS ($0.04 vs $0.19), Q3 guide midpoint sits below consensus, and the stock gapped -26.95% to $73.78 and has since made… Theme leader · Analog semiconductors · AI datacenter infrastructure analysed · VREX Varex Imaging Corporation fresh LOW Signed all-cash takeout: Teledyne agreed on 2026-08-10 to buy Varex at $18.90/share (~$1.1B). The 2026-08-14 close of $18.49 leaves roughly $0.41 of gross gap into a closing guided for early calendar 2027 with a 2027-05-10 outside date.… Earnings inflection · Medtech & diagnostics analysed · VRNS Varonis Systems, Inc. LOW Take-private leg is aging without confirmation: two months after the 2026-06-23 Bloomberg report there is no bidder, price or 13D, an unexplained 9.3% mid-August pop round-tripped inside six sessions, and the 2026-08-21 close of $41.23… Earnings inflection · Cybersecurity · AI datacenter infrastructure catalyst · VSH Vishay Intertechnology, Inc. LOW Cycle-turn re-rate has fully round-tripped: down ~46% from $69.47 to the high-$30s, now under the $50 June placement and below every covering analyst's target. Q1's 1.34 book-to-bill and $1.6B backlog were real but sit at ~35x forward into… Earnings inflection · Industrial power & grid catalyst · VSXY Victorias Secret & Co. LOW Turnaround re-accelerated with no new number: the July mid-$70s range broke, a $99.97 52-week high printed, then 11% came back into the 2026-09-03 Q2 report. Consensus target $91.40 sits ~3% over the $89.02 close on 2026-08-14, so the… Special situation · Consumer discretionary rotation catalyst · W Wayfair Inc. LOW Margin-inflection turnaround has stalled: after the June Evercore-driven pop, W has faded ~10% back to the ~$84–85 recovery base ahead of the binary Aug 4 Q2 print. Wedbush's Jul 16 Neutral/$104 initiation and a ~$100-capped consensus mark… Special situation · Consumer discretionary rotation · Housing, homebuilders & proptech analysed · WDAY Workday, Inc. LOW The 2026-08-27 Q2 FY27 print — cRPO against a guided 13.5–14.5% band — is the binary that lands first. Earnings inflection · AI enterprise software catalyst · WEAV Weave Communications, Inc. LOW Beaten-down vertical-SaaS front-office platform for healthcare SMBs, down ~36% YTD and basing off the $4.24 low, repositioning around AI-receptionist monetization (TrueLark, 2025). Still a ~17% grower with GAAP losses, so the re-rate is… Theme leader · AI enterprise software · AI datacenter infrastructure analysed · WGS GeneDx Holdings Corp. fresh LOW Busted-growth genomics name; the recovery off the −49% May guide-cut crash has stalled in the low-$60s, below the $74.83 200-day. The confirmed Aug 3 Q2 print (blended ARR vs the ~$3,300 baseline) is the binary — the same day as the… Earnings inflection · Medtech & diagnostics analysed · WHD Cactus, Inc. LOW International wellhead order narrative from the 2026-07-29 Q2 beat is intact, but the re-rating leg is largely spent: Citigroup cut to Neutral on 2026-08-20 while raising its target to $75, and the shares closed $69.43 on 2026-08-21, 5.8%… Cyclical recovery · Oil, energy & geopolitical · AI datacenter infrastructure catalyst · WING Wingstop Inc. LOW Two analyst target cuts in ten days (Wells Fargo to $170, DA Davidson to $200) into the 2026-07-29 Q2 print signal de-risking ahead of the H2 comp-turn binary; a ~50% relief bounce off the $116.35 low is unproven, and the print — not… Earnings inflection · Consumer discretionary rotation · Managed care & health services analysed · WK Workiva Inc. LOW Earnings-power re-rate: Q2 on 2026-08-04 hit a 16.8% non-GAAP operating margin — the 2027 target, a year early — and lifted the FY26 adjusted EPS guide from $2.85–2.95 to $3.38–3.39 on a revenue guide that barely moved. Activist Irenic's… Special situation · AI enterprise software catalyst · WLFC Willis Lease Finance Corporation LOW Engine-leasing supercycle still printing records (Q1 rev +23%, EPS $4.03 vs $3.02 est), but the theme is maturing and the stock has faded ~18% off its 2026-07-06 ATH into the now-completed 3-for-1 split. The event stack has collapsed to… Cyclical recovery · Space economy · Small-cap value rotation catalyst · WPP WPP PLC LOW Post-relegation turnaround leg is now being re-rated by the sell side rather than by news: Citigroup lifted its target GBX 285→430 on 2026-08-10 while staying Neutral, and the 2026-08-06 results gap has held with the 2026-08-21 close at… Special situation · Consumer discretionary rotation · AI enterprise software catalyst · WRLD World Acceptance Corporation LOW Post-print leg has cooled, not extended: the 2026-07-24 gap ran ~$181 to ~$208 but the 2026-08-14 close of $194.75 gives back half of it, RSI 48.9, -13.0% from the $223.83 high. The 2026-08-13 $50M buyback authorization is inclusive of… Special situation · Fintech & consumer credit · Small-cap value rotation analysed · WSC WillScot Holdings Corporation LOW Cyclical modular-space leasing recovery with a small data-center kicker and an activist/M&A floor, but range-bound and digesting: shares drifted to ~$26 under the $31.88 high after the 2026-06-27 Russell growth-index removal. The confirmed… Theme leader · AI datacenter infrastructure · Industrial power & grid analysed · WSM Williams-Sonoma, Inc. LOW Sell-side re-rating leg: six price-target raises between 2026-08-04 and 2026-08-14 (Goldman $261, RBC $192→$260, Telsey $255, Citi $248, two at $240) took WSM to a 52-week high of $251.78 on multiple expansion — RBC moved to 25x from 20x… Defensive · Consumer discretionary rotation · Freight & logistics catalyst · XENE Xenon Pharmaceuticals Inc. LOW Q2 (2026-08-06) cleared the last procedural gate — FDA pre-NDA meeting completed, azetukalner FOS NDA still guided to Q3 2026, cash $1,245.1M — and the stock still closed 2026-08-14 at $62.35, 12.1% below the $70.96 July high with RSI… Earnings inflection · Precision biotech & therapeutics · Binary-catalyst biotech analysed · XGN Exagen Inc. LOW Autoimmune-diagnostics re-rating on the 2026-08-04 Q2 print: revenue $19.941M vs $17.817M consensus, FY26 guide lifted to $72–75M, adjusted EBITDA loss down to $0.1M. Price ran from a $4.68 pre-print close to $7.92 on 2026-08-21 with… Defensive · Medtech & diagnostics analysed · XHG XChange TEC.INC LOW Sub-$1 China insurance ADS re-rated ~4x in two sessions on a 2026-08-13 non-binding LOI to acquire HK AI insurtech First Cycle — terms undisclosed, subject to definitive agreements. The leg being bought is an AI-insurance pivot; the FY2025… Retail squeeze · M&A & special situations analysed · XOS Xos, Inc. LOW First-ever U.S. Air Force award (prototype OTA for the Xos Hub mobile BESS, announced 2026-08-17, terms not disclosed) took the stock ~100% on 2026-08-18 and put a defense-pivot narrative on a going-concern EV maker that just missed Q2… Retail squeeze · Defense & aerospace · EV & autonomous mobility analysed · XRAY DENTSPLY SIRONA Inc. LOW Stock faded from $13.78 pre-print to $11.59 on 2026-08-14 — the narrative leg came and went, and the $11–12 shelf is what remains. Special situation · Medtech & diagnostics · Semi foundry & equipment catalyst · XRX Xerox Holdings Corporation LOW Distressed-deleveraging special situation that round-tripped its June activist pop into a binary 2026-07-30 Q2 print. At ~$2.60 it sits below the $2.75 Hold consensus and inside the $2.25–$2.50 target band; anchor buyer STARTEEPO (8.8M sh,… Special situation · M&A & special situations · Cyclical industrials analysed · XTLB XTL Biopharmaceuticals Ltd. LOW Delisting binary fully resolved — Nasdaq confirmed compliance 2026-07-20 — and the pivot pop has bled off: no dated company release since, ADS $2.94 (2026-07-25) → $2.79 (2026-08-14), RSI 44.4. Event narrative is saturated; the next leg… Special situation · Precision biotech & therapeutics · M&A & special situations analysed · XXI Twenty One Capital, Inc. LOW The one re-rate catalyst just died: Tether's Strike–Elektron three-way merger was scrapped on 2026-07-21 and CEO Jack Mallers quit, dropping XXI to a fresh all-time low near $4.46. A leveraged-Bitcoin-treasury proxy stuck below 1.0x float… Compounder · Crypto exchanges & financials analysed · YAAS Youxin Technology Ltd LOW July's re-ignition failed: the 2026-07-14 RiverBit term sheet and 2026-07-15 Guangzhou AI agreement produced no higher low, and the response was a second reverse split (1-for-5, effective 2026-07-30). Two splits inside ten months now… Retail squeeze · Semi foundry & equipment · Crypto exchanges & financials analysed · YEXT Yext, Inc. LOW Legacy presence-management vendor repositioning into answer-engine optimization; the recovery extended to $6.35 (2026-08-21), up 72.6% in three months with RSI(14) 69.6, on no operating datapoint newer than the 2026-06-02 Q1 print. On… Special situation · AI enterprise software · Cyclical industrials catalyst · YSS York Space Systems Inc. LOW Roll-up/defense-growth leg is broken: the 2026-08-13 FY26 guide cut to $375–405M from $545–595M (vs $560.341M consensus) is the first company-sourced confirmation the revenue base moved. Close $10.93 on 2026-08-14, -54.5% over 3m, RSI… Earnings inflection · Space economy analysed · ZBRA Zebra Technologies Corporation LOW The post-print re-rating has stopped extending: after the 2026-08-04 guidance raise (adj EPS $6.35 vs $4.36; FY26 EPS to $20.75–$21.25) the shares topped at $383.06 and closed 2026-08-21 at $368.51 with RSI(14) 76.4, two open-market… Theme leader · AI enterprise software · Physical AI & robotics analysed · ZENA ZenaTech, Inc. LOW Section 232 drone tariffs signed 2026-08-13 and effective 2026-09-03 re-rated the UAS cohort; ZENA is the sub-$3, issuance-funded expression, closing 2026-08-14 at $2.14 with RSI(14) 84.7 and still 68.0% under the $6.69 52-week high.… Retail squeeze · Defense & aerospace · Cyclical industrials catalyst · ZS Zscaler, Inc. LOW Post-crash recovery leg is complete: the 2026-05-27 gap-down (~31.5% on a 16–17% FY27 growth frame) has been fully retraced to $181.75 (2026-08-21) with RSI 71.5, and six houses marked targets to $200–225 between 08-17 and 08-21 on no new… Earnings inflection · Cybersecurity · AI datacenter infrastructure catalyst · ZVRA Zevra Therapeutics, Inc. LOW The June patent re-rating fully reversed: EMA's CHMP issued a negative opinion on arimoclomol's EU application 2026-07-24 (efficacy not proven), and ZVRA gapped ~24% to the high-$9s, cutting through the $11.50 base. EU expansion is now… Earnings inflection · Rare disease & gene therapy · Binary-catalyst biotech analysed ·